<!DOCTYPE html> <html class=pb-page data-request-id=74cfa989-cde0-4f3d-bcec-5e2f117835c3 style lang=en><!--
 Page saved with SingleFile 
 url: https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.13477 
 saved date: Sun Nov 27 2022 00:14:23 GMT-0500 (Eastern Standard Time)
--><head data-pb-dropzone=head><meta charset=utf-8><style>:root{--sf-img-27: url("data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCI+PHBhdGggZD0iTTcuNDA2IDcuODI4TDEyIDEyLjQyMmw0LjU5NC00LjU5NEwxOCA5LjIzNGwtNiA2LTYtNnoiIGZpbGw9IiNmZmYiIHN0cm9rZT0iI2ZmZiIvPjwvc3ZnPg==")}<!---->.osano-cm-window{-webkit-font-smoothing:antialiased;-moz-osx-font-smoothingz:auto;--fade-transition-time:700ms;display:block;font-family:Helvetica,Arial,Hiragino Sans GB,STXihei,Microsoft YaHei,WenQuanYi Micro Hei,Hind,MS Gothic,Apple SD Gothic Neo,NanumBarunGothic,sans-serif;font-size:16px;left:0;line-height:1;position:absolute;top:0;width:100%;z-index:2147483638}.osano-cm-close{stroke-width:1px;border-radius:50%;border-style:solid;border-width:2px;box-sizing:initial;cursor:pointer;height:20px;margin:.5em;min-height:20px;min-width:20px;order:0;outline:none;overflow:hidden;padding:0;text-decoration:none;transform:rotate(0deg);transition-duration:.2s;transition-property:transform,color,background-color,stroke,stroke-width;transition-timing-function:ease-out;width:20px;z-index:2}.osano-cm-close:focus,.osano-cm-close:hover{stroke-width:2px;transform:rotate(90deg)}.osano-cm-link{cursor:pointer;text-decoration:underline;transition-duration:.2s;transition-property:color;transition-timing-function:ease-out}.osano-cm-link:active,.osano-cm-link:hover{outline:none}.osano-cm-link:focus{font-weight:700;outline:none}.osano-cm-dialog{align-items:center;font-size:1em;line-height:1.25;overflow:auto;padding:1.5em;position:fixed;transition-duration:.7s,0ms;transition-property:opacity,visibility;z-index:2147483637}.osano-cm-dialog--hidden{opacity:0;transition-delay:0ms,.7s;visibility:hidden}.osano-cm-dialog--type_bar{box-sizing:border-box;display:flex;flex-direction:column;left:0;right:0}@media screen and (min-width:768px){.osano-cm-dialog--type_bar{flex-direction:row}}.osano-cm-dialog--type_bar .osano-cm-dialog__content{flex:5;margin-bottom:.25em;width:100%}@media screen and (min-width:768px){.osano-cm-dialog--type_bar .osano-cm-dialog__content{max-height:30vh}}.osano-cm-dialog--type_bar.osano-cm-dialog--position_bottom{bottom:0}.osano-cm-content__message{margin-bottom:1em;padding-bottom:1.5em;word-break:break-word}.osano-cm-storage-policy{display:inline-block}.osano-cm-info-dialog{height:100vh;left:0;position:fixed;top:0;transition-duration:.2s,0ms;transition-property:opacity,visibility;width:100vw;z-index:2147483638}.osano-cm-info-dialog--hidden{opacity:0;transition-delay:0ms,.2s;visibility:hidden}.osano-cm-info{-webkit-animation:delay-overflow .4s;animation:delay-overflow .4s;bottom:0;box-shadow:0 0 2px 2px #ccc;box-sizing:border-box;max-width:20em;overflow-x:visible;overflow-y:visible;position:fixed;top:0;transition-duration:.4s;transition-property:transform;width:100%}.osano-cm-info--position_left{left:0;transform:translate(-100%)}.osano-cm-info-views{align-items:flex-start;display:flex;flex-direction:row;flex-wrap:nowrap;height:100%;transition-duration:.4s;transition-property:transform;width:100%}.osano-cm-header{position:-webkit-sticky;position:sticky;top:0;z-index:1}.osano-cm-info-dialog-header{align-items:center;display:flex;flex-direction:row-reverse;left:auto;min-height:3.25em;position:-webkit-sticky;position:sticky;top:0;width:100%;z-index:1}.osano-cm-info-dialog-header__header{align-items:center;display:flex;flex:1 1 auto;font-size:1em;justify-content:flex-start;margin:0;order:1;padding:1em .75em}.osano-cm-info-dialog-header__close{position:relative}@-webkit-keyframes delay-overflow{0%{overflow-x:hidden;overflow-y:auto}}@keyframes delay-overflow{0%{overflow-x:hidden;overflow-y:auto}}@-webkit-keyframes osano-load-scale{0%{transform:translateY(-50%) scale(0)}to{opacity:0;transform:translateY(-50%) scale(1)}}@keyframes osano-load-scale{0%{transform:translateY(-50%) scale(0)}to{opacity:0;transform:translateY(-50%) scale(1)}}.osano-cm-window{direction:ltr;text-align:left}.osano-cm-dialog{background:#edeff5;color:#838391}.osano-cm-info-dialog{background:rgba(0,0,0,0.45)}.osano-cm-header,.osano-cm-info-dialog-header{background:linear-gradient(180deg,#fff 2.5em,rgba(255,255,255,0) 100%)}.osano-cm-info{background:#fff;color:#000}.osano-cm-close{background-color:transparent;border-color:transparent}.osano-cm-info-dialog-header__close{color:#000;stroke:#000}.osano-cm-info-dialog-header__close:focus{background-color:#000;border-color:#000;stroke:#fff}.osano-cm-info-dialog-header__close:hover{stroke:#141414}.osano-cm-info-dialog-header__close:focus:hover{stroke:#ebebeb}.osano-cm-link{color:#29246a}.osano-cm-link:hover,.osano-cm-link:active{color:#29246a}.osano-cm-link:focus{color:#3d387e}<!----></style><meta http-equiv=X-UA-Compatible content="IE=edge"><meta name=pbContext content=";requestedJournal:journal:14631326;issue:issue:doi\:10.1111/dom.2019.21.issue-1;page:string:Article/Chapter View;article:article:doi\:10.1111/dom.13477;ctype:string:Journal Content;journal:journal:14631326;website:website:dom-pubs;wgroup:string:Publication Websites;pageGroup:string:Publication Pages;subPage:string:Full Text"><meta name=robots content=noarchive><meta property=og:title content="Cardiovascular outcomes of sodium glucose cotransporter‐2 inhibitors in patients with type 2 diabetes"><meta property=og:type content=Article><meta property=og:url content=https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.13477><meta property=og:image content="https://dom-pubs.onlinelibrary.wiley.com/cms/asset/5eea22fd-029f-4590-bfdd-c6cfa1636bd6/dom.2019.21.issue-1.cover.jpg?trick=1669525890580"><meta property=twitter:image content="https://dom-pubs.onlinelibrary.wiley.com/cms/asset/5eea22fd-029f-4590-bfdd-c6cfa1636bd6/dom.2019.21.issue-1.cover.jpg?trick=1669525890580"><meta property=og:site_name content="Diabetes, Obesity and Metabolism"><meta property=og:description content="
Aims
To determine the association between cardiovascular diseases (CVD) and SGLT2 inhibitors compared to sulfonylureas and dipeptidyl peptidase-4 (DPP4) inhibitors and to examine within-class effect..."><meta name=viewport content="width=device-width,initial-scale=1"><meta name=citation_doi content=10.1111/dom.13477><meta name=dc.identifier content=10.1111/dom.13477><meta name=citation_journal_title content="Diabetes, Obesity and Metabolism"><meta name=citation_title content="Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes"><meta name=citation_keywords content="antidiabetic drug"><meta name=citation_keywords content="cardiovascular disease"><meta name=citation_keywords content="SGLT2 inhibitor"><meta name=citation_volume content=21><meta name=citation_issue content=1><meta name=citation_firstpage content=28><meta name=citation_lastpage content=36><meta name=citation_publication_date content=2019/01/01><meta name=citation_online_date content=2018/08/16><meta name=citation_issn content=1463-1326><meta name=citation_language content=en><meta name=citation_author content="Ghadeer K. Dawwas"><meta name=citation_author_institution content="Department of Pharmaceutical Outcomes and Policy College of Pharmacy, University of Florida Gainesville Florida"><meta name=citation_author content="Steven M. Smith"><meta name=citation_author_institution content="Department of Pharmacotherapy and Translational Research College of Pharmacy, University of Florida Gainesville Florida"><meta name=citation_author_institution content="Department of Community Health and Family Medicine College of Medicine, University of Florida Gainesville Florida"><meta name=citation_author content="Haesuk Park"><meta name=citation_author_institution content="Department of Pharmaceutical Outcomes and Policy College of Pharmacy, University of Florida Gainesville Florida"><meta name=citation_abstract_html_url content=https://onlinelibrary.wiley.com/doi/abs/10.1111/dom.13477><meta name=citation_fulltext_html_url content=https://onlinelibrary.wiley.com/doi/full/10.1111/dom.13477><meta name=citation_pdf_url content=https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13477><meta name=citation_publisher content="John Wiley &amp; Sons, Ltd"><meta name=article_references content="
 Dawwas, GK,  Smith, SM,  Park, H.  Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes. Diabetes Obes Metab.  2019; 21: 28– 36. https://doi.org/10.1111/dom.13477
"><meta name=Description content="Aims To determine the association between cardiovascular diseases (CVD) and SGLT2 inhibitors compared to sulfonylureas and dipeptidyl peptidase-4 (DPP4) inhibitors and to examine within-class effec..."><title>Cardiovascular outcomes of sodium glucose cotransporter‐2 inhibitors in patients with type 2 diabetes - Dawwas - 2019 - Diabetes, Obesity and Metabolism - Wiley Online Library</title><meta name=referrer content=origin-when-cross-origin><meta name=google-site-verification content=ffz4i4DxIJCdGpRXe0XN6KG6o4FYI-nnFW9I_dg8piM><meta http-equiv=origin-trial content=A751Xsk4ZW3DVQ8WZng2Dk5s3YzAyqncTzgv+VaE6wavgTY0QHkDvUTET1o7HanhuJO8lgv1Vvc88Ij78W1FIAAAAAB7eyJvcmlnaW4iOiJodHRwczovL3d3dy5nb29nbGV0YWdtYW5hZ2VyLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1RoaXJkUGFydHkiOnRydWV9><meta http-equiv=origin-trial content=A751Xsk4ZW3DVQ8WZng2Dk5s3YzAyqncTzgv+VaE6wavgTY0QHkDvUTET1o7HanhuJO8lgv1Vvc88Ij78W1FIAAAAAB7eyJvcmlnaW4iOiJodHRwczovL3d3dy5nb29nbGV0YWdtYW5hZ2VyLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1RoaXJkUGFydHkiOnRydWV9><meta http-equiv=origin-trial content="Az6AfRvI8mo7yiW5fLfj04W21t0ig6aMsGYpIqMTaX60H+b0DkO1uDr+7BrzMcimWzv/X7SXR8jI+uvbV0IJlwYAAACFeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A+USTya+tNvDPaxUgJooz+LaVk5hPoAxpLvSxjogX4Mk8awCTQ9iop6zJ9d5ldgU7WmHqBlnQB41LHHRFxoaBwoAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><meta http-equiv=origin-trial content="A7FovoGr67TUBYbnY+Z0IKoJbbmRmB8fCyirUGHavNDtD91CiGyHHSA2hDG9r9T3NjUKFi6egL3RbgTwhhcVDwUAAACLeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXRhZ3NlcnZpY2VzLmNvbTo0NDMiLCJmZWF0dXJlIjoiUHJpdmFjeVNhbmRib3hBZHNBUElzIiwiZXhwaXJ5IjoxNjgwNjUyNzk5LCJpc1N1YmRvbWFpbiI6dHJ1ZSwiaXNUaGlyZFBhcnR5Ijp0cnVlfQ=="><link rel="shortcut icon" href="data:image/x-icon;base64,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"><style>.sf-hidden{display:none!important}</style><link rel=canonical href=https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.13477><meta http-equiv=content-security-policy content="default-src 'none'; font-src 'self' data:; img-src 'self' data:; style-src 'unsafe-inline'; media-src 'self' data:; script-src 'unsafe-inline' data:;"><style>img[src="data:,"],source[src="data:,"]{display:none!important}</style><body class=pb-ui>
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 <style>@-webkit-keyframes dual-ring{0%{-webkit-transform:rotate(0deg);transform:rotate(0deg)}100%{-webkit-transform:rotate(360deg);transform:rotate(360deg)}}@keyframes dual-ring{0%{-webkit-transform:rotate(0deg);transform:rotate(0deg)}100%{-webkit-transform:rotate(360deg);transform:rotate(360deg)}}</style>
 
<style>/*! font-weight: bold; *//*! padding: 10px 10px; */</style>
<style>/*! normalize.css v5.0.0 | MIT License | github.com/necolas/normalize.css */html{font-family:sans-serif;line-height:1.25;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}article,aside,footer,header,nav,section{display:block}main{display:block}a{background-color:transparent;-webkit-text-decoration-skip:objects}a:active,a:hover{outline-width:0}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;vertical-align:baseline}sup{top:-.5em}img{border-style:none}svg:not(:root){overflow:hidden}button,input,select{font-family:sans-serif;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=submit],button{-webkit-appearance:button}[type=button]::-moz-focus-inner,[type=reset]::-moz-focus-inner,[type=submit]::-moz-focus-inner,button::-moz-focus-inner{border-style:none;padding:0}[type=button]:-moz-focusring,[type=reset]:-moz-focusring,[type=submit]:-moz-focusring,button:-moz-focusring{outline:1px dotted ButtonText}[type=search]{-webkit-appearance:textfield;outline-offset:-2px}[type=search]::-webkit-search-cancel-button,[type=search]::-webkit-search-decoration{-webkit-appearance:none}::-webkit-file-upload-button{-webkit-appearance:button;font:inherit}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.container:after,.container:before{content:" ";display:table}.container:after{clear:both}@media (min-width:532px){.container{width:100%}}@media (min-width:768px){.container{width:736px}}@media (min-width:992px){.container{width:960px}}@media (min-width:1200px){.container{width:1080px}}.row{margin-left:-15px;margin-right:-15px}.row:after,.row:before{content:" ";display:table}.row:after{clear:both}*,:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}.col-lg-4,.col-lg-8,.col-md-3,.col-md-4,.col-md-12{position:relative;min-height:.0625rem;padding-right:15px;padding-left:15px}@media (min-width:768px){.col-sm-4,.col-sm-12{float:left}.col-sm-4{width:33.33333%}.col-sm-12{width:100%}}@media (min-width:992px){.col-md-3,.col-md-4,.col-md-8,.col-md-12{float:left}.col-md-3{width:25%}.col-md-4{width:33.33333%}.col-md-8{width:66.66667%}.col-md-12{width:100%}}@media (min-width:1200px){.col-lg-4,.col-lg-8{float:left}.col-lg-4{width:33.33333%}.col-lg-8{width:66.66667%}}.alert__format:after,.alert__format:before,.border-top:after,.border-top:before,.citationFormats .form-footer:after,.citationFormats .form-footer:before,.clearfix:after,.clearfix:before,.loi:after,.loi:before,.notified-group .radio--primary:after,.notified-group .radio--primary:before,.personal-information:after,.personal-information:before,.printMailing .checkbox--primary:after,.printMailing .checkbox--primary:before,.scroll-target-wrapper:after,.scroll-target-wrapper:before,.section__separator:after,.section__separator:before,.subjects-container .accordion-tabbed__content:after,.subjects-container .accordion-tabbed__content:before,.terms-of-use .checkbox--primary:after,.terms-of-use .checkbox--primary:before,.toc-item__footer:after,.toc-item__footer:before,.toc__latest-issue:after,.toc__latest-issue:before{content:" ";display:table}.alert__format:after,.border-top:after,.citationFormats .form-footer:after,.clearfix:after,.loi:after,.notified-group .radio--primary:after,.personal-information:after,.printMailing .checkbox--primary:after,.scroll-target-wrapper:after,.section__separator:after,.subjects-container .accordion-tabbed__content:after,.terms-of-use .checkbox--primary:after,.toc-item__footer:after,.toc__latest-issue:after{clear:both}.pull-left{float:left}.pull-right{float:right}@media (min-width:992px){.visible-lg{display:block!important}}.hidden-xs{display:block}@media (max-width:531px){.hidden-xs{display:none!important}}@media (min-width:532px) and (max-width:767px){.hidden-sm{display:none!important}}.hidden-md{display:block}@media (min-width:768px) and (max-width:991px){.hidden-md{display:none!important}}.hiddenLabel{position:absolute;top:-624.9375rem;left:-624.9375rem}[class*=grid-]:not([class*=item]):not([class^=icon-]):after,[class*=grid-]:not([class*=item]):not([class^=icon-]):before{content:" ";display:table;clear:both}.grid-item{width:100%}body{background:#fff;line-height:1.4;min-height:100vh}a{cursor:pointer}a,a:focus,a:hover{color:inherit;text-decoration:none}a:focus,a:hover{outline:0}a i[class*=icon-]:before{display:inline-block}img{max-width:100%}i[class*=icon-]{transition:transform .5s}.fixed-element{position:sticky;z-index:5}.fixed-element:after,.fixed-element:before{content:"";display:table}.pb-ad{display:none;height:0}@media (min-width:992px){.pb-ad{display:table;height:auto;margin-left:auto;margin-right:auto}}.sr-only{position:absolute;width:.0625rem;height:.0625rem;padding:0;overflow:hidden;clip:rect(0,0,0,0);white-space:nowrap;border:0}[role=button]{cursor:pointer}h1,h2,h3{margin-top:0;margin-bottom:.9375rem}h2{font-size:1.375rem}h3{font-size:1.25rem}.rlist{list-style:none;padding:0;margin:0}.rlist--inline{list-style:none;padding:0;margin:0}.loa{margin:0 0 .625rem}.btn,button{display:inline-block;border:none;text-align:center;font-size:1rem;background:#a1a1a1;font-weight:700;transition:all .25s;font-family:Open Sans,icomoon,sans-serif;line-height:1rem}.billingBtn .disabled.payPallBtn,.billingBtn .payPallBtn:disabled,.billingBtn .payPallBtn[disabled],.btn.disabled,.btn:disabled,.btn[disabled],.button.disabled,.button:disabled,.button[disabled],[type=button].disabled,[type=button]:disabled,[type=button][disabled],[type=submit].disabled,[type=submit]:disabled,[type=submit][disabled],button.disabled,button:disabled,button[disabled]{opacity:.4}.billingBtn .disabled.payPallBtn:focus,.billingBtn .disabled.payPallBtn:hover,.billingBtn .payPallBtn:disabled:focus,.billingBtn .payPallBtn:disabled:hover,.billingBtn .payPallBtn[disabled]:focus,.billingBtn .payPallBtn[disabled]:hover,.btn.disabled:focus,.btn.disabled:hover,.btn:disabled:focus,.btn:disabled:hover,.btn[disabled]:focus,.btn[disabled]:hover,.button.disabled:focus,.button.disabled:hover,.button:disabled:focus,.button:disabled:hover,.button[disabled]:focus,.button[disabled]:hover,[type=button].disabled:focus,[type=button].disabled:hover,[type=button]:disabled:focus,[type=button]:disabled:hover,[type=button][disabled]:focus,[type=button][disabled]:hover,[type=submit].disabled:focus,[type=submit].disabled:hover,[type=submit]:disabled:focus,[type=submit]:disabled:hover,[type=submit][disabled]:focus,[type=submit][disabled]:hover,button.disabled:focus,button.disabled:hover,button:disabled:focus,button:disabled:hover,button[disabled]:focus,button[disabled]:hover{background:#b0b0b0;color:#fff}.billingBtn .payPallBtn:active,.billingBtn .payPallBtn:focus,.billingBtn .payPallBtn:hover,.btn:active,.btn:focus,.btn:hover,.button:active,.button:focus,.button:hover,[type=button]:active,[type=button]:focus,[type=button]:hover,[type=submit]:active,[type=submit]:focus,[type=submit]:hover,button:active,button:focus,button:hover{cursor:pointer;background:#bdbdbd;color:#fff}input,select{border:1px solid #767676;background:inherit;width:100%;font-size:.9375rem;margin-bottom:1.25rem;line-height:1rem}select{max-height:2.75rem}label{display:block;float:none;margin-bottom:.8125rem}.input-group span{line-height:1rem}input::-webkit-inner-spin-button,input::-webkit-outer-spin-button{-webkit-appearance:none;appearance:none;margin:0}.mb-3{margin-bottom:1rem!important}@font-face{font-family:Open Sans;font-style:normal;font-weight:300;src:url(data:text/plain;base64,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)format("woff2");unicode-range:u+000-5ff}@font-face{font-family:Open Sans;font-style:normal;font-weight:600;src:url(data:text/plain;base64,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)format("woff2");unicode-range:u+000-5ff}@font-face{font-family:Open Sans;font-style:normal;font-weight:700;src:url(data:text/plain;base64,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)format("woff2");unicode-range:u+000-5ff}@font-face{font-family:Open Sans;font-style:italic;font-weight:400;src:url(data:text/plain;base64,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)format("woff2");unicode-range:u+000-5ff}@font-face{font-family:Open Sans;font-style:normal;font-weight:400;src:url(data:text/plain;base64,d09GMgABAAAAADKsABIAAAAAZIgAADJEAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGoEYGyAcgiYGYD9TVEFUXgCCDgiBfAmfFBEQCoGGUPZjC4QEAAE2AiQDiAQEIAWEeAcgDIUfG2FZFexYj3gcgExuaqOoEp0wiro4SD0q+v/rgRwjtkEHov9WMUZQpQLACDDUq332aJadZ6kN42DTXiJEhBAhIkQE0cueivoVGkOFP5VeHSwdah3fmR2WNYmxWwhKZeteW2uC7/QvQ3L7NTKX5E+HPtYN/ZnJnHB0g6uq8J+oNG9wBo7zUXOHYJsdSDhURMVoMLJRVEIQKxCwAiMxctrYgbnpdOJcutRV1m8/ef75/fH/Y+6z9rnvfSYjg64QM9gY1ZycwPh/yHIF9/Z7bZXqJexDgwylV6FmLgbuATIMW+o1SEP3LjJxiOUs+TL2hqbYft+tzbbnxw2y0ws0xFzn70yXRtktmJaKc9ZdaDt1hZhmeGCf71SwzPVvZC/qC1gplPN4AbAsd+9+evfqkvKISBIG3iaRXPvPuWk0ZnIqNIL7pvrNljpbpF1JtmT3xEn/ztWOWydw6DUD/BuAB/CHOQzu3f47NQk+xRKfcpmy7tg4pXWwFnjZ4G6rtdr+Vff53oshdCqST6ldhslSjikHTE2BUhy7bE23U9flD2MGnarEEAIMGrCDZfBYhOAgZ0yUrq/Hmetr3yP7+HoZH2eTGha0ZTRmctaHls9X0+xa3aW2ekB+UWRN4GTNTBLNAr87kg7X7F4uXb+7uruquqx2y55RSzYPWUuSIaYFU/IUYr+c8vYEeAQagoSX8Qh4BDriwDl5ATSxDYDKGjz6dNsv8qNW0PDR1CXWIL8ewG8XOJhGP4ZqiZJ36jIfqOjOHfzT+ItGx61qtxJEIhKETKH394Z6/eOS8O5rHzMWVXUq5nv2lNcwt2HWHL4v+0VVREREVO3hsvMBBBRaIqr95TIsUUHQljxEYB4iyIF8iHARCXmI6DxEbB4izoE8x778cWfyV93M33Yv/8DT/HPv8p99Ed8gD/HjQIj//A/yXhEAYHYFCDAbDUUcyLzEKaeRGEAUbHh7lqcmsMMMjBfStZoBdsvtrFRAv9FQGt1kg5OfKODqQm4qYFzP5aTA1Tdw4rgLbmHmpIPQFnXmwyIpekRFKISCo1DBkh8V7NwTiTiMc6kknMjz3INx2BdRyTipoELBrNmnXQcJiw786JdPfqM3j/fZf77446u/vvm/Z7hV87AgFlSImNUwLVo99yJ9YJp0+Qp+EqJs2fFHwhRn3ARYPZU2cAB+cJ0HQH8UQuHRFq1dEo6CoTKAyv7YfM6n+kA2Aqbfsc3/zwCiozUCkBcBAGBndCEAcGAgrUJCCnu7mBHo/dfkJEIgQP71iTmoIP/86DQQFVAI0jR6thKanbEBILKdTOVJSr23N6DjuwGyHocCjSvIIw/zn7Jp/VdBLmahhRlWytKesSzlfT5lG6qbbQvbPWrHq9WoDat9Xf/e4nCTuGncPF5mevWfQEAOCiNxYbeVRrOYN4X/mkKJ2nFq5fkv62/GhDFHVpbNg6fFNJtV5ielNu2n0fhvfPutAf8+HO3f3HjSfXk+WXkcHr95tHAYfFUCD9/vx+bJm4GjMZGvN5fe9p33Pvi5Yon1d8mBFysiLLD9i/ztMTnktv/xQtZf/isAZszpvvIClWIeOrOMaDXL/HC2pGnQL0WLAUUmNcdBtX7jGnxQoyDEWxRBa9icFWIWz7TpMyJOZy21NQUWGhotUtkYHqI9I0aHp1tkwrxFVZr0xkGWcnVah9VTeGo16kpffrcPCpTaqSNEhcqjP7VO/abXY0tRR8FOuza8TJ8Azq+vt6e7rramuqqyoryslFdSXFRYkJ+Xm5PNzcrMSE9LTUlOSkyI57BZcczYmOioyIjwsNCQ4CBGIC2ASiGT/P18iT7eeurMgfzo8G6WAj/mxvroXk0lP5jj43vkPogY8ltBsyXYkTODsWs1tTFes4EF063L0biSsYLQi4VqSiBonG4w4cGodNSSYcCY7mnGL6/eLuOpOigeUlTZYe2OVgfwtmqKe2pPygRokWw8gaP5aasTPl2cxz8naLaeMWrZsFtLlyUXTsqnoeH1hCfLqAOKqTquFubdy7e4QrCsdFBh47viaSCN87xJBc/4i/RXFaCWRBCaF0Mn5cBh1tn82PGpR7SUsyHvq+Jo5eaHxKZeSwRFirIfW5PNvrSXrjquoH7scL8QUhwKn67nHJYoak0CxIupSqo+qx+b7oTXlS2lqWI5LpweqxCO1CWXNkKGouOMTMMyBmXYgMU2WMbNpNZNwzWPz7kEQsDBS5IEE3Opx0fcHthDe0JldClhnvhFn/A/gvIQfg2xDGmS0vHEEab/pDVdNaTH30YKFE3d350EaymF/vQ63tXZg9Wdpfs1hFO8dGMCWSSfoV5rJWqyrNaOqYM0SXAqeM2vxBGkpmAnDncyaOOfsW+2QrueITlea/bp9HVZbqXjeWMg8ajUNfc4P43smWBF5aBodc7vqmVwdG/J7VAyyWD6KXpUfTknnY4G67Yob0uVVsiIHcPZ4+t2dEKms4fqYUISYe5H6wJBVJT0PVKPTEHkCPCs1H/JLW7R889kjBdEsEP3VG98hFrCcgSLCp0YFMb457N6jVoJmmyzXhuMkn3TDi8cQ7CfJKug1o6Jy7hd0DSajRQ9Omo2PUHYUnFuZSII7JZ36QkmL1rJkVawIzBNgHZ2k7Ik+XampZNwnFc8cck+lhFaRk1LryVZSnyiWa9lT6K6dr0Th5JsPtXLzcv8SqlF4EUOrHPD420+jcRGtC5KuM/OfVCckTpurQS4hBHfx4nHztDKq0wCLX5ji5VeHqcJjqY+JsfvZSxkmk2PIPkUzE7L9qUUwPQtFyaGKH+QwazGvLdVThWRjpKonO/y1a1tdEhHcKeRjkXnJIXuMcLoLyW30MaDmeoB0ThHszhoaTsWLU3Xpc7GDmdAujvLkbZQ8BQCS1pjo63BG7SJygW3Gw370xiWrtdplPbWBBIbmoTscIX1NZsIKOXliokB64v1Ae0OcEmySHJMGNEuXkbgBsL0XnFYsWw5rqFCe6ECkLKySKSDxo7rFhufYD1kiYGbqggW16e/lCgSBoIF11fkpKg70nMJA7kqOt1yHiwbyqlNYx1HHWEQZA/E/h54FW1Pu+Tu+YMMFmwa2NcIDwwt2co7XXNTArQ5tFRRMiI8XGFSOnc7ic5PYVvpBl8Kr4DiuBfaiE2MJp4mUEek2Y/s1dUaQVhGSJ+YxheXBpypEmcaEo+48aIFp44XS9kdv0mkwbVHQpxopQPYgJWmEpPr8NJgev3jzYfoACa+YSNf2nRVbKw5LwkMHAX2ymUEApe2ki06jK/bd4cCJcHZDGSvC+vzlR8pKTLK0B8ue38fSG+kKjYkhy0/oGTU0T9YJbc7MkGmoxWR3vPgKdFycl7UaLURX7jmSTb7mjRofiS0WxnrW/SDVKO+d4BW3jRrs2qDP62AswoQdbPrhFJAHASFQWoF/0KQudHtPfFmJ0KZ41ln1JafnmRj/BwKq5m6c+gAL/X9FAZDehtMrdx0TXM63O6lHa8yDjO8ZbUYN1QIoNyyyQEpSemWVSXGQLq1iSACN4DbPyB6CDKXGXFVcJYecL3RgzAH39H2CDX7YPdoq2HRN4hg04lkrq2RBs4sNA3NFb7zKnx9B9JASFc2rX0LaGGtXIS7T6auIzoYt0F9nBC5VP2l2iw0JBFKY+HQqIptsTm2OwiIcMSZF3NiaCci4VG2LyIcsg24JeljK72t0Otz+sTDeYPCKlPDTF/lBpGJE6rLTd3OpV0P31AOR9+V56Q5hoxjeV2Qk8bkhMYkC/w/4DsvAaxaXD4iJJLzhcCBrdckc8tKbvMAqU5jPsnV0wdyuTm0/BhBvH5BaJKeAiy4Ba6//c/n3AfTA2Py+4CDHHsert+Tvlf2SS1DJq3pjTf5qfsWkkr/Q7MGNroxF6mHDq25Oj68ZBe68tvJFe/eDrcXJXoWweIsSoZDOlWRxGxynVwq2Qgp47P3HhM+j8lgvDo+yaR0nFN2X91PwLr534w2R2DakSvveOBwVbyu9Ffu7Cc7l46pKMqvpBw75ypwBB+Hl5cpRjn3KITBYh7bhyTDg/ArTiirn4CZP2ThEYojDN6wHvCfO8WSyFcCowqm+Qsji44KBvlLQ3cwFL3tyk4COILGl7xk6pLRn6mhubuhkCB5iEXJPdJRfHLl1pxDwj9DchypivmSTbvZt8YWUgPy5fSvegoql2Dfzd2z3wLc6ZeAiBNG8bY7pV962XBSilM7cnGQJWjUBkfmMxcHECJEoUhAzm3bOvOQ+LahDQA9AGoCUgcAIHoeAPsPkDwMAFCQw4ZbAt0ExdFa5BGAzfD4Dqc7N+F9adk7uGweDEhTtxPEmwK5JRP0aMuib05wIwgY+KZSAtgcJyOyvveB3LcsTY94Cz320P60/0qPzuIWfdgHWbKed5w07sF2N7aXcY3ruTe3D81oIUMbqrwaOBlus7QWTghx1hg5LRBfD3b0uI3DHHfyrPphf6DGOIRsGYjiNRqn1sG4DedEP3lxc9SycuO58dyJVMcqL/L2DJbcXUa2l+0gDwdB3DTHH+hvibJpknA233+Uvvw4W9qUEtZCah2vtIb/WHm9YeHDP69Exh1Sbn6YJ7o6X0VBz8jlfX8mpAh8IwBfBaLVwYdHWImXJp/5rOkJWaEiYRVZzMJZs2QzXigcDBjOzWELaDvGcI4pPcObx5MFELXohDgQpBHVySnSx2soFUpkzxw/SY8OJLnhwvH518j5mmM/9Y67TphBqhqWpbBijua9OR0jla1jwUYPNsaxjY+81KvOGWMRrOkOsaH4YVuFqdbZHvaAJ/Z+/t4PHbbzuMyRlFonJ26c/eVEZZBydqImrjqVHA01EpFzP+oG2VngVJHV4p4QxccI0igLMZIb4qaAntL7dpRKgFGDXnMIcVr3boLFfo5odPVxLBI6cWipFHbPfPwV0cQifJaddLFd37e7Pj5KNLtOatBtWNXo0kNld3jGILW1AAwBymQJEXSS/bKFmn5681vrzJ6aNMQ3/lcmP0n0GaSx41zFw8eOJDXjJqRuTVuhIW9W8jtx0UNlFQjrPQsRl2oD1QTpyMoZi2VLU4xsEmvs6pC4AV6ekN3Mia7pjhmenKP52FBCTxg2n6r35NMfrXGdrWMdvREeL4Q6IA4kOu5yuWKgKqtrNsUXaW4AAKMVJeIQMIABDC/zIy1wXsInsgiThEGDp9Z7kjvaoxYrrWpYMrxtBHQ4NgbtoTNXVvGxcCQwT4hT4PhxKpN5Jz2ntUZPggGcDgNJpGskmAikGKioG8bu3XRKcLlqYpTwljzpmRrXgVz+/0pBlXD8QRz5ptck+6+3tBVNV+crOArHPwmyNUZKg2dAGKsb8Lb5XhU3ko6XCJNBtj1KU6U/7DSOcm5MftJWb0soo1bjAtitzQC0nLt6ZAwOygWVJV1/TNDqJHH31+YyRrTRt/B0E55vzf7ZJ/XWWInZ9ddCDzUyMJBrLfV8Pm2logTOpxCoPpP8P+9MZEPvz2uEjAwRZXjFlhNhKNN/h8Am3Fqnk8k5mo4NqrGh80ZybituJA6rifqoEUDmw5N6rDL3GrjQwFPC3Xblzeq+ncI6UIMVzUlYHmrT10lDQT+uEQygqbuuRF5PtZgTm/vIeSXApZpxtYbii6S7eihZUHPrBD1ooUOYNOeA/mpOIRSsmMuo32+O6CD26asP/3hbOuBf1Lb2RqzKt4wTVS1SrunebOF1pXkIl02CXNMd/rntJzd+Y4kir77yHrlJP438Q9b/6VWG57CdAj6Kvk4pPjNR3W4axK0RCvrSrQS/bSlFUdfhOQtc6FXf0sCs4t5jrbXeil54sEsE3D1OWoqk0Lo4bkE4qVFGGARJb8MKYnWxBhnPSEZxrJ+bE9oUJLXIzhvgg1FLcWj0K7K4hHntzGgEe3AQWI4NuE9oH3OGgvqBeriV17qvDEkHqmSa4QpxULOVr8bHGMRPesTUEy9ws6qIJBUSWSc43jc7Cb2g+0IqGTyAmTnZVqcVQuCBwk/iFnLvfy5ho8WCJzN4DVS0viHeMBgMQbcQ8e0pbfdKbs/27MyRwEPcynUY56Mur8fTRrxUrJFMoDbSqAUdjTWw5rc5QPk2OdmeXj/wYEqHZ+6GPCXWTC7u8aEFTufs0WdeFXJfqIZTkuFOq82G9IhBa3gsvTmVUx1SKuXgh9ZU45k5ulbY+mr9NypQY6PkLomsb+P6O4qWLQVEuWpFfCEwzkW7TAfneJmwrYfesW4X5JJu1FC+Ek5TrR61ctFv+eKC5smDfZo1B7vj587RlGjKIQ29cgGyXvm7zilbdlkXbtBrB33uN+7jop91LMQt4GgKnVTVRZXChwb7OmkvBJHSy5uw1NmM84Z0Pc9WgrrABBMk/frnih9D8LUZwIXrD93Hd7ssfzpZuf23ZO17x0UTE33MD5NM75l0V9+O6YxRrVa0bP+3ffIunS/a3c/sVscCXj1dptH3fyi6YxSl59YRoHHMPHHlX0etxPpaLvp310lWs9zIRpAibQPMvQH2vAbgwrkMkPGa4laKMBUSR5Vb+EvM83/7ogztogxtk6IAfPc8gI/Vh68IQsVfnEafGmh0JAt/284tv9zBfe7aJqFQiTy+Wn0v2l9tFS1qB88VaSAODtP2vyrfNpCq7I3//LRmZtxFKuE5BqLqsuIqgZ/AZwdeOyeKQ5bAmnyJuD193HxyCykNL4d1ulFH5SOO3Z8Nws6c+p0yNfc3RbBJl5191EEzOvD0tt56bwBx4/n+JMk7HbNztzoSJPcrv3P5M3eXnyyO0bYW7n0Tmr3anBPYXxdDUmxrO8VhmsVxfU1T3n7T/NXKDL+la7lY1U2qprJc+DJmKLBDslj1+YSf2k2rvPQeB0o6xd+d3UuvMonENVNiWGZVQbl5giuh9bmnDOlaVnwKbskwOrrcxpNFILtxWii5BuUmK4lR3Sr18wCOO9ft3n1GhjYlXB4o+fwnOyyppP1j9/zK/hOnT9TOxdJ3Z+/F5AQJFXKF89Kat07LMWRIZ0zUZjH+ckFnpSZuzisQhHvQK12HsKGYQAlqkLckQzpELuwcJrtxUUqz/YF8hHQwmkKPlUlRyv2HXulUdrpVfW9NLbvMds5UrapuvzzhZ7m51fCv3s1yc69hfUU7mmV9cb2oVC2e551JSYYrZDkxqIGhngFGWGmtzvAThxaPvi5UHxO9ywqo1Ith9xNCm9MmRRZ3IA8iPVsKszKCB8wJeAuer/YRax9nAeIccjo3NTorLLp9fWxckyPT+biQ9/vwZvXf14Vd9F6cqHmDTKW6Pbeb6XeosYZ4oC0uLaRRa2dnSq0qxkrm0hdlBeWfuAshFcZRpE/iLsgUjTUBQGBrFQaQj6KplSYu9Uv8zZNqlxservX1vDl7pvuutjYjsmmzOOlBV8J36Mb66dnEEe0grXa61jg+Y/hNecXv1T150FuNbXU1Q7vQA16AeVRnPl3x0dtbr0f5CZX8bPkJJ6qVk0e4l36QRrIgI48pWA+pVp0MtS5IOa1wQzfNc/L+xjGTnygLd0McxxdjdXTlcFebUPeodMXOZZvQeB8PR49sOcZhvzRjhzDPsK5IMVZqfn5+dnFhUT63qLQoszjfWDYYe1lPJMBdTDGRUqPnX70UGLrYdGbySH1JXUVRW6TLSqWzACCwyrIMIlFAZPTpT9rZTukb1tjaVWMM3lr6o9frXv+n5xXoz/4t+M52banyBz+ZdtWGeMsiI+uN1dODc5WRvgGcwylVx/ddvZW9VYmoLmyeAggsLngaILDT4kGMyNW1g5cvTJ6q4VZnjbSurXCmToVZ5LIdyGlVYQ5LFV4CYq1C/w5RFrlY15s3E6kdvcM6+kCkniE78vjm4au/prDj/AmXn3/xoR36KZQaPWVvqE4d4WoVfz8pL11IquYTr9btLfz7pHqo+1FNyV8r3Eo14Sg/KZvbnkQ4Wl1FOMxPyJkffowxwEbifRCr2D6BO1LVI8cqJM68IYg0TWyQOo1UiWGXOirauhslJbYc86nLntZ81OeBW7dmtpRFUI0tvPLdknQSdXsp9KyIxkeda6wFHT+cbbWnSp9uQHaRv4elnTvPPl4nXrsrIICrhMnWD5KYrTgXL2Ue0uzE4Fc0DNIG3dzfs/+5V7rXJERzVD2ricSd8n07FFLItTqkysXA0MWGCzPH6otry4raIlyXK92VPZagx3hbchRp4gdvpM0DaV/ZgFtniw5IPyMuDEX+UcnBxhNEQ9EEaYosZfx00cqxwo8qCfKxBFFzWZZK/v8jkbPS34jKQOuM5c/FPprxylHFyMuW46qMZ0Urqtdea7PZXa0B8aY+qO4axksNl3AT9zCeY59Shnq6dkeoZeW7Ym0ZUrSiDIdr4ayjS7Ywd9PVMSszs3DW1omyMA/Q0TZDq+XhsU5eAYGhDKpThsJ3/2SfTJ70nCqzK5WvnieSpLmq5k81tLJNNqeLhi5mWGcoBuibEjCJGPD30u/7F5cMvguvddNvG3YaqtL9zS+vrWUb6skKH3iM73Z5+3PFL0jwrbR+oGugl9/2GpnTlfPzuKmxvu7Jqu2/JeouOGXeEQtfC05rtn/aQDgrTG3ZFcdIWbfwM2Y2cClJHZHMODb4aq3tLRt/A5m9+XyjCM+czLltf6XlFUuS/tPdQfW6QT76rNuTrSJrDhdz7gP+jSdFTk8dG2T3aQdotdO0BvGc2GGbgmRdshExPaXHIYU9SAhrTktL735AF8DWkT6NvMxU2qAZQcOS56tzyopdMRmmw7YK38UJdh1EbCBHclOjU8Miwht9qK2pmyqF/BnUqBSIO7Qzg2bpDdXZW/TvSe0QtVarOqQg1S+2ysnP41wlGq37llKvm8vIyyDGVjkSPU9b4croCjtXrpb5xag6zA8/7tqkKta0Xy03iFW2V3U/a1RCizk3lJKs+k/l89WOJm+Ln4dI0ao6wDuwX7B/gDdwf6f8gOijKGqliVP9UuuJE7gr9XfX+rqfnzvTdceAxgHW3O2zKcYYL/o1Vdigm8RmhTvYp4ZELnVjqK6hcRoMse8afpDWF4w64Wjfst6q3/o19wsg4dHWwT/p6eAD3e2CsQfWS9cP6YlQXFjEWn1S1SIjdKlJMDnwEWm5Uklwd6B04ICmGMWecdMiDj/dYJ3K+NVSzFsiLqnREcMUmMMpveYryiiUmNgWNNnZI3NXkvzcCm7eM5996UJ9r8okI83LM2MPV0OwVhtJyDjXcESp67k5MSssKBIHW39RUcZ2TH2XhAgr7BlRPWQ9bIhouSqo5RTSCF4p0kWUHwXw+dqIxZkgZQvaO3NPdF/d7JyWC8Wfza0vrikv5Ee47al0ExBrlYZ26CdSqvX8awzeo6mQ7dLC88ez8xUXn7i1c3/Mscnx89le997zn+2b7Mfwps5lMWW8006F1SYOLCEhLu6Ie+CiZYz/JTJyqy2ZlZjg7saLStidK+XoQUvVj5WrZS4EGHV+INTtU7x2Z1hcZvXI9Gh9yMwIKc05Vi5Nv+o/ujTaSvasS4JSml6FEg1rFBXMqWqXrZS6UEYa6CAk6xHFBI0v3VAaobTownPXA67ZNjZSxvu8NaF49g0F+2gCp5jLZFZmcTztYxTwjFt7dvFjpvlP9T/v2d2j4KboO16kK4uO9fCw8XB1sPdwtrHydLa3d3VTr5W+7BHsHBa8hUE6u/t7Uzx0dVYLMdBWyVaerra2Lm72Vu5uFvdjm0e7sS0doj3iS7nMuOKseLZxMKwrnpROKiW9LpC86+ntTIy2ks1pVw/GNYVlslLi5fLoWZzg4HR2IFcuJDYlNGNQHnvi9lBYWmyytyKXwY2XD8mKZ+QpxrOSw9KalQ26mLUhteJG8JeIAFJBnWdsRzcfWZwYohiCdbENkStiS4txnoRjU1z62x0mJ3pRVlxMhYqRUMaNjbH2cLO19XK1tHjg1svZDX3nkynGZLyFfjstVcThCFWCq18GGq51LwIfZetO0jA1CdTyN/HWwpv5PYwTz8loiDGiEXshammaOzxQtfDGY8WcA0ihlACVWIUbnsmuGeTFGPAYsSh1/Xj1nZeC8xYqOoZ2dyqIrmIPbq435h27zxnKndD10tCaBgjr8ZKLd1n1DSGtLoyOCi5Rd8g0aUUw1pka2jTmmZneHDHW01dZPlKhr/qXv4y28LkU0VbgPoUjFr1Sq1CukePlou2+volRgX5DHoReQ5JUpkjKRqMHTUZjlOXRmKWSJQPZ7ky0b5fvZ7cSNwzOUPt05qKRJ86h8m+HTmB2Ja9lebBkcM9g6XCkZrELaUqhFzSfJB5JMqtjb5Vu7dkq2WpsZmyuJhspWQslvty7EGMj4JVd8ul3c54CcOFvfhDD5sShlsmOheZ2cP3b8qdrNFu6hzpFLLikKEja2T/Zyb4w6sIIedTD/oRxbhopMVY0lw1L9e6vCmAxGr0C+yo+PWKq/MlyjlG7+D7Yoa6UysmrH2ytZt3ZPZ5pppBKKxTTMop1jXUj2ySELZd5VN3S0A3GStUapztkvY+QX8D6yzDQAWZo3Rs4+c+aaSo5EVMyUybpblwSGoVCYWhGzOIsDrsoOy6mKjsuoSJLJZy72toTXCysPFzsbS9iIsbvzzKwM6d+pUzNv6dAtHYYHng2/TeLwSmzp8jm+i1fw5ZknywxMQkxuUUcLdufKHmnY27+ZgdHcr/Sa9e/83f5SRLK4cmt/XFt6b+981IPpu31dfMcdwyQySUuXZOMcuazOf4qeDetMStcTJPXRntcdg6f5bXR2OB1iM/MXRi6pUybEm65obz8lYoDF6+JEY3KKfHFhDDJnIGcz1+zDVkNJ5TR6r6t01u107HkXVyhaij2y3WUj1EVOamAELIjeKmETSLX6PhX70HOzWxUXdh5/rjrdNEfd7J8cYC+wvU75CgGESOanii+QBIPNjM3J2k6qrBl2NZ5uoUV4bKoxIWDRQ6/nZ/eL0BuNXU0bRUnPexM+CFyZN+ZuYQRrWDtDrrmBP70sCeIPbKzgB5dO7RL0Xj1bO2RgGK+OkvboRx6hpW9VlWRtPkgcyllXYOsN0gxOGoWsTQ80lq/2riSx3Om5wT45esF8sZjKQvZqzPCvvxPnzMdccJ5AsPYkalKvitXfF+olt2FX9WkW4QGaEvBu0rv+Irr0GI8iXzTnNtYNZGoNa1Omb9sjRCbCBsZ5JuyM0/UxK2F84r/1oQhntW8oBBJ0XjJ5kBiU2JL1f63EcOm7+ZQU0bYvWO8ktLV3LX/84z1VhY7WkNpuZOOZTgxMbEgAVEgvrg/xqHF0LFHE9mscF+fnanZwRGqmwyOEdveFGek8fPbvKABhlBxs6JF+9Fkr7R+7NKj42rLUZ/CIkxCTU1xRngkLFXYL/8DtRbuci1mtEGXrV2ngWGnnW2X6G4AF55rO5QZebaO11uS5NVS6RuFA3BLCYZH/xG5xCY/b37ih74PFZEXNvMnDmmnlUh1m2a4cZ0iFB5rpKrm+KOhOgACTJDABwnJGNFgec1+QHJypQS2R6wRzXHJREZ+V2Mq6GSTmucaVdhOqaBKTlIlm67UFlypaa9E4gswYYlQF6qY39qfJgK0ExRW8L5pJdZ9elSKT5XiVJ/mMIfugBeZUjXMUfelyQJMavigQ4YyQejbBDdhut9SpnUangatt5RppIRbXw0BgQcx98puQAQBCtIIKxocqbBrJifnKbI5zYi3/g5lC4oc93NMChHseliolNmVkwdCdee4ZlS7vly4QqUoQETJQp0AoKrNusFNtag/lQf9gxRLinZErJnXh6FOVulAUQUSpHFQzohQc2Yf4RS2/dnSdVuqtsdDRNP7ClLShxn/pwMC8qH/d2vxLlMXS4Mua/ESCAYS90sf8Nb2IEywA1wHHKAq0tq5/qQlNpCOWJr0jSVBBy3N7pdS35wrnJQqIjTtypqlpfHwfNKXtVZG3W6tCHeAnThZS2qoSkFrs3togXeRzWIpx2cRe5uYAsBHNxKVMLUTp0WYCs0u0rmbqjELlA8BdXr9pVKFKTqRLjtkl4SEaZqlS39YUjTZ0u3+isohhyqHePfNGeVU0APAOwx0F5UucJOmegUOLyOzy3BGv+sqoeDmO43NWzWTZTCuBIBUqRmp1BjvgUVkbB6rTIQCLQqROUXt7GszqHBoCzM6GUnWYVaR9r3rDVkZt6BCnA0trdf9XqqkFlLpErvdOZtOX+wRZ2pq0B9NzFhoMU11Y1Ljo3Uj/qiKe6yAsd2mAbH3gw0A4LFjcPb2E/PrnpqG0IFutrPtk6zadk6HUq9S5BOgMY2ntEiHdrmoJVpCLSJNHEqtFB1wEiRkJkuJDjgNXZklKBkL2heJs13NTENUaY+GoZpy8P3jraUE4+MVCLAEB3Jns5/WsKDjWmmapK07/N7nxHvMnz+Lkfnwx6/b239/Zx3q5eqP1EW2z79vAZyxSyAugej5bjkLZ/IcMpi8tIeLDT/ouE3kHywc8OaOOotsA9z7aDsCT7S12I/ARTS8IfyJ0f2uLaDT8Bw9E4EFDglc+Hzt8gNx6XDJwJnIIYOtlxaNPLGHi78GPcCzH+x2/Qb1gYWZZoJz8JcWjTyxh+Nu+Fnuj6is3F4Dyh35fvtkzHQiSdv1LmXC729/LfkhLm3fKBnDmdsvS0HI4O2rsTu8LQ8dLpAJuBCY4+Il8CfgEJAaJA1sjTIRwdw/OrAiafF2ZC+DJiFbt9smocEI3D3vCHshFvVMtBBYMA0sf5BtoBVoWsgPcMRAqnZAeOYW5hluq48y3Ku7K7INMRIEft0h1x91h0XKVms5DkCBqWNuPvpgDSTW4xwkliPTBl2WRRdsdi86jhgIzwEAmYF07VhsRFImIPswgfGSA86tVoKzB9aGn7UH9r5hkfJS6eEIC4QLAU4T0Hm4N22A0cAdX0Bgwbo7uhKSBCY0Yge/TznEJc0kK1i/ROZnDrGTtl2chMCDieEC84MRgRqwQdDJFUARyggcAFQhboD+k4FBU3dAcT8B2QYCjiwZCDwytBz8SabVyeztf/Fasce+1VbePulj+dJDo0nDMQ/q6Pmw2u4Inmfch+FXfOk2nwrfNzPwMLAm17ZjPTYC/r+6544HRc6iDsZYthsuHIYRdaynms8zpMeB3wfccR52CYEF0gNbD8Uu5Q0X+EH4ecD1YVgsLHLsRlzCnjs79BYX+hmcG77fwT6R9drmT5/6297VP3oDn1HGDhx9hp6o5nv34/hUR1E4F4qTEZbAdjW7aSW72Z1/gVEn17hfRddfkGpOrWmXqKCdY4oj5xm010VB2w5AdfHILU0ftFkhFOqGN2Qq/oCUBBjWvv3ulQzAsftsKgluk1SxTp0nN9r4VAK4eC+aMfRM2uSbM4pjPz6XQh5cRU7MUZA3vbPHKTeYYPUitpRRSG2+p0/CSd7EiRoKutN1huT5qikXpNf8jDNCSA3IaoRcbxw4Tql8dq7n6zXN8eygSzwZtAAMzUAlp9ofjJSqwa09AHrH1gvkcGRxCVfCaVvNNByfp+F1nkWxDgd3XQOASNLTDBhGSc2nU0mxUmINX0XwFXXMoQYQ+s0GGaphmgJsLZJXyPYsYaE1uAZp3qDZsf1rHKajTz/Foffe22zAlCS/qkUPIPcukoMX/vNc4R4nTUB59CRVrbZh4o7eii/DC03c914ehZrvusnVZGh5eYOVN18mSYVW+xhbT14PlmAY1vjODw2IUWD9VzorxvOFUWtlg6GdRROipEavE+4ENVgiBerPmlR6O4XZDmKR4nsMppxELHXh61nG1c8lqVzGhtyO7HaUCFDSHvuekqI7vQ9GhjF1OluaRU1CloJRbK9tFJ253yORrldE043vyXyap9arpSdhzggF0B/rtYXqV/Ad76TvdTd54/8I0IbjaT+CxhGPBRzzg0la3ge2a4SP4voApTklxpT+hUyQtK0iubT/VZVD27pdZzeJU28bjJLF38ZyK0SaRlHTJDHXabPZuGjtfu84u4iPyvgpSHs1LzDZTZM+6cOdRbsOdeeA91KXjo+PwPRMck6YXVPn/8d4uYzjsoxCatFlUTjemJsb20psCdupt0jxUuYVazDVBJVtistR753b7CnZbhUvW2YE2rX0z/RTey0DwE9g96qPOE9J1pOvQJeONottCRA+6Zjspax7uTpH0ee8dwpVisrOs7xn+RWpbsYZm0yW50UR6/4C6Uls0fIQ86FB3Dvi2XL0LAqxn0P/rkL2u7Osyc1+cxtrTPryoLmhVE0HoA53E6in4N9YXWlMYrMShsApTg3QqMZRZx/wcSethIBSxj1QHT+0ZwbuF+tA1ZbMfHH0LeK6JVsz9Tz35ZBh6dOXw4an/x4UQQp9Y9RPqrKSkbXKFKtJGG+EGLQeNuZyaGxvYQDguLmGP65qNSa8NM5aUJywq54pq6ZspzMhLDhEdfO9ua+OR6Uaonris6uEQxB1FWlUcSD1/YRznzdN/bQ01CPqHBfL8twoirMkemepukD1LEbeV2/GPG2Z8bcyi5jLupptsnHxaqUXu9HKPmSvsrts3YclP7dqHK0T5ygEmAUE9CXwUc+i0CyLeRAAduoHRBLxsH3o4Ah6Q1dMo67GqGyeTXuKFV8a6ypkzyZV7AN7PqNPR95PrqpDQkOTux9XgeLrDX+Kwth8rnu/cEC2wsKxoeu5RqteDdY9ImPeGT3yLkou4gJTHClLVykqSy0HwFd3AoZIBSAM6NnLqnLXKSHCFBDlWesbEIifSZDBuJFtaxWb7cPD1dXCmmGcKW37XlhLbjzyV4kOh0AIgEjKf/El2dfHR/+ivV+TvPO/g26cVD9dqpuG3hNd/N1axeuiH7xo9PsrQCeTKCeUAwtwfH4jH0LgaR0kKYM+ZWAQ4AQYZDdDv5454/IZrKL2FLJkknDwIKvBnIhw2c/1YxB1Jf26fyzMw7uUikOMqj1lo5Nb1taYLducDtrCyyWWUhhPWOs+V1bjISZFQFh9RthcX2+3oCNURFURpBGwD+zUjfdyDIy8d9cUzpdoPcrKI+/9GzHSQ2r9AcbtEF1pfUB1wriWD8vV80rGjPfCCji2bvMrUZk1jRFdCGCVJDiBT0Z+4NiDpe7h4O+LEGRcmeVxnI0MKGD3khudj/uMBrFw6a5pkm2enyXEOUzBz0VHmgfbIRy7S7uvgHrbNqyRvRxNEgLAxpke2DIZv35owklhyYLM1XgyGrKFxvdg78T1tTvrTB86PyJjr/5/uVF2juDRQPBHdZSO6XlnPcvNqyRoZ7q3A3Us+ot0xZ/LSzS0MfDjzMmozQaGttdoYvUY1GS7+4p6CMtCoFQ1Oe/ncx/J2Bd67FU0DwucFqE+qiLT7vj3+qZ3Br25sVvwUxQ399h/KRXiOIIVRmpX7EvqCi+VWsnxZXPQeY52QLCRfTMYJLzAcq/rMrxUclr0tgoM221iJlvX99vcTcDxCrgKDA/TYMx5e2bADh3Y894eANbjH5peq3d/rvNRN9ez1e9wTACvRjdy34EasTGrD+6qi/1+s17HlUsL3sQWZQelegPiR36YaBCddawtnCrqBNbYmjvwSe33gQHm0y9AQ48u3VLqp5FJsraUyQSEHWjV/hzfZGp/j0q4R50QPbykgQIiPJrvZr3LJZ1+t2KbJKXbnx/7CZ7F/ft1Lvxz/P+r4eCmOAAgQItHIEDjv7gN7njpSqzwsO7ztCGpLxztkgB8C7x+wVZxbfXLlbywm1Op6czIsss43rD47lgRof3drk8/xGJJqkTS/br1DRa1KgRgz6IsFfO/ZodeXNHLddx6DqP00qHU65XFBjfa4LOtrMiBvZGI57a6hLsQGC6eSWh34KZLT6yWFAoKunwkoCZio3vKnKKyfpmjX+DgZWp9IXoVMWC54YVo8LG1gdjqOYSDJDcD+L1ZhJwQaWsDuaWvpgIBJ4FtTnNXg896G1+NG8ZLctUWuoN5eqjikgbKaO5uRuwfyMn9psamd6LVxpZVRRepvFBK5JeKkOeGdLQngd6RGzLbkFArKuDD4smuqlHLlgZ6gMo2HOgGarxFBnqEytEl1O53CvVveJ2ydVmsDoe71PxH6AS6EETh3qYWAvrXbn/sRdpOqt3i7HzcsTSQvKMdZtHavzb0ctJcTKmkVFaHaJ3ce9UxXBoyC0CeeMkH6sKOoM9+977mNid3dcWrp7irifVONgH83zU3vtA/nt3G1VyqVHIftb9rzBddyfHaUSe3wr7K0BzRCXhBJFale90gdJZ1wxweftRHIYh2F4DcAwJAgk9ODDgoDFP9APSDbauIgAAAbfdtsDaf4gJwHYS0BQHdWIevE2Hj3HUwGoFeB6cUresQcHHZj2aV6AUBxPM0rgtUXugq/cHsTOsVsSutt8Vu+2f/EU8ZMhXiSpIgUQ4cC2bfFIcxGJyUKtMiHWkgJkT2SQNwU5E8K9ZS6i7XInFSXFnqqbEjMlvqwPTTSJA0wXYzcUywjkx7ZBYZz0wqjvh3eboc2Uy5pc5+3Z6+C0HvpQS5UudyWTJh9lNy5IMqfApfCl63YYxNo200IYIfRFJJ7rpwNjdPmyfAX81srJxVZkBlopimMpHBXW6KyhtJCPwqREhR7MwUZSpNwwyE74DLUZOFniLMayI+72j7ORa+gbuys+VUeBeG5dlRkXtuyznnZe/ncfdqZ+1lmce2jK0sfYlG2hKnrpOdstrJc1nSmIDE8QQJIxfxIwGcqcbsKW1jTVTEDXubOcSxPeOYPrGj+7ao3gaiYxzR3uzwti2sTUBoo7aQpkNw0+OgmjajigOrvU2vymhluYBSUG1Tipicf21SFvtnvcwvc4NvahN57MNke7OYwNIyL9rBk5Z54Dx3xG642a6kzYW8cE4QO8Uoc4x+cIiW2Edf2F7/PYqtltJmPjaoSv8a6NmhLwrlDnl2QVvJF6nSBO4DzJfweIHDBfXIc0SiECF2JRVHUp59PJ6dczwBTPdP3Fb8OLKMuXHr5hXLZ1d97k8fn8x2H+/MTpKd5Jy92Skx51iBlsePj2b7j/dm2ZDqPEuOkr3kf10SBP599Ub9hZI6rjLv8cFs+/HW7CDZSs7pzVaJnONq2z7exSP8nXfYQSULuj+8lgvgl1xPkBv/g14MsTxt6CwvXEL8mXz34wdcKQb43e5+ccANfVeneJS0mdNWfKzuKHuKjy2bsMOGI71bV3ZCJLN9UFa1PwA8QYbHmx/4dv0P/5XPAwAA)format("woff2");unicode-range:u+000-5ff}@font-face{font-family:Open Sans;font-style:italic;font-weight:600;src:url(data:text/plain;base64,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)format("woff2");unicode-range:u+000-5ff}@font-face{font-family:icomoon;src:url(data:font/woff;base64,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)format("woff");font-weight:400;font-style:normal}[class*=" icon-"],[class^=icon-]{font-family:icomoon!important;font-style:normal;font-weight:400;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.icon-Icon_Share:before{content:""}.icon-search:before{content:""}#pane-pcw-references.empty:after,#pane-pcw-references .NoContentMessage:after,.icon-chain:before{content:""}#pane-pcw-related.empty:after,#pane-pcw-related .NoContentMessage:after,.icon-related-circles-extend-button:before{content:""}.icon-mail_outline:before{content:""}.icon-Icon_Tools:before{content:""}.icon-icon-lock_open:before{content:""}.icon-arrow_l:before{content:""}.accessDenial--tab .accordion-tabbed__tab.js--open .accordion-tabbed__control:before,.icon-section_arrow_d:before{content:""}.icon-list-unordered:before{content:""}#pane-pcw-details.empty:after,#pane-pcw-details .NoContentMessage:after,.icon-Icon_Information:before{content:""}html{font-size:100%}body{width:100%;color:#1c1d1e;font-size:.875rem;overflow-x:hidden;word-wrap:normal;font-family:Open Sans,icomoon,sans-serif}@media (max-width:991px){body{overflow-x:visible}}a.visitable:visited{color:#61165e}.pageBody{min-height:calc(100vh - 17.9375rem);padding-bottom:2.5rem}body :focus{outline:2px solid #0096ff;outline:2px solid rgba(0,150,255,.560784);outline:.125rem solid rgba(0,150,255,.560784);outline:5px auto -webkit-focus-ring-color;outline:.3125rem auto -webkit-focus-ring-color}.banner-wrapper .pb-ad{display:table;height:auto}.relative{display:inline-block;position:relative}p{margin-top:.3125rem;margin-bottom:.3125rem}@-webkit-keyframes spinner{0%{transform:rotate(0deg)}to{transform:rotate(1turn)}}@keyframes spinner{0%{transform:rotate(0deg)}to{transform:rotate(1turn)}}@media (min-width:992px){.article-row{display:flex}}.comma .accordion-tabbed__tab-mobile:last-of-type .comma-separator,.comma li:last-of-type .comma-separator,.loa-authors .accordion-tabbed__tab-mobile:last-of-type .comma-separator,.loa-authors li:last-of-type .comma-separator{display:none}.comma .publication_contrib_author{display:inline-block}.comma__item:last-of-type .comma-separator{display:none}button.btn{background:#005274;font-size:.75rem;border-radius:0}.billingBtn a.payPallBtn:active,.billingBtn a.payPallBtn:focus,.billingBtn a.payPallBtn:hover,.billingBtn button.payPallBtn:active,.billingBtn button.payPallBtn:focus,.billingBtn button.payPallBtn:hover,.billingBtn input.payPallBtn:active,.billingBtn input.payPallBtn:focus,.billingBtn input.payPallBtn:hover,.customBtn:active,.customBtn:focus,.customBtn:hover,a.btn:active,a.btn:focus,a.btn:hover,button.btn:active,button.btn:focus,button.btn:hover,input.btn:active,input.btn:focus,input.btn:hover{background:#003951}.quick-search__button.btn{background-color:#767676}.billingBtn .quick-search__button.payPallBtn:before,.quick-search__button.btn:before{font-size:35px;font-size:2.1875rem;color:#fff}.doi-access-container .doi-access-wrapper{margin-left:.5rem;padding-left:.5rem;border-left:1px solid #d8d9da}.doi-access-wrapper{font-size:.75rem;font-weight:600}.doi-access-wrapper .doi-access{line-height:normal}.doi-access-wrapper .icon-icon-lock_open{font-size:.9375rem;margin-right:.3125rem}.doi-access-wrapper .full-access{color:#008765}input,select{padding:.8125rem .5rem;border-radius:2px;color:#1f1f1f}select{font-size:.75rem;font-weight:500;-webkit-appearance:none;-moz-appearance:none;appearance:none;padding-right:2.1875rem;background-image:url(data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCI+PHBhdGggZD0iTTcuNDA2IDcuODI4TDEyIDEyLjQyMmw0LjU5NC00LjU5NEwxOCA5LjIzNGwtNiA2LTYtNnoiLz48L3N2Zz4=);background-repeat:no-repeat;background-position:calc(100% - .625rem) 50%;background-size:1.125rem;font-family:Open Sans,icomoon,sans-serif}option{font-size:.875rem}::-webkit-input-placeholder{font-size:14px;font-size:.875rem;font-weight:300;font-style:normal;color:#767676;opacity:1!important}:-moz-placeholder,::-moz-placeholder{font-size:14px;font-size:.875rem;font-weight:300;font-style:normal;color:#767676;opacity:1!important}label{font-size:.8125rem;font-weight:400;color:#1c1d1e}form ::-webkit-input-placeholder{font-size:14px;font-size:.875rem;font-weight:300;font-style:normal;color:#767676;opacity:1!important}form :-moz-placeholder,form ::-moz-placeholder{font-size:14px;font-size:.875rem;font-weight:300;font-style:normal;color:#767676;opacity:1!important}@media (-ms-high-contrast:active),(-ms-high-contrast:none){select{background-image:none;padding-right:.5rem;padding-top:.6875rem;padding-bottom:.75rem}}@supports (-ms-accelerator:true){select{background-image:none;padding-right:.5rem;padding-top:.6875rem;padding-bottom:.75rem}select.country.jcf.jcf-hidden{min-height:2.75rem}}h1,h2,h3{font-weight:600}.article__body h2{line-height:1.2;font-family:Open Sans,icomoon,sans-serif}.article__content .section1{font-weight:600}.w-slide{left:100%;position:fixed;top:0;width:100%;transition:all .25s;background:#fff;bottom:0;z-index:9999}.w-slide_head{position:fixed;width:100%;z-index:20;box-shadow:0 0 .3125rem 0 rgba(0,0,0,.2);font-size:.875rem}.w-slide__content{background:#fff;overflow-y:scroll;-webkit-overflow-scrolling:touch}.w-slide__back{float:left}.w-slide__title{display:inline-block;position:absolute;transform:translateX(100%);transition:all 50ms;left:50%;overflow:hidden}.accordion__content{width:100%;clear:both}.accordion__control{width:100%;cursor:pointer}.accordion__control:active,.accordion__control:focus,.accordion__control:hover{text-decoration:none;color:#006ec6}.accordion-tabbed__control{width:100%;cursor:pointer}.accordion-tabbed__control:active,.accordion-tabbed__control:focus,.accordion-tabbed__control:hover{text-decoration:none;color:#005293}[data-db-target-of]{display:none;text-align:left}table td:not([align]),table th:not([align]){text-align:left}.tab__pane{font-size:.875rem}.tab__content .tab__pane{padding-top:.625rem}.tab__content .tab__pane.active{display:block}.tab__nav{font-size:.6875rem}.tab__nav li{display:inline-block}.tab__nav i{text-align:center}.tab__nav a{display:block;border-bottom:.0625rem solid #edebe6}.tab__nav .active a{border-bottom-width:.125rem;border-bottom-color:#005293}.tab__nav .active a i{color:#005293}.tab--flex .tab__nav{display:flex}.tab--flex .tab__nav:after,.tab--flex .tab__nav:before{display:table;clear:both;content:" "}.tab--flex .tab__nav li{flex:1;text-align:center}.tab-link:not(.primary-blue-color){color:#000;font-weight:600}@media (max-width:991px){.accordion-tabbed__control i{display:none}}.creative-work__title{overflow-y:hidden;position:relative}.creative-work .loa{overflow:hidden;position:relative;color:#999}.creative-work a:hover{color:inherit}@-webkit-keyframes pulse{0%{opacity:.5}to{opacity:1}}@keyframes pulse{0%{opacity:.5}to{opacity:1}}@-webkit-keyframes fade-slide-in{0%{opacity:0;transform:translateY(-.625rem)}to{opacity:1;transform:translateY(0)}}@keyframes fade-slide-in{0%{opacity:0;transform:translateY(-.625rem)}to{opacity:1;transform:translateY(0)}}.article-table-content{display:block;width:100%}.article-table-content table{width:100%;border-spacing:0;border-collapse:collapse}.article-table-content th:first-child{border-left:none}.article-table-content th:last-child{border-right:none}.article-section__table-footnotes{padding:.875rem}.article-section__table-footnotes ul{margin:0;padding:0;list-style:none}@-webkit-keyframes fadeOut{0%{opacity:1}to{opacity:0}}@keyframes fadeOut{0%{opacity:1}to{opacity:0}}.coolBar{margin-bottom:.9375rem}.coolBar i{display:inline-block;text-align:center}.coolBar i+span{vertical-align:middle;margin-left:.625rem}.coolBar__zone{float:left;color:#212121}.coolBar__second{float:right}.coolBar__section{color:#212121;float:left;position:relative}.coolBar__section>a{margin-left:.9375rem}.coolBar__section>a:first-child{margin-left:0}.coolBar__wrapper{background:#fff}.coolBar__wrapper{border-bottom:2px solid #d8d9da;padding-top:1.125rem}.coolBar [class*=__ctrl]{font-size:.75rem;color:#767676;font-weight:400;display:inline-block;margin:0;padding:0 0 1.0625rem}@media (min-width:992px){.coolBar [class*=__ctrl]{text-transform:uppercase}}.coolBar i{font-size:1.125rem;color:#005274;vertical-align:middle}.coolBar--sections i{padding-bottom:.125rem;color:#005274}.coolBar__section{padding:0}.coolBar .relative{margin-left:1.125rem}@media (max-width:991px){.coolBar .relative{margin-left:0}}.pdf-download.pdf-download.pdf-download{line-height:.875rem}.pdf-download.pdf-download.pdf-download img{width:1rem;vertical-align:middle;margin-right:.3125rem}@media (max-width:991px){.pdf-download.pdf-download.pdf-download img{margin-right:.75rem}}.fixedCoolBar{position:relative}table tr{font-weight:400}@media screen and (max-width:1200px - 0.0625rem){.alphanumeric-title{margin-right:.3125rem}}@media (min-width:992px){.cart-indicator__wrapper{display:flex;align-items:center}}@media (min-width:1200px){.cart-indicator__wrapper .pull-left,.cart-indicator__wrapper .pull-right{float:none;display:flex;align-items:center}.cart-indicator__wrapper .login-bar-container{position:static;top:auto;right:auto;transform:none;max-width:7.5rem}}@keyframes placeholder{0%{background-position:0 50%}50%{background-position:100% 50%}to{background-position:0 50%}}.ui-widget-content{border-radius:0}.ui-widget-content.ui-autocomplete{height:auto}.quick-search{padding-top:.9375rem;padding-bottom:.9375rem}.quick-search input{-webkit-appearance:none;-moz-appearance:none;appearance:none;border-radius:0}@media (max-width:991px){.quick-search{padding-top:.625rem}}.quick-search:after{content:"";display:block;clear:both}.quick-search .tab__pane{padding:0}.quick-search .input-group{margin-bottom:0}@media (max-width:991px){.quick-search .input-group{padding:.625rem 0}}.quick-search .input-group:after{content:"";display:table;clear:both}.quick-search__button{color:#000}@media (min-width:992px){.quick-search__button{top:.0625rem}}@media (max-width:991px){.quick-search__button{bottom:.6875rem}}.quick-search .quick-search-pane__anywhere input[type=search]{padding-right:2.5rem}@media (max-width:991px){.quick-search .quick-search-pane__anywhere input[type=search]{max-height:2.375rem}}.quick-search :-moz-placeholder{color:#9e9e9e}.quick-search ::-webkit-input-placeholder{color:#9e9e9e}.ui-autocomplete{list-style:none;outline:0}.institution{color:#005293;font-size:.75rem;line-height:1.5;margin:0}@media (min-width:992px){.institution{text-align:right;padding:.4375rem .9375rem;display:inline-block}}article{padding-top:.625rem}article .tab__content{background:#f5f5f5;flex:1;overflow-y:auto;overflow-x:hidden}article .loa-wrapper{margin-bottom:.5rem}article .accordion-tabbed__tab-mobile{border-top:none;display:inline-block}article .author-name{display:inline;font-weight:400;margin-bottom:.25rem;padding-bottom:.25rem}article .author-name span{display:inline-block;margin-bottom:.1875rem;padding-bottom:.25rem}.article__content .coolBar--sections{overflow-y:initial}@media (min-width:768px){.epub-section{font-size:.88rem;line-height:.88rem}}@media (min-width:768px){.article-tools__ctrl:not(.defaultSize){font-size:14.04px;font-size:.8775rem;line-height:.88rem}}.article-tools__ctrl:not(.defaultSize) span{margin-left:.625rem}.input-group{position:relative}.loginBar{display:inline-block;color:#005293}.loginBar .show-login{text-align:center}.loginBar .sign-in-label{display:block}/*! jQuery UI - v1.12.1 - 2018-04-24
* http://jqueryui.com
* Includes: sortable.css, core.css, datepicker.css, slider.css, theme.css
* To view and modify this theme, visit http://jqueryui.com/themeroller/?scope=&folderName=base&cornerRadiusShadow=8px&offsetLeftShadow=0px&offsetTopShadow=0px&thicknessShadow=5px&opacityShadow=30&bgImgOpacityShadow=0&bgTextureShadow=flat&bgColorShadow=666666&opacityOverlay=30&bgImgOpacityOverlay=0&bgTextureOverlay=flat&bgColorOverlay=aaaaaa&iconColorError=cc0000&fcError=5f3f3f&borderColorError=f1a899&bgTextureError=flat&bgColorError=fddfdf&iconColorHighlight=777620&fcHighlight=777620&borderColorHighlight=dad55e&bgTextureHighlight=flat&bgColorHighlight=fffa90&iconColorActive=ffffff&fcActive=ffffff&borderColorActive=003eff&bgTextureActive=flat&bgColorActive=007fff&iconColorHover=555555&fcHover=2b2b2b&borderColorHover=cccccc&bgTextureHover=flat&bgColorHover=ededed&iconColorDefault=777777&fcDefault=454545&borderColorDefault=c5c5c5&bgTextureDefault=flat&bgColorDefault=f6f6f6&iconColorContent=444444&fcContent=333333&borderColorContent=dddddd&bgTextureContent=flat&bgColorContent=ffffff&iconColorHeader=444444&fcHeader=333333&borderColorHeader=dddddd&bgTextureHeader=flat&bgColorHeader=e9e9e9&cornerRadius=3px&fwDefault=normal&fsDefault=1em&ffDefault=Arial%2CHelvetica%2Csans-serif
* Copyright jQuery Foundation and other contributors; Licensed MIT */.ui-helper-hidden-accessible{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}.ui-widget{font-family:Arial,Helvetica,sans-serif}.ui-widget{font-size:1em}.ui-widget.ui-widget-content{border:1px solid #c5c5c5}.ui-widget-content{background:#fff;color:#333}.ui-corner-all{border-top-left-radius:3px}.ui-corner-all{border-top-right-radius:3px}.ui-corner-all{border-bottom-left-radius:3px}.ui-corner-all{border-bottom-right-radius:3px}.institution{border-right:0;padding:0 .9375rem}.institution-wrapper{display:inline-block;vertical-align:middle;margin-left:.9375rem;padding-left:0;border-left:1px solid #edebe6}.institution-wrapper img{vertical-align:middle}@media (max-width:767px){.article-header__references-container{margin-top:.625rem}}.article-header__references-container .header-note-content{display:inline}.article__body{margin-top:1.25rem}.article__body .article-section__citedBy .accordion__control{position:relative;z-index:1}.article-citation{margin-bottom:1.125rem}.article-citation .icon-mail_outline{display:inline-block;vertical-align:middle}.article-citation .citation .loa-wrapper.loa-authors .accordion-tabbed{color:#8b8b8b;font-size:.875rem}.article-citation .loa-authors .accordion-tabbed__tab-mobile{position:relative}@media (min-width:992px){.article-citation .loa-authors .accordion-tabbed__tab-mobile{display:inline-block}.article-citation .loa-authors .accordion-tabbed__tab-mobile span{display:inline}}.publication-cover-info .cover-image__image.hasDetails~.cover-image__details{padding-top:.625rem}.publication-cover-info .cover-image__details{font-weight:400;line-height:1.25rem}.cover-image-wrapper{vertical-align:middle}.extra-info-wrapper{margin-bottom:1.25rem}.extra-info-wrapper .volume-issue{font-weight:600}.extra-info-wrapper .volume-issue .val{padding-left:.3125rem}.extra-info-wrapper .page-range{color:#767676}.extra-info-wrapper p{line-height:1.09375rem}.article-row-right .tab__nav{border-bottom:2px solid #9e9d99}@media (min-width:768px){.article-row-right .tab__nav{padding:0 1.25rem}}.article-row-right .tab__nav li{margin-bottom:0}.article-row-right .tab__nav a{border:none;color:#757472;padding:.1875rem;font-size:.75rem}.article-row-right .tab__nav a h2{font-size:.75rem;margin-bottom:0;line-height:2;font-weight:400}.article-row-right .tab__nav i{color:#005293;font-size:1.25rem;font-weight:400;display:block;padding:.3125rem}.article-row-right .tab__nav .active a{color:#005274;border-bottom:4px solid #005274;font-weight:400}.article-row-right .tab__nav .active i{font-weight:inherit}.article-row-right .tab__content{position:relative;padding-top:0;background-color:#efeff0;min-height:18.75rem;max-height:calc(100vh - 4.6875rem)}.article-row-right .tab__content .tab__pane{position:relative;padding:0}.article-row-right .tab__spinner{position:absolute;top:0;right:0;bottom:0;left:0;height:auto}.article-row-right__panes .lot>li{padding:1.25rem}.article-row-right__panes .lot>li~li{border-top:1px solid #d8d9da}.article-row-right__panes .lot .creative-work{border-bottom:none;padding-bottom:0;margin-bottom:0}.article-row-right__panes .lot .creative-work__title{font-size:.875rem;font-weight:500;height:auto;text-overflow:inherit;display:block;margin:0 0 .625rem;color:#005274;line-height:1.25rem;text-decoration:underline}.article-row-right__panes .lot .creative-work__title a{font-weight:400;text-decoration:none}.article-row-right__panes .lot .creative-work .loa{height:auto;text-overflow:inherit;display:block;margin-bottom:.9375rem;font-size:.8125rem}.article-row-right__panes .lot .creative-work .loa a{color:#1c1d1e}.article-row-right__panes .lot .creative-work .loa a:hover{color:#005274;text-decoration:underline}.article-row-right__panes .lot .creative-work .parent-item{color:#1c1d1e;font-size:.8125rem;font-weight:400;text-transform:none}.article-row-right__panes .lot .creative-work .parent-item a,.article-row-right__panes .lot .creative-work .parent-item span:first-child{font-weight:600}#pane-pcw-related{list-style:none}.article-section__references{font-family:Open Sans,icomoon,sans-serif}.article-section .article-section__references .accordion__control{position:relative;z-index:1}.article-section .noteLink{font-size:.875rem;position:relative;top:-.4375rem}.article-section .noteLink{padding:.3125rem 0;font-style:unset;margin-left:.125rem}.article-section .article-accordion.accordion{margin-bottom:1.5rem;margin-top:2rem}.article-section .article-accordion h2{font-size:1rem}.article-section .article-accordion>h2{margin-bottom:0}.article-section .article-accordion>h2 .accordion__control{display:flex;align-items:center;margin-bottom:0;padding:.625rem 1.5rem;background:#005274;color:#fff!important;font-size:1.125rem;font-weight:600}.article-section .article-accordion>h2 .accordion__control #support-information-section{display:flex;align-items:center;width:100%;color:#fff}.article-section .article-accordion>h2 .accordion__control i[class*=icon-]{color:#fff;font-size:.5rem;font-weight:700;margin-top:.1875rem;margin-left:auto}.article-section .article-accordion>h2+.accordion__content{padding:1.5rem;border:1px solid #005274}.article-section__sub-content{margin-bottom:1.125rem}.article-section__sub-content p{margin-top:0}.article-section a{font-size:inherit}.article-section__header{margin:0 0 .625rem}.article-section__content .article-section__title:before{display:none}.article-section__content a{display:inline}.article-section__content{line-height:1.5;margin:0;position:relative}.article-section__content li{line-height:inherit}.article-section__abstract{border-left:4px solid #d8d9da;padding:0 0 0 .625rem;margin-top:1.25rem;margin-bottom:.625rem;overflow:auto}.article-section__full a:not(.getFTR__link--color){color:#2f7bae!important}.article-section__full .article-section__content p{line-height:1.5rem;font-size:1rem;overflow-wrap:break-word;word-wrap:break-word}.article-table-content{margin-bottom:1.875rem;overflow:hidden}.article-table-content .article-section__table{display:table;margin-top:0}.article-section__table{position:relative}.article-section__table tbody{border-top:1px solid #bdbbb7}.article-section__table td,.article-section__table th{font-size:.875rem;padding:.5rem;vertical-align:top;line-height:1.5rem}.article-section__table th{border-top:0}.article-section__table th:first-child{border-left:none}.article-section__table th:last-child{border-right:none}.article-section__table td{font-weight:400}.article-section__table tr:not(:last-child) td{padding-bottom:0}.article-section__table td.left-aligned{text-align:left}.article-table-caption{font-size:1rem;line-height:1.625rem;margin-bottom:.625rem}.article-table-caption .table-caption__label{font-weight:600}.article-table-content-wrapper{overflow-x:auto;max-height:37.5rem;margin-top:.9375rem}.article-table-content-wrapper thead tr th{border:0;position:sticky;z-index:2;background-color:#eee}.article-table-content-wrapper thead tr th:before{content:"";border-right:1px solid #9e9d99;position:absolute;top:0;right:0;bottom:0}.article-table-content-wrapper thead tr th:last-of-type:before{border-right:none}.article-table-content-wrapper thead tr:first-child th{top:0}.article-table-content-wrapper+.article-section__table-footnotes{font-size:.75rem;line-height:1.625rem}@media (max-width:767px){.primary-heading{font-size:.75rem}.article-citation{padding-bottom:.375rem}.article-citation:after{border-bottom:2px solid #d8d9da;content:"";position:absolute;z-index:1;left:0;right:0}}@media (max-width:991px){.accordion-tabbed__control i.icon-mail_outline{display:inline}}.w-slide__content{background-color:#efeff0;color:#1c1d1e;padding:3rem 0 0;margin-top:1rem;height:100%}.w-slide_head{background-color:#005274;color:#fff;line-height:3.125rem;max-height:100%;font-weight:400;padding:0 1.25rem}.w-slide_head:after{content:"";display:block;width:0;height:0;border:10px solid transparent;border-top-color:#005274;position:absolute;top:100%;left:50%;margin-left:-.625rem}.w-slide__title{color:#fff;max-height:100%}.w-slide__back{color:#fff;text-transform:capitalize}.w-slide__back i{color:#fff;font-size:.75rem;font-weight:700;margin-top:.75rem;margin-right:.625rem}.w-slide__back:focus,.w-slide__back:hover{color:#fff}.skip-links a{position:absolute;top:-100%;padding:.5rem;font-weight:600;color:#fff;background-color:#000;z-index:13}.skip-links a:focus{top:0}.footNotePopup__item{position:relative;padding:0 .9375rem;display:inline-block}.article__content{z-index:unset}.article__content article{padding-top:0}.article__content.article-row-left:focus{outline:none}@media (min-width:769px){.article__content.article-row-left .coolBar{height:3.8125rem}}section.article-section a{color:#005274}.w-slide__btn i{display:inline-block}@media (max-width:991px){.w-slide__btn i{font-size:1rem}}article .abstract-group .article-section__header{display:inline-block;font-size:1.5625rem;color:#414246;font-weight:400;margin-bottom:.9375rem}article .abstract-group .article-section__content{font-size:1rem}a.bibLink:hover,a.tab-link:hover{background:#2f7bae;color:#fff!important}.citation a{color:#005274}.citation h1.citation__title{margin:.5rem 0}@media (max-width:991px){.citation h1{font-size:.75rem;display:inline-block;font-weight:600}.citation h1:after{content:"/";margin:0 .1875rem}}.citation .journal-banner-text{margin:0;font-size:0}@media (max-width:991px){.citation .journal-banner-text{font-size:.75rem;display:inline-block;font-weight:600}.citation .journal-banner-text>a:after{content:"/";margin:0 .1875rem}}.citation--logo{display:inline-block;margin:.3125rem 0}@media (max-width:991px){.citation--logo{display:none}}.citation__title{color:#1c1d1e;line-height:1.875rem}@media (max-width:991px){.citation__title{font-size:1.125rem}}.citation .openUrl{line-height:1.125rem;font-weight:600}.epub-sections{margin:.9375rem 0;color:#767676}@media (max-width:991px){.epub-sections{line-height:1.5}}.epub-state{color:#8b8b8b}.epub-section{opacity:1;display:inline-block;margin:0;font-size:.875rem;line-height:1.15}.epub-section>span{display:inline-block}.epub-section>span.epub-state{white-space:pre}@media (max-width:991px){.epub-section{display:block;margin-bottom:.3125rem}}@media (min-width:992px){.epub-section:not(:last-child):after{font-weight:400;content:"|";margin-left:.3125rem;margin-right:.3125rem;display:inherit;font-size:inherit;line-height:inherit}}.epub-doi{font-weight:600;word-wrap:break-word}.epub-date{color:#1c1d1e;font-weight:500}.doi-access-container{margin:.625rem 0}.doi-access-container,.doi-access-container .primary-heading{display:flex;align-items:center}.doi-access-wrapper{display:flex;align-items:center}@media (max-width:991px){.doi-access-wrapper .icon-icon-lock_open{margin-right:0}}.doi-access-wrapper .access-type{display:flex;align-items:center;line-height:normal}article{margin-bottom:1.25rem;color:#1c1d1e}article [class*=loa-authors]{margin:.9375rem 0}article .author-name{font-size:.875rem;padding:0;line-height:1.25rem;color:#005274}article .author-name span{padding:0;margin:0}article .author-name i{margin:0;float:none}article .author-name i.icon-mail_outline{margin-left:.1875rem}@media (max-width:991px){article .accordion-tabbed__tab-mobile{position:relative}}.article-citation .desktop-authors .accordion-tabbed__tab-mobile i.icon-mail_outline{font-size:1rem}.article-citation .desktop-authors .accordion-tabbed__tab-mobile .comma-separator{position:static;display:inline-block;padding-right:.25rem;color:#8b8b8b;box-shadow:none}.article-citation .desktop-authors .accordion-tabbed__tab-mobile:last-of-type .comma-separator,.article-citation .mobile-authors .accordion-tabbed__tab-mobile:last-of-type .comma-separator{display:none}@media (min-width:1200px){.quick-search form{text-align:right}.quick-search__button{position:static;background-color:#b8b8b8}.quick-search select{width:auto;padding-top:.9375rem;padding-bottom:.9375rem;max-height:none;position:relative;border-color:#005274;background-image:var(--sf-img-27);color:#fff}.quick-search select{right:-100%;z-index:1;background-color:#005274}.quick-search .tab{text-align:right}.quick-search .tab__content{display:inline-block;vertical-align:top}.main-search-field-wrapper{display:block}.main-search-field-wrapper .input-group{display:inline-block;vertical-align:top}}.main-search-field-wrapper{position:relative}.quickSearchAutocomplete.ui-autocomplete{z-index:12;padding:0;margin:0}.quick-search{width:auto;display:inline-block;float:right}.quick-search__button{box-shadow:0 .0625rem 0 0#767676,.0625rem 0 0 0#767676,0-.0625rem 0 0#767676;position:relative;right:.0625rem;top:.0625rem;bottom:.0625rem;height:2.875rem;width:2.875rem;max-height:100%;z-index:2;border:2px solid #fff}.quick-search__button.btn{padding:0}.quick-search select{transition:all .8s}.quick-search input{vertical-align:middle;margin-top:0;margin-bottom:0;width:15.125rem;min-width:12.5rem;height:3rem;max-height:100%;padding:.9375rem 0 .9375rem .9375rem;background:#fff;border-color:#767676}.quick-search .fakeQSInput{position:absolute;right:0;outline:none;z-index:1;margin-right:2.875rem}@media (max-width:1199px){.quick-search .fakeQSInput{display:none}}.quick-search .actualQSInput{transition:all .8s;display:block;width:15.125rem;position:relative;right:-15.125rem;z-index:2}@media (max-width:1199px){.quick-search .actualQSInput{right:0}}.quick-search ::-webkit-input-placeholder{font-size:16.8px;font-size:1.05rem;font-weight:300;font-style:normal;color:#767676;opacity:1!important}.quick-search :-moz-placeholder,.quick-search ::-moz-placeholder{font-size:16.8px;font-size:1.05rem;font-weight:300;font-style:normal;color:#767676;opacity:1!important}@media (max-width:1199px){.quick-search .search-within{position:absolute;left:0;margin:0;color:#fff;border-radius:0;background-color:#005274;border-color:#005274;background-image:var(--sf-img-27);z-index:3}}@media (min-width:768px) and (max-width:1199px){.quick-search .search-within{top:0;width:25%;border-right:0;padding:1.0625rem .625rem;max-height:100%}}@media (max-width:767px){.quick-search .search-within{top:3.25rem;border-top:0;padding:.4375rem}}.header-quicksearch{display:inline-block;position:absolute;right:12.5rem;top:auto;z-index:12}@media (max-width:1199px){.header-quicksearch{position:static;padding-right:.9375rem;vertical-align:middle;margin:0;display:inline-block}}@media (min-width:1200px){.header-quicksearch{top:50%;transform:translateY(-50%);max-height:3rem}}.header-quicksearch .quick-search{padding:0;z-index:12}@media (min-width:1200px){.header-quicksearch .quick-search{min-width:18.125rem}}@media (max-width:1199px){.quick-search-wrapper .quick-search{display:none;position:absolute;right:0;left:0;background:#fff;border-top:4px solid #005274;padding:1.25rem;box-shadow:0 .3125rem .25rem -.25rem rgba(0,0,0,.32);margin-top:.8125rem}.quick-search-wrapper .quick-search input{display:inline-block;vertical-align:middle;margin-top:0;margin-bottom:0;height:3.125rem;border:1px solid #b8b8b8;padding:1.375rem 0 1.75rem .9375rem;background:#fff;width:100%}.quick-search-wrapper .quick-search input.fakeQSInput{margin:0}}@media (max-width:1199px) and (min-width:768px) and (max-width:1199px){.quick-search-wrapper .quick-search input.quickSearchFilter{width:calc(75% - 3.125rem);margin-right:3.125rem;left:25%}}@media (max-width:1199px){.quick-search-wrapper .quick-search .main-search-field-wrapper{background:#fff}.quick-search-wrapper .quick-search .main-search-field-wrapper .input-group{padding:0;display:block}.quick-search-wrapper .quick-search__button{background-color:#005274;border-color:#005274;bottom:auto;padding:.4375rem;width:3.125rem;height:3.125rem;position:absolute}}@media (max-width:1199px){.ui-widget-content.ui-autocomplete{max-height:9.375rem;overflow:scroll}}.dropdown.hover,.dropdown.js--open,.dropdown:focus,.dropdown:hover{background-color:#003950}@media (max-width:991px){.dropdown.hover,.dropdown.js--open,.dropdown:focus,.dropdown:hover{background-color:transparent}}.dropdown i[class*=_arrow]{font-size:.375rem;font-weight:700;color:#fff;line-height:1;opacity:.84;margin-left:.3125rem;padding:.1875rem 0 .1875rem .1875rem}@media (max-width:991px){.hubpage-menu{background-color:transparent;border-bottom:none;position:fixed;z-index:10;width:100%}}.hubpage-menu li:last-child a{border-right:none}.hubpage-menu a{display:block;text-transform:uppercase;line-height:.75rem;color:#fff;font-weight:600;overflow:hidden}@media (min-width:992px){.hubpage-menu a{border-right:1px solid #fff;padding:.5rem 1.25rem}}.hubpage-menu .pull-left li{padding:0;display:inline-block;vertical-align:middle}@media (max-width:991px){.hubpage-menu .pull-left li{display:block}}.hubpage-menu .pull-left a{padding:1.25rem;border:none;font-size:.75rem}@media (max-width:991px){.hubpage-menu .pull-left a{font-size:1.125rem}}.hubpage-menu nav{box-shadow:none;z-index:11}@media (max-width:991px){.hubpage-menu nav .icon-section_arrow_d{display:none}}.hubpage-menu .dropdown{position:static}.hubpage-menu .dropdown.hover,.hubpage-menu .dropdown:focus,.hubpage-menu .dropdown:hover{background-color:#003950}@media (max-width:991px){.hubpage-menu .dropdown:hover{background-color:transparent}}@media (max-width:991px){.hubpage-menu__nav{transition:all .5s;background-color:#005274;left:0;overflow-y:scroll;top:0;bottom:0;width:100vw;height:0}.hubpage-menu__nav,.hubpage-menu__nav li{padding:0;display:block}.hubpage-menu__nav a{text-transform:none;font-size:1.125rem;line-height:1.375rem;font-weight:600;padding:1.125rem 1.0625rem}.hubpage-menu__nav>ul li .dropdown__toggle.w-slide__btn:after{content:"";display:inline-block;float:right;font-family:icomoon!important;speak:none;font-style:normal;font-variant:normal;text-transform:none;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;line-height:1.25rem;font-size:12px;font-size:.75rem;font-weight:bolder}}@media (max-width:991px){.hubpage-menu .pull-left,.hubpage-menu .pull-right{float:none}}.show-recommended__title{padding:.9375rem .9375rem 0;margin-bottom:0}.cover-image__image img{box-shadow:0 0 .25rem 0 rgba(0,0,0,.5)}.cover-image__image.hasDetails{width:35%;max-width:7.8125rem;float:left;clear:left}.cover-image__image.hasDetails img{max-width:100%;max-height:9.375rem}@media (max-width:991px){.cover-image__image.hasDetails img{width:100%;font-size:.75rem}}.cover-image__image.hasDetails~.cover-image__details{float:left;width:65%;padding-left:.9375rem}.cover-image__image.hasDetails a{display:block}.advert{font-size:.75rem;line-height:1.75rem;color:#9e9d99;margin:0 auto .625rem;overflow:hidden;position:relative}.advert:before{display:block;content:"Advertisement";position:absolute}.advert-rail{padding-top:1.75rem;display:block;height:17.375rem;width:18.75rem;margin-top:.9375rem;margin-bottom:.9375rem}.advert-rail:before{top:0;left:0}.advert-leaderboard{padding-left:1.75rem;max-height:5.625rem;max-width:20.5rem;min-height:1.875rem}.advert-leaderboard:before{transform:rotate(-90deg);bottom:28px;bottom:1.75rem;left:-28px;left:-1.75rem}@media screen and (min-width:768px){.advert-leaderboard{max-width:47.25rem;min-height:5.625rem}}.advert--no-spinner{background:none}.loginBar .sign-in-label{font-size:.875rem;color:#005274;font-weight:600}.loginBar .show-login{display:inline-block}@media (max-width:991px){.loginBar .sign-in-label{display:none}}/*! fancyBox v2.1.5 fancyapps.com | fancyapps.com/fancybox/#license */.pageHeader{box-shadow:0 0 .25rem rgba(0,0,0,.32);position:relative;width:100%;background-color:#fff;z-index:12}@media (max-width:991px){.pageHeader .container{width:100%}}@media (min-width:1200px){.pageHeader .institution{display:flex;flex-direction:row;align-items:center}.pageHeader .institution img{width:auto;max-width:6.25rem}}.pageHeader .contents{display:flex;align-items:center;flex-wrap:wrap;padding:1rem 0 0}@media (min-width:992px){.pageHeader .contents{padding:1.5625rem .9375rem}}@media (min-width:1200px){.pageHeader .contents{display:flex;align-items:center}}.pageHeader .contents>.pull-left,.pageHeader .contents>.pull-right{flex-grow:1;flex-shrink:1}@media (max-width:767px){.pageHeader .contents>.pull-left{flex-basis:40%}}@media (max-width:1199px) and (min-width:992px){.pageHeader .contents>.pull-left{flex-basis:70%;display:flex;align-items:center}}@media (min-width:1200px){.pageHeader .contents>.pull-left{flex-basis:45%;display:flex}.pageHeader .contents>.pull-left .institution-wrapper{display:flex}}.pageHeader .contents>.pull-right{display:flex;justify-content:flex-end;align-items:center}@media (max-width:767px){.pageHeader .contents>.pull-right{flex-basis:60%}}@media (max-width:1199px) and (min-width:992px){.pageHeader .contents>.pull-right{flex-basis:30%}}@media (min-width:1200px){.pageHeader .contents>.pull-right{flex-basis:40%;margin-left:auto}.pageHeader .contents>.pull-right .cart-indicator__wrapper{display:flex;align-items:center}}@media (max-width:1199px){.pageHeader .contents .cart-indicator__wrapper .pull-left,.pageHeader .contents .cart-indicator__wrapper .pull-right{width:auto}}.pageHeader .cart-indicator__wrapper .pull-left{width:auto}.logo-container{display:flex;align-items:center}@media (min-width:992px){.logo-container>a{display:flex}.logo-container>a>img{flex-shrink:0}}@media (min-width:1200px){.logo-container{max-width:40%}}@media (min-width:992px) and (max-width:1199px){.logo-container{max-width:40%}}@media (max-width:991px){.logo-container{padding:0 0 0 .9375rem}}.login-bar-container{display:inline-block;max-width:9.375rem;text-align:center;vertical-align:middle}@media (max-width:1199px){.login-bar-container{padding-right:.9375rem}}@media (min-width:1200px){.login-bar-container{right:.9375rem;position:absolute;top:50%;transform:translateY(-50%);margin-top:0;z-index:12}}.institution-box.has-image .institution__image{width:auto;max-height:3rem;max-width:17.8125rem;margin-right:0}@media (min-width:992px){.institution-box.has-image .institution__image-link{display:block}}.page-footer a{color:#fff}@media (min-width:992px){.page-footer li~li{margin-top:.9375rem}}.main-footer{background:#003951;color:#fff;padding:2.5rem 0 2.1875rem;font-size:1rem;font-weight:300;z-index:2;position:relative}.copyright .copyright{padding-top:.5rem}.copyright-container{font-size:.75rem;margin-top:3.4375rem;color:#fff}.copyright-container a{color:#fff}@media (min-width:992px){.footer-links{text-align:left}}@media (max-width:991px){html{overflow-x:hidden}}.hub-footer li{line-height:.875rem}.hub-footer .hub-copyright{font-size:.75rem}@media (max-width:991px){.hub-footer .hub-copyright{margin-top:2rem}}.hub-footer-logo{width:6.5rem}@media (min-width:992px){.hub-footer-logo{margin-bottom:4.6875rem}}.hub-first-footer{background:#efeff0;padding:2.5625rem 0;z-index:4;position:relative}@media (max-width:767px){.hub-first-footer{padding:2.0625rem 0 1.8125rem}}.hub-first-footer .hub-links{font-weight:600}@media (max-width:767px){.hub-first-footer .hub-links{margin-bottom:.9375rem}}.hub-first-footer .hub-links li a{font-size:.75rem;text-transform:uppercase}@media (max-width:991px){.hub-first-footer .hub-links li{margin-bottom:.9375rem}}@media (max-width:991px){.hub-first-footer .hub-links{margin-bottom:2.6875rem}}.hub-page-body article{margin-top:.9375rem}.body-text p>a,.body-text p>span>a.tab-link{font-weight:600;text-decoration:underline}.doi-access-wrapper .doi-access{text-transform:capitalize}</style>
<style>.hubpage-menu{background-color:#290403}a,.hub-first-footer .hub-links,.hub-first-footer .hub-links li a,.tab__content a{color:#d3033d}.search--filter.dropBlock,.side-section-header,.side-section-header a,.slideshow--full-width-image .owl-dots .owl-dot span,.quick-search.open .quick-search__button,.expanded--quickSearch .quick-search .quick-search__button,.hubpage-menu .dropdown.hover,.hubpage-menu .dropdown:hover,.hubpage-menu .dropdown:focus,.hubpage-menu .menu-item.hover,.hubpage-menu .menu-item:hover,.hubpage-menu .menu-item:focus,.loi--res .side-section-header{background-color:#d3033d}</style>
<style>img#mainLogo{width:100%!important;height:100%!important}.article-section__abstract{padding-left:20px}article .article__content h2.article-section__title,article .article__content h3.article-section__sub-title{font-family:open sans,Arial,icomoon,sans-serif;line-height:1.2;margin-bottom:12px;margin-top:12px;color:#1f1f1f}article .article__body h2,article .article__content h2.article-section__title{color:#00a185;font-size:26px}article .article__content h3.article-section__sub-title{font-size:22px;font-weight:400}article .article-section__sub-content{margin-top:10px}.article-section__content p{margin-bottom:16px}article .article-section__content{font-size:16px}article .article-table-content{border:none}article .article-table-content table{border:1px solid #9e9e9e;color:#000;margin:15px 0}article .article-section__table thead{background-color:#eee;border:1px solid #9e9e9e;font-weight:600}article .article-section__table th{border-left:1px solid #b2b2b2;color:#000;font-weight:600}article .article-section__table th:first-child{border-left:none}article .article-section__table td{font-size:12px;padding:12px}.article-citation a.citation--logo{max-width:100%}</style>
<style>.publication-cover-info{margin-bottom:20px}.article-row-right>.pb-ad{margin-left:0;margin-bottom:10px}.admin-message{background-color:#005274;color:white}.banner-wrapper .pb-ad{padding:0}.hubpage-menu nav{padding-bottom:0;position:relative}.advert.advert-leaderboard{margin:15px 0}.banner-wrapper{box-shadow:none}h1.citation__title{font-size:1.375rem}@media (max-width:991px){h1.citation__title{font-size:1.125rem}h1.citation__title:after{content:""}}.cart-indicator__wrapper{padding:0}</style>
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<style>#_atssh{width:1px!important;height:1px!important;border:0!important}</style><style>@keyframes atRecommendedJumboAnimatedBackground{0%{transform:scale(1,1)}to{transform:scale(1.1,1.1)}}</style><style>@keyframes fadeIn{0%{opacity:0}to{opacity:1}}@keyframes fadeInUp{0%{opacity:0;transform:translateY(20px)}to{opacity:1;transform:translateY(0)}}@keyframes fadeInDown{0%{opacity:0;transform:translateY(-20px)}to{opacity:1;transform:translateY(0)}}@keyframes fadeInLeft{0%{opacity:0;transform:translateX(-20px)}to{opacity:1;transform:translateX(0)}}@keyframes fadeInRight{0%{opacity:0;transform:translateX(20px)}to{opacity:1;transform:translateX(0)}}@keyframes fadeOut{0%{opacity:1}to{opacity:0}}@keyframes fadeOutUp{0%{opacity:1;transform:translateY(0)}to{opacity:0;transform:translateY(-20px)}}@keyframes fadeOutDown{0%{opacity:1;transform:translateY(0)}to{opacity:0;transform:translateY(20px)}}@keyframes fadeOutLeft{0%{opacity:1;transform:translateX(0)}to{opacity:0;transform:translateX(-20px)}}@keyframes fadeOutRight{0%{opacity:1;transform:translateX(0)}to{opacity:0;transform:translateX(20px)}}@keyframes slideInUp{0%{transform:translateY(1500px)}0%,to{opacity:1}to{transform:translateY(0)}}@keyframes slideInDown{0%{transform:translateY(-850px)}0%,to{opacity:1}to{transform:translateY(0)}}@keyframes slideOutUp{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(-250px)}}@keyframes slideOutUpFast{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(-1250px)}}@keyframes slideOutDown{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(350px)}}@keyframes slideOutDownFast{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(1250px)}}@keyframes slideInLeft{0%{opacity:0;transform:translateX(-850px)}to{transform:translateX(0)}}@keyframes slideInRight{0%{opacity:0;transform:translateX(1250px)}to{transform:translateX(0)}}@keyframes slideOutLeft{0%{transform:translateX(0)}to{opacity:0;transform:translateX(-350px)}}@keyframes slideOutRight{0%{transform:translateX(0)}to{opacity:0;transform:translateX(350px)}}</style>
<div data-nosnippet class=osano-cm-window dir=ltr> <div class="osano-visually-hidden sf-hidden" hidden> </div> <div role=dialog id=56f04fb5-b0c9-47cf-a803-9e3cab412215 aria-describedby=56f04fb5-b0c9-47cf-a803-9e3cab412215__label class="osano-cm-window__dialog osano-cm-dialog osano-cm-dialog--hidden osano-cm-dialog--position_bottom osano-cm-dialog--type_bar"> <button class="osano-cm-dialog__close osano-cm-close sf-hidden"> <svg width=20px height=20px viewBox="0 0 20 20" role=img aria-labelledby=2a3c9b57-6b22-49f6-a561-ea2dac573f33> <title id=2a3c9b57-6b22-49f6-a561-ea2dac573f33>Close this dialog</title> <line role=presentation x1=2 y1=2 x2=18 y2=18></line> <line role=presentation x1=2 y1=18 x2=18 y2=2></line> </svg> </button> <div class="osano-cm-dialog__content osano-cm-content"> <span id=56f04fb5-b0c9-47cf-a803-9e3cab412215__label class="osano-cm-content__message osano-cm-message"> This website stores data such as cookies to enable essential site functionality, as well as marketing, personalization, and analytics. By remaining on this website you indicate your consent. </span> <a rel=noopener tabindex=0 href=https://www.wiley.com/privacy target=_blank class="osano-cm-storage-policy osano-cm-content__link osano-cm-link" aria-describedby=osano-cm-aria.newWindow>Privacy Policy</a> </div> </div> <button id=42a365e7-da28-44c8-af7a-9bb640976f71 class="osano-cm-window__widget osano-cm-widget osano-cm-widget--position_left sf-hidden" title="Cookie Preferences" aria-label="Cookie Preferences"> <svg width=40 height=40 viewBox="0 0 71.85 72.23" xmlns=http://www.w3.org/2000/svg> <path d="m67.6 36.73a6.26 6.26 0 0 1 -3.2-2.8 5.86 5.86 0 0 0 -5.2-3.1h-.3a11 11 0 0 1 -11.4-9.5 6 6 0 0 1 -.1-1.4 9.2 9.2 0 0 1 .4-2.9 8.65 8.65 0 0 0 .2-1.6 5.38 5.38 0 0 0 -1.9-4.3 7.3 7.3 0 0 1 -2.5-5.5 3.91 3.91 0 0 0 -3.5-3.9 36.46 36.46 0 0 0 -15 1.5 33.14 33.14 0 0 0 -22.1 22.7 35.62 35.62 0 0 0 -1.5 10.2 34.07 34.07 0 0 0 4.8 17.6.75.75 0 0 0 .07.12c.11.17 1.22 1.39 2.68 3-.36.47 5.18 6.16 5.65 6.52a34.62 34.62 0 0 0 55.6-21.9 4.38 4.38 0 0 0 -2.7-4.74z" stroke-width=3 style=fill:rgb(255,255,255);stroke:rgb(41,36,106)></path> <path d="m68 41.13a32.37 32.37 0 0 1 -52 20.5l-2-1.56c-2.5-3.28-5.62-7.15-5.81-7.44a32 32 0 0 1 -4.5-16.5 34.3 34.3 0 0 1 1.4-9.6 30.56 30.56 0 0 1 20.61-21.13 33.51 33.51 0 0 1 14.1-1.4 1.83 1.83 0 0 1 1.6 1.8 9.38 9.38 0 0 0 3.3 7.1 3.36 3.36 0 0 1 1.2 2.6 3.37 3.37 0 0 1 -.1 1 12.66 12.66 0 0 0 -.5 3.4 9.65 9.65 0 0 0 .1 1.7 13 13 0 0 0 10.5 11.2 16.05 16.05 0 0 0 3.1.2 3.84 3.84 0 0 1 3.5 2 10 10 0 0 0 4.1 3.83 2 2 0 0 1 1.4 2z" stroke-width=3 style=fill:rgb(255,255,255);stroke:rgb(41,36,106)></path> <g style=fill:rgb(55,205,143)> <path d="m26.6 31.43a5.4 5.4 0 1 1 5.4-5.43 5.38 5.38 0 0 1 -5.33 5.43z"></path> <path d="m25.2 53.13a5.4 5.4 0 1 1 5.4-5.4 5.44 5.44 0 0 1 -5.4 5.4z"></path> <path d="m47.9 52.33a5.4 5.4 0 1 1 5.4-5.4 5.32 5.32 0 0 1 -5.24 5.4z"></path> </g> </svg> </button> <div role=dialog aria-modal=true id=518a717d-17f9-4058-a8bc-7eb94ea995d1 aria-labelledby=518a717d-17f9-4058-a8bc-7eb94ea995d1__label aria-hidden=true class="osano-cm-window__info-dialog osano-cm-info-dialog osano-cm-info-dialog--hidden"> <span tabindex=0 aria-hidden=true role=first></span> <div role=presentation class="osano-cm-info-dialog__info osano-cm-info osano-cm-info--position_left"> <div role=presentation class="osano-cm-info__info-dialog-header osano-cm-info-dialog-header"> <p role=heading aria-level=1 id=518a717d-17f9-4058-a8bc-7eb94ea995d1__label class="osano-cm-info-dialog-header__header osano-cm-header"> </p> <button class="osano-cm-info-dialog-header__close osano-cm-close"> <svg width=20px height=20px viewBox="0 0 20 20" role=img aria-labelledby=9cf941cf-fd43-41eb-a24b-90606bd01594> <title id=9cf941cf-fd43-41eb-a24b-90606bd01594>Close Cookie Preferences</title> <line role=presentation x1=2 y1=2 x2=18 y2=18></line> <line role=presentation x1=2 y1=18 x2=18 y2=2></line> </svg> </button> </div> <div role=presentation class="osano-cm-info__info-views osano-cm-info-views osano-cm-info-views--hidden osano-cm-info-views--position_0" style=transform:translateX(0%)> </div> </div> <span tabindex=0 aria-hidden=true role=last></span> </div> </div>
<div class=skip-links>
 <ul class=rlist>
 
 <li><a href=#article__content tabindex=1>Skip to Article Content</a></li>
 <li><a href=#pane-pcw-detailscon tabindex=1>Skip to Article Information</a></li>
 
 </ul>
</div>
 <div id=pb-page-content data-ng-non-bindable>
 <div data-pb-dropzone=main data-pb-dropzone-name=Main>
 <div data-widget-def=pageHeader data-widget-id=62175478-b98a-43d5-90f2-1f2045ac1a7e class=pageHeader>
 
 
 <header class=page-header>
 <div data-pb-dropzone=main>
 
 
 
 <div data-widget-def=ux3-layout-widget data-widget-id=bb5b5e2c-d3d6-4015-b586-eeade38f59d4 class=admin-message>
 
 
 <div class=container><div class=row><div>
 
 
 <div class=pb-ad>
 <div style="background=blue;">
 <div class=container>
 <p style=text-align:center><b>Working off-campus?</b> Learn about our <a href="https://dom-pubs.onlinelibrary.wiley.com/action/clickThrough?id=101169&amp;url=https%3A%2F%2Fonlinelibrary.wiley.com%2Fresearchers%2Fread%2Faccess-options&amp;loc=%2Fdoi%2F10.1111%2Fdom.13477&amp;pubId=64223431&amp;placeholderId=1029&amp;productId=1011" target=_blank tabindex=2><font color=white><u>remote access options</u></font></a></p>
 </div>
</div>
 </div>
 
</div></div></div>
 </div>
 
 
 <div class=container><div class=row><div class="contents col-md-12">
 <div data-widget-def=UX3InstitutionBanner data-widget-id=4d1f2e23-571a-4b27-8ab7-e7cd8ca15964 class="institution-wrapper-mobile hidden-lg padded-content sf-hidden" aria-hidden=true>
 
 
 
 </div>
 
 
 <div class=pull-left>
 <div data-widget-def=ux3-general-image data-widget-id=ff262197-0fb8-4973-aaa2-2fceba4b5a61 class="logo-container hidden-xs hidden-sm hidden-md">
 
 
 <a href=https://dom-pubs.onlinelibrary.wiley.com/ title="Diabetes, Obesity and Metabolism" tabindex=2><img id=mainLogo alt="Diabetes, Obesity and Metabolism" src=data:image/png;base64,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></a>
 </div>
 
 <div data-widget-def=ux3-general-image data-widget-id=6b601b23-7301-47c8-8889-242d041241c4 class="logo-container-mobile hidden-lg hidden-md hidden-sm sf-hidden">
 
 
 
 </div>
 
 <div data-widget-def=UX3InstitutionBanner data-widget-id=14d0e2f8-27d3-42d0-a477-72015e14e818 class="institution-wrapper hidden-xs hidden-sm hidden-md institution--block">
 
 
 <div class=institution><div class="institution-box has-image"><a href=https://uflib.ufl.edu/ title="University of Florida Libraries" target=_blank class=institution__image-link><img src="data:image/jpeg;base64,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" alt="Logo for: University of Florida Libraries" class=institution__image></a><div class="institution-info-wrapper sf-hidden"></div></div></div>
 </div>
 
</div><div class=pull-right>
 <div data-widget-def=UX3QuickSearchWidget data-widget-id=48175bb0-0f70-46e6-bb89-7e2781fdb8e4 class=header-quicksearch>
 
 
 <div class=quick-search-wrapper><a href=# title=search aria-label=Search class="quick-search__item sf-hidden"></a><div data-linkto-page=true class="quick-search quickSearchFormContainer"><div class=main-search-field-wrapper style=overflow:hidden><div class="tab clearfix"><input type=search placeholder=Search value tabindex=13 aria-label=Search class="fakeQSInput quickSearchFilter"><label for=search-within class=sr-only>Search within</label><select name=search-within id=search-within tabindex=10 class=search-within><option value=#pane-67065c09-4a88-49cd-934c-ac707951d35c0 data-url=thisCategory data-value=14631326 selected>This Journal<option value=#pane-67065c09-4a88-49cd-934c-ac707951d35c1 data-url=https://dom-pubs.onlinelibrary.wiley.com>DOM Journals<option value=#pane-67065c09-4a88-49cd-934c-ac707951d35c2 data-url=https://onlinelibrary.wiley.com>Wiley Online Library</select><ul role=tablist class="rlist tab__content"><li id=pane-67065c09-4a88-49cd-934c-ac707951d35c0 aria-labelledby=pane-67065c09-4a88-49cd-934c-ac707951d35c0-con role=tab class="tab__pane quick-search-pane__anywhere active"><form action=/action/doSearch name=thisJournalQuickSearch title="Quick Search"><div class="input-group option-0"><label for=searchField0 class=hiddenLabel>Search term</label><input type=search name=AllField id=searchField0 placeholder=Search data-auto-complete-max-words=7 data-auto-complete-max-chars=32 data-contributors-conf=3 data-topics-conf=3 data-publication-titles-conf=3 data-history-items-conf=3 value tabindex=9 class="autocomplete actualQSInput quickSearchFilter ui-autocomplete-input" autocomplete=off><span role=status aria-live=polite class=ui-helper-hidden-accessible></span><div class="search-options-wrapper quickSearchFilter sf-hidden"></div></div><button type=submit title=Search tabindex=11 aria-label="Submit Search" class="btn quick-search__button icon-search"></button></form><li id=pane-67065c09-4a88-49cd-934c-ac707951d35c1 aria-labelledby=pane-67065c09-4a88-49cd-934c-ac707951d35c1-con role=tab class="tab__pane quick-search-pane__anywhere sf-hidden"><li id=pane-67065c09-4a88-49cd-934c-ac707951d35c2 aria-labelledby=pane-67065c09-4a88-49cd-934c-ac707951d35c2-con role=tab class="tab__pane quick-search-pane__anywhere sf-hidden"></ul></div></div></div></div>
 </div>
 
 <div data-widget-def=ux3-layout-widget data-widget-id=5ef13ed1-f4ac-4b62-a426-07ec9576a586 class=cart-indicator__wrapper>
 
 
 <div class=pull-left>
 <div data-widget-def=eCommerceCartIndicatorWidget data-widget-id=4a9f7c04-a273-4a25-91fb-8e7bd9970288 class=cart-indicator__wrapper>
 
 
 
<div class=eCommerceCartIndicatorWidget>
 
 
 
</div>
 </div>
 
</div><div class=pull-right>
 <div data-widget-def=literatumNavigationLoginBar data-widget-id=d384ca92-7137-45d6-b3c2-78c9c0a98c2b class=login-bar-container>
 
 
 
 
 
 
 <div class="loginBar login-open">
 <a href="https://dom-pubs.onlinelibrary.wiley.com/action/showLogin?uri=%2Fdoi%2F10.1111%2Fdom.13477&amp;aria-label=Log+in+or+Register" class=show-login role=button uri=/doi/10.1111/dom.13477 aria-label="Log in or Register">
 <span class="icon-profile_empty sf-hidden"></span>
 <span class=sign-in-label>Login / Register</span>
 </a>
 
 </div>
 
 </div>
 
</div>
 </div>
 
 
 <a href=#main1 title="menu drawer" data-db-switch=icon-close_thin data-db-target-for=hub-menu class="hubpage-menu__burger hidden-lg sf-hidden"></a>
</div>
</div></div></div>
 </div>
</header>
 </div>
 
 <div data-widget-def=pageBody data-widget-id=72100436-7a82-49fc-933b-c6c9d8c42914 class="pageBody hub-page-body body-text">
 
 
 <main id=main-content tabindex=-1>
 
 <div class="page-body pagefulltext">
 <div data-pb-dropzone=main>
 
 
 <div>
 
 <div class=hubpage-menu>
 <nav role=navigation data-db-target-of=hub-menu class="container hubpage-menu__nav visible-lg dropBlock__holder">
 <ul class="pull-left rlist--inline">
 <li role=menuitem aria-label=Journals class="dropdown menu-parent"><a id=main1-1 href=# title=Journals data-toggle=dropdown data-slide-target=#hubMain-sub-1 class="dropdown__toggle w-slide__btn"><span>Publications</span><i aria-hidden=true class="icon-section_arrow_d pull-right visible-lg"></i></a>
 <div id=hubMain-sub-1 aria-labelledby=main1-1 aria-hidden=true role=menu class="dropdown__menu sf-hidden">
 
 </div>
 </li>
 </ul>
 </nav>
</div>
</div>
 
 <section class=hub-journal-bar>
 <div data-widget-def=literatumAd data-widget-id=0220a30b-90c0-4b51-8637-141edf12f86a class=banner-wrapper>
 
 
 
 <div class=pb-ad>
 <aside role=complementary>
 <div id=advert-leaderboard class="advert advert-leaderboard advert--no-spinner" data-google-query-id=CNSBkc7MzfsCFQno4wcdmjsELg>
 
 
 
 <div id=google_ads_iframe_/2215/wly.endocrin_000051/diabetes-obesity-metabolism_dom_0__container__ style="border:0pt none"></div></div>
 </aside>
 </div>
 
 </div>
 
 
 
</section>
 <section data-widget-def=ux3-layout-widget data-widget-id=0f7bccba-8328-4dbd-a1fa-e84c526dd9ab>
 
 
 <div class=container><div class=row><div class=col-md-12>
 
 <div>
 
 <article data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1111%2Fdom.13477&amp;pbContext=%3BrequestedJournal%3Ajournal%3A14631326%3Bissue%3Aissue%3Adoi%5C%3A10.1111%2Fdom.2019.21.issue-1%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1111%2Fdom.13477%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3A14631326%3Bwebsite%3Awebsite%3Adom-pubs%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;accordionHeadingWrapper=h2" data-related="/action/ajaxShowRecommended?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1111%2Fdom.13477&amp;pbContext=%3BrequestedJournal%3Ajournal%3A14631326%3Bissue%3Aissue%3Adoi%5C%3A10.1111%2Fdom.2019.21.issue-1%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1111%2Fdom.13477%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3A14631326%3Bwebsite%3Awebsite%3Adom-pubs%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata" data-details="/action/ajaxShowPubInfo?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1111%2Fdom.13477&amp;pbContext=%3BrequestedJournal%3Ajournal%3A14631326%3Bissue%3Aissue%3Adoi%5C%3A10.1111%2Fdom.2019.21.issue-1%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1111%2Fdom.13477%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3A14631326%3Bwebsite%3Awebsite%3Adom-pubs%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;accordionHeadingWrapper=h2&amp;showSubjects=true&amp;taxonomiesCodes=enter+your+taxonomy+codes+here&amp;displayCitedByLink=true&amp;displayAlmetricDropzone=true&amp;taxonomyUri=publication-features&amp;topicUri=hide-issue-metadata" data-mathjax="https://cdnjs.cloudflare.com/ajax/libs/mathjax/3.2.0/es5/tex-mml-chtml.min.js?config=TeX-MML-CHTML"><div class="row article-row"><div id=article__content tabindex=-1 class="col-sm-12 col-md-8 col-lg-8 article__content article-row-left"><div data-pb-dropzone=mrwBannerDropZone class=mrw-banner-dropzone>
 
 
</div><div class=article-citation><div class=citation>
 <div class=pb-dropzone data-pb-dropzone=publicaitonContent-series-title><div id=journal-banner-text class=journal-banner-text><a href=https://dom-pubs.onlinelibrary.wiley.com/journal/14631326 title="Diabetes, Obesity and Metabolism homepage">Diabetes, Obesity and Metabolism</a></div><a href=https://dom-pubs.onlinelibrary.wiley.com/toc/14631326/2019/21/1 class="volume-issue sf-hidden">Volume 21, Issue 1</a><span class="citation__page-range sf-hidden"> p. 28-36</span><a href=https://dom-pubs.onlinelibrary.wiley.com/journal/14631326 title="Diabetes, Obesity and Metabolism homepage" class=citation--logo><img id=journal-banner-image test=test-value alt="Diabetes, Obesity and Metabolism" src=data:image/jpeg;base64,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 class=journal-banner-image></a></div>
 <div class="doi-access-container clearfix"><span class=primary-heading><span class=primary-heading>ORIGINAL ARTICLE</span></span><div class=doi-access-wrapper><div class="full-access access-type"><i aria-hidden=true class=icon-icon-lock_open></i><div class=doi-access>Full Access</div></div></div></div>
 <h1 class=citation__title>Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes</h1>
 <div class=pb-dropzone data-pb-dropzone=publicaitonContent-versions></div>
 <div class="loa comma visible-xs mobile-authors loa-authors-trunc sf-hidden">
 
 </div>
 <div class="loa-wrapper loa-authors hidden-xs desktop-authors">
 <div id=sb-1 class=accordion>
 <div class=comma__list>
 <div class=accordion-tabbed><span class="accordion-tabbed__tab-mobile accordion__closed"><a href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Dawwas%2C+Ghadeer+K" class="author-name accordion-tabbed__control" data-id=a1 data-db-target-for=a1 aria-controls=a1 aria-haspopup=true id=a1_Ctrl role=button><span>Ghadeer K. Dawwas MBA</span><i aria-hidden=true class="icon-section_arrow_d sf-hidden"></i></a><span class=comma-separator>, </span><div class="author-info accordion-tabbed__content sf-hidden" data-db-target-of=a1 aria-labelledby=a1_Ctrl role=region id=a1>
 
 
 </div></span><span class="accordion-tabbed__tab-mobile accordion__closed"><a href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Smith%2C+Steven+M" class="author-name accordion-tabbed__control" data-id=a2 data-db-target-for=a2 aria-controls=a2 aria-haspopup=true id=a2_Ctrl role=button><span>Steven M. Smith PharmD</span><i aria-hidden=true class="icon-section_arrow_d sf-hidden"></i></a><span class=comma-separator>, </span><div class="author-info accordion-tabbed__content sf-hidden" data-db-target-of=a2 aria-labelledby=a2_Ctrl role=region id=a2>
 
 
 
 </div></span><span class="accordion-tabbed__tab-mobile accordion__closed"><a href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Park%2C+Haesuk" class="author-name accordion-tabbed__control" data-id=a3 data-db-target-for=a3 aria-controls=a3 aria-haspopup=true id=a3_Ctrl role=button><span>Haesuk Park PhD<i aria-hidden=true class=icon-mail_outline></i></span><i aria-hidden=true class="icon-section_arrow_d sf-hidden"></i></a><span class="comma-separator sf-hidden">, </span><div class="author-info accordion-tabbed__content sf-hidden" data-db-target-of=a3 aria-labelledby=a3_Ctrl role=region id=a3>
 
 
 
 
 
 
 
 </div></span></div>
 </div>
 </div>
 </div>
 <div class=epub-sections><div class=epub-section><span class=epub-state>First published: </span><span class=epub-date>23 July 2018</span></div>
 <div class=epub-section><a class=epub-doi aria-label="Digital Object Identifier" href=https://doi.org/10.1111/dom.13477>https://doi.org/10.1111/dom.13477</a></div><div class="epub-section cited-by-count"><span>Citations: <a href=#citedby-section>41</a></span></div></div><span class=openUrl><a href="https://dom-pubs.onlinelibrary.wiley.com/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1111/dom.13477&amp;type=tocOpenUrl&amp;url=https%3A%2F%2Fufl-flvc.primo.exlibrisgroup.com%2Fopenurl%2F01FALSC_UFL%2F01FALSC_UFL%3AUFL%3F" title="OpenURL University Of Florida" class="sfxLink visitable" target=_blank>Check for Full Text</a></span>
 <div class=epub-sections>
 <div class="article-header__references-container no-truncate" id=dom13477-note-1001 tabindex=0>
 <div class=header-note-content aria-labelledby=header-note><b>Funding information</b> This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit-sector.</div>
 </div>
 </div>
</div></div><div class=fixedCoolBar style=padding-top:0px><nav aria-label="Article navigation and tools" class="coolBar stickybar" style=top:auto;width:auto;left:auto><div class="stickybar__wrapper coolBar__wrapper clearfix"><div class="rlist coolBar__zone"><div class=coolBar__section><a data-db-target-for=article data-db-switch=icon-close_thin aria-haspopup=true aria-controls=article_Pop role=button id=article_Ctrl class="coolBar__ctrl hidden-lg sf-hidden"></a><div data-db-target-of=article aria-labelledby=article_Ctrl role=menu id=article_Pop class="coolBar__drop fixed rlist dropBlock__holder sf-hidden"></div></div><div class="coolBar__section coolBar--sections"><a id=sections_Ctrl data-db-target-for=sections data-db-switch=icon-close_thin aria-haspopup=true aria-controls=sections_Pop role=button class=coolBar__ctrl><i class=icon-list-unordered></i><span>Sections</span></a><div data-db-target-of=sections aria-labelledby=sections_Ctrl role=menu id=sections_Pop class="coolBar__drop dropBlock__holder rlist fixed sf-hidden"></div></div></div><div class="coolBar__second rlist"><div class="coolBar__section coolBar--download PdfLink cloned"><a href=https://dom-pubs.onlinelibrary.wiley.com/doi/epdf/10.1111/dom.13477 title=ePDF class="coolBar__ctrl pdf-download"><img src="data:image/png;base64,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" alt=PDF>PDF</a></div>
 
 <div class=relative><a href=# data-db-target-for=0e406ce9-5c43-4e2d-b741-e0b43d1f1865 data-db-switch=icon-close_thin aria-haspopup=true aria-controls=0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop role=button id=0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl aria-label=Tools class=article-tools__ctrl><i aria-hidden=true class=icon-Icon_Tools></i><span>Tools</span></a><div data-db-target-of=0e406ce9-5c43-4e2d-b741-e0b43d1f1865 aria-labelledby=0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Ctrl role=menu id=0e406ce9-5c43-4e2d-b741-e0b43d1f1865_Pop class="article-tools__block fixed dropBlock__holder sf-hidden"></div></div>
 
 <div class=relative><a id=share-access__ctrl href=# data-db-target-for=dff42abe-4b17-4fe9-a9c5-625405cd1007 data-db-switch=icon-close_thin aria-haspopup=true aria-controls=share_Pop role=button aria-label=Share class=share-access__ctrl><i aria-hidden=true class=icon-Icon_Share></i><span>Share</span></a><a id=share__ctrl href=# data-db-target-for=dff42abe-4b17-4fe9-a9c5-625405cd1007 data-db-switch=icon-close_thin aria-haspopup=true aria-controls=share_Pop role=button class="share__ctrl hidden sf-hidden"></a><div data-db-target-of=dff42abe-4b17-4fe9-a9c5-625405cd1007 aria-labelledby=share-access__ctrl role=menu id=share_Pop class="share__block dropBlock__holder fixed sf-hidden">
 
 
</div></div>
</div></div></nav></div><div id=accessDenialslot class=accessDenialslot></div><div class=article__body><article>
 
 <div class=abstract-group>
 <section class="article-section article-section__abstract" data-lang=en id=section-1-en lang=en>
 <h2 id=d9094371 class="article-section__header section__title main abstractlang_en">Abstract</h2>
 <div class="article-section__content en main">
 
 <section class=article-section__content id=dom13477-sec-0001>
 
 <h3 class="article-section__sub-title section1" id=dom13477-sec-0001-title> Aims</h3>
 
 <p>To determine the association between cardiovascular diseases (CVD) and SGLT2 inhibitors compared to sulfonylureas and dipeptidyl peptidase-4 (DPP4) inhibitors and to examine within-class effects of SGLT2 inhibitors.</p>
 </section>
 
 <section class=article-section__content id=dom13477-sec-0002>
 
 <h3 class="article-section__sub-title section1" id=dom13477-sec-0002-title> Methods</h3>
 
 <p>A retrospective cohort analysis was conducted using Truven Health MarketScan. New users of SGLT2 inhibitors, sulfonylureas or DPP-4 inhibitors were included. Primary outcome was incident CVD, defined as non-fatal myocardial infarction or non-fatal stroke; secondary outcomes were hospitalization because of heart failure and lower extremity amputation. Proportional hazards models, after propensity score matching, were used to obtain hazard ratios (HR) and 95% confidence intervals (CI).</p>
 </section>
 
 <section class=article-section__content id=dom13477-sec-0003>
 
 <h3 class="article-section__sub-title section1" id=dom13477-sec-0003-title> Results</h3>
 
 <p>In fully adjusted models, use of SGLT2 inhibitors was associated with a decreased risk of developing CVD compared with use of sulfonylureas (HR, 0.50; 95% CI, 0.45, 0.55) and DPP-4 inhibitors (HR, 0.57; 95% CI, 0.52, 0.62), respectively. Analyses revealed no evidence of within-class effects: dapagliflozin vs sulfonylureas (HR, 0.55; 95% CI, 0.43, 0.70) or DPP-4 inhibitors (HR, 0.57; 95% CI, 0.46, 0.70); and canagliflozin vs sulfonylureas (HR, 0.61; 95% CI, 0.54, 0.69) or DPP-4 inhibitors (HR, 0.66; 95% CI, 0.54, 0.71). Additionally, SGLT2 inhibitors were associated with lower risk of hospitalization because of heart failure compared to both sulfonylureas and DPP-4 inhibitors, as well as lower risk of lower extremity amputation compared to sulfonylureas.</p>
 </section>
 
 <section class=article-section__content id=dom13477-sec-0004>
 
 <h3 class="article-section__sub-title section1" id=dom13477-sec-0004-title> Conclusion</h3>
 
 <p>Using population-based data, incident use of SGLT-2 inhibitors was associated with a decreased incidence of CVD compared to use of sulfonylureas and DPP-4 inhibitors. These findings were consistent between dapagliflozin and canagliflozin, suggesting that CVD reduction is a class effect for SGLT2 inhibitors. In addition, SGLT2 inhibitors portended lower risk of hospitalization because of heart failure (vs sulfonylureas and DPP-4 inhibitors) and lower risk of lower extremity amputation (vs sulfonylureas).</p>
 </section>
 </div>
 </section>
 </div>
 <div class=pb-dropzone data-pb-dropzone=below-abstract-group></div>
 
 <section class="article-section article-section__full">
 <section class=article-section__content id=dom13477-sec-0005>
 
 <h2 class="article-section__title section__title section1" id=dom13477-sec-0005-title>1 INTRODUCTION</h2>
 
 <p>Type 2 diabetes now affects more than 350 million patients worldwide,<span><a href=#dom13477-bib-0001 class="bibLink tab-link" id=dom13477-bib-0001_R_d9094365e359 data-tab=pane-pcw-references aria-label="Reference 1 - Cardiovasc Diabetol">1</a></span> putting these individuals at higher risk of developing micro- and macrovascular complications including cardiovascular diseases (CVDs).<span><a href=#dom13477-bib-0002 class="bibLink tab-link" id=dom13477-bib-0002_R_d9094365e361 data-tab=pane-pcw-references aria-label="Reference 2 - Diabetes Obes Metab">2</a></span> Maintaining optimal glycaemic control can delay or reduce the risk of potential complications.<span><a href=#dom13477-bib-0002 class="bibLink tab-link" id=dom13477-bib-0002_R_d9094365e363 data-tab=pane-pcw-references aria-label="Reference 2 - Diabetes Obes Metab">2</a></span> However, debate continues regarding which antihyperglycaemic drugs optimally reduce complications. Recent evidence from randomized clinical trials (RCTs) suggests that sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as dapagliflozin, canagliflozin and empagliflozin, may exhibit cardioprotective effects.<span><a href=#dom13477-bib-0003 class="bibLink tab-link" id=dom13477-bib-0003_R_d9094365e365 data-tab=pane-pcw-references aria-label="Reference 3 - Cardiovasc Drugs Ther">3</a></span> For example, the Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME) reported a 14% reduction in the risk of CVD (non-fatal myocardial infarction [MI] and non-fatal stroke) and CVD-related death in the empagliflozin group compared to the placebo group.<span><a href=#dom13477-bib-0004 class="bibLink tab-link" id=dom13477-bib-0004_R_d9094365e367 data-tab=pane-pcw-references aria-label="Reference 4 - N Engl J Med">4</a></span> Similarly, the Canagliflozin Cardiovascular Assessment Study (CANVAS) trial reported a lower risk of CVD events with canagliflozin compared to placebo (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.75, 0.97).<span><a href=#dom13477-bib-0005 class="bibLink tab-link" id=dom13477-bib-0005_R_d9094365e370 data-tab=pane-pcw-references aria-label="Reference 5 - N Engl J Med">5</a></span> Subsequently, these results were supported by a meta-analysis of RCTs which found a net protective effect of SGLT2 inhibitors against major CVDs (relative risk [RR], 0.85; 95% CI, 0.77, 0.93), heart failure (RR, 0.67; 95% CI, 0.55, 0.80) and all-cause death (RR, 0.79; 95% CI, 0.70, 0.88).<span><a href=#dom13477-bib-0006 class="bibLink tab-link" id=dom13477-bib-0006_R_d9094365e372 data-tab=pane-pcw-references aria-label="Reference 6 - Diabetes Res Clin Pract">6</a></span></p>
 
 <p>Although RCTs are the gold standard in assessing the effectiveness of medications, the restricted environment of RCTs limits generalizability to real-world settings and often does not allow for assessment of heterogeneity in treatment effects. Evidence generated using real-world data can complement RCTs in guiding prescribing decisions in clinical practice.<span><a href=#dom13477-bib-0007 class="bibLink tab-link" id=dom13477-bib-0007_R_d9094365e376 data-tab=pane-pcw-references aria-label="Reference 7 - N Engl J Med">7</a>, <a href=#dom13477-bib-0008 class="bibLink tab-link" id=dom13477-bib-0008_R_d9094365e376 data-tab=pane-pcw-references aria-label="Reference 8 - Cardiovasc Diabetol">8</a></span></p>
 
 <p>Several observational studies have recently evaluated the cardiovascular safety of SGLT2 inhibitors among patients with type 2 diabetes.<span><a href=#dom13477-bib-0009 class="bibLink tab-link" id=dom13477-bib-0009_R_d9094365e380 data-tab=pane-pcw-references aria-label="Reference 9 - J Clin Endocrinol Metab">9</a>-<a href=#dom13477-bib-0017 class="bibLink tab-link" id=dom13477-bib-0017_R_d9094365e380 data-tab=pane-pcw-references aria-label="Reference 17 - J Am Coll Cardiol">17</a></span> One population-based study, which used data from the Health Improvement Network database, found that, compared to use of other glucose-lowering agents, the use of empagliflozin was associated with lower risk of all-cause mortality, irrespective of baseline CVD.<span><a href=#dom13477-bib-0009 class="bibLink tab-link" id=dom13477-bib-0009_R_d9094365e382 data-tab=pane-pcw-references aria-label="Reference 9 - J Clin Endocrinol Metab">9</a></span> Similarly, the first analysis from the Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors (CVD-REAL) study and two follow-up analyses of the same study showed a lower risk of death and hospitalization as the result of heart failure with use of SGLT2 inhibitors compared to other glucose-lowering medications (eg, sulfonylureas, thiazolidinediones [TZDs]) but showed no difference in incidence of non-fatal MI and non-fatal stroke.<span><a href=#dom13477-bib-0010 class="bibLink tab-link" id=dom13477-bib-0010_R_d9094365e384 data-tab=pane-pcw-references aria-label="Reference 10 - Circulation">10</a>, <a href=#dom13477-bib-0011 class="bibLink tab-link" id=dom13477-bib-0011_R_d9094365e384 data-tab=pane-pcw-references aria-label="Reference 11 - Lancet Diabetes Endocrinol">11</a>, <a href=#dom13477-bib-0013 class="bibLink tab-link" id=dom13477-bib-0013_R_d9094365e384 data-tab=pane-pcw-references aria-label="Reference 13 - Diabetes Obes Metab">13</a></span> In contrast, the most recent analyses of the CVD-REAL study and two other observational studies, which primarily focused on canagliflozin, reported a lower risk of non-fatal MI and non-fatal stroke but a higher risk of lower extremity amputation with the use of SGLT2 inhibitors compared to other glucose-lowering medications.<span><a href=#dom13477-bib-0012 class="bibLink tab-link" id=dom13477-bib-0012_R_d9094365e386 data-tab=pane-pcw-references aria-label="Reference 12 - BMJ">12</a>, <a href=#dom13477-bib-0014 class="bibLink tab-link" id=dom13477-bib-0014_R_d9094365e386 data-tab=pane-pcw-references aria-label="Reference 14 - Diabetes Obes Metab">14</a>, <a href=#dom13477-bib-0015 class="bibLink tab-link" id=dom13477-bib-0015_R_d9094365e386 data-tab=pane-pcw-references aria-label="Reference 15 - Circulation">15</a>, <a href=#dom13477-bib-0017 class="bibLink tab-link" id=dom13477-bib-0017_R_d9094365e386 data-tab=pane-pcw-references aria-label="Reference 17 - J Am Coll Cardiol">17</a></span></p>
 
 <p>In the first analysis of the CVD-REAL study, which included data from the United States and Europe, the reduction in risk of heart failure and death was reported across countries, regardless of variability in the use of SGLT-2 inhibitors, with canagliflozin dominating the United States and dapagliflozin dominating Europe, suggesting a class effect.<span><a href=#dom13477-bib-0010 class="bibLink tab-link" id=dom13477-bib-0010_R_d9094365e390 data-tab=pane-pcw-references aria-label="Reference 10 - Circulation">10</a></span> Similarly, the results of the CVD-REAL 2 study, which included Asian and Middle Eastern populations, suggested that reduction in cardiovascular outcomes (eg, MI, stroke) with the use of SGLT2 inhibitors was a class effect.<span><a href=#dom13477-bib-0016 class="bibLink tab-link" id=dom13477-bib-0016_R_d9094365e392 data-tab=pane-pcw-references aria-label="Reference 16 - J Am Coll Cardiol">16</a></span> Although prior studies have suggested a class effect, none have explicitly evaluated the within-class effect of SGLT2 inhibitors.</p>
 
 <p>Additionally, there has been conflicting evidence regarding the risk of amputation with the use of SGLT2 inhibitors.<span><a href=#dom13477-bib-0018 class="bibLink tab-link" id=dom13477-bib-0018_R_d9094365e398 data-tab=pane-pcw-references aria-label="Reference 18 - Diabetes Obes Metab">18</a>, <a href=#dom13477-bib-0019 class="bibLink tab-link" id=dom13477-bib-0019_R_d9094365e398 data-tab=pane-pcw-references aria-label="Reference 19 - Diabetes Obes Metab">19</a></span> Therefore, our primary objectives were to (1) determine the incidence of CVD with the use of SGLT2 inhibitors compared to other oral, second-line glucose-lowering drugs, namely sulfonylureas and DPP-4 inhibitors, among patients with type 2 diabetes and (2) to compare the within-class effects of SGLT2 inhibitors. Secondarily, we aimed to assess the association between use of SGLT2 inhibitors vs sulfonylureas or DPP-4 inhibitors on and the risk of hospitalization because of heart failure or of lower extremity amputation.</p>
 </section>
 <section class=article-section__content id=dom13477-sec-0006>
 
 <h2 class="article-section__title section__title section1" id=dom13477-sec-0006-title>2 METHODS</h2>
 
 <section class=article-section__sub-content id=dom13477-sec-0007>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0007-title>2.1 Data source</h3>
 
 <p>We conducted a retrospective cohort study using the Truven Health MarketScan (Truven Health Analytics, Ann Arbor, MI, USA), a commercial and Medicare supplemental claims database from January 2013 to December 2015. The database captures information on outpatient, inpatient, health expenditure, enrollment and prescription drug claims of more than 57 million individuals. The commercial data include privately insured employees and their dependents who are covered under employer-sponsored health insurance programs. The Medicare data represent the healthcare experience of retirees who are covered by Medicare supplemental insurance.</p>
 </section>
 
 <section class=article-section__sub-content id=dom13477-sec-0008>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0008-title>2.2 Study population and exposure determination</h3>
 
 <p>Patients were included if they were 18 years of age or older and had a diagnosis of type 2 diabetes (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM], 250.x0 or 250.x2) based on one inpatient or two outpatient encounters at two different service dates within one year prior to treatment initiation. Additionally, patients were required to have 12 months of continuous enrollment in a medical and pharmacy benefits programme prior to the index-date, and to have at least one prescription of an antidiabetic medication of interest including SGLT2 inhibitors (dapagliflozin, canagliflozin or empagliflozin), sulfonylureas (chlorpropamide, tolbutamide, tolazamide, glimepiride, glipizide or glyburide) or DPP-4 inhibitors (sitagliptin, saxagliptin, alogliptin or linagliptin). These specific comparators were chosen to represent commonly used second-line therapies based on the most updated treatment algorithms for patients with type 2 diabetes, and also to avoid time-lag bias.<span><a href=#dom13477-bib-0020 class="bibLink tab-link" id=dom13477-bib-0020_R_d9094365e422 data-tab=pane-pcw-references aria-label="Reference 20 - Clin Diabetes">20</a>, <a href=#dom13477-bib-0021 class="bibLink tab-link" id=dom13477-bib-0021_R_d9094365e422 data-tab=pane-pcw-references aria-label="Reference 21 - Diabetes Care">21</a></span></p>
 
 <p>The date of the dispensing of the first eligible prescription was designated as the index date. A new-user design, which avoids the biases introduced by including prevalent users, such as the under-ascertainment of early events or immortal time bias, was employed.<span><a href=#dom13477-bib-0021 class="bibLink tab-link" id=dom13477-bib-0021_R_d9094365e426 data-tab=pane-pcw-references aria-label="Reference 21 - Diabetes Care">21</a>, <a href=#dom13477-bib-0022 class="bibLink tab-link" id=dom13477-bib-0022_R_d9094365e426 data-tab=pane-pcw-references aria-label="Reference 22 - Am J Epidemiol">22</a></span> Patients were considered to be exposed as long as they continued to refill their prescription, allowing a gap of 7 days or less between refills. Patients were excluded if they had a diagnosis of type I diabetes (ICD-9-CM code 250.x1 or 250.x3) or end-stage renal disease (ESRD) (ICD-9-CM: 585.6), of if they had a prescription for any antidiabetic medication of interest during the baseline period or initiated more than one antidiabetic medication of interest on the same day.</p>
 
 <p>Follow-up for outcomes began at the index date and continued until the first occurrence of an outcome of interest, discontinuation of index medications, initiation of study comparator, inpatient death, end of enrollment or end of study period, whichever took place first. In a subgroup analysis, we also examined outcomes associated with use of individual SGLT2 inhibitors including dapagliflozin and canagliflozin, compared to use of sulfonylureas and DPP-4 inhibitors. For this subgroup analysis only, switching within the SGLT2 inhibitor class prompted censoring of follow-up.</p>
 </section>
 
 <section class=article-section__sub-content id=dom13477-sec-0009>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0009-title>2.3 Study outcomes</h3>
 
 <p>The primary study outcome was first occurrence of a composite of a CVD event, defined as non-fatal MI (ICD-9: 410.x) or non-fatal stroke (ICD-9: 433.x1, 434 [excluding 434.x0], or 436), presenting at primary or secondary discharge diagnosis. The same outcome definition, using primary diagnosis only, was also examined in the sensitivity analysis. The secondary outcome of hospitalization because of heart failure was measured using ICD-9-CM codes 402.×1, 404.×1, 404.×3, or 428.××. Lower extremity amputation was measured using primary and secondary diagnosis, according to ICD-9-CM codes 84.11, 84.12, 84.13, 84.14, 84.15, or 84.16; or, CPT-4 codes 27880, 27881, 27882, 27886, 27888, 28800, 28805, 28810, 28820, or 28825.</p>
 </section>
 
 <section class=article-section__sub-content id=dom13477-sec-0010>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0010-title>2.4 Adjustment for confounders</h3>
 
 <p>To balance comparison groups and minimize potential bias as the result of confounding, propensity score (1:1) matching was used for selection of the paired samples (SGLT2 inhibitors vs sulfonylureas, and SGLT2 inhibitors vs DPP-4 inhibitors). The propensity score was generated by fitting a logistic regression model to predict the probability of receiving the SGLT2 inhibitors vs the comparators in each pairwise comparison. Patients were matched based on the propensity score using a caliber of 0.1 to the nearest neighbor. In development of the study protocol, limitations of prior studies (eg, choice of the comparator group, prevalent vs incident user design) were considered and covariates were extracted from a prior protocol developed by the Mini-Sentinel, an active surveillance program monitored by the food and drug administration.<span><a href=#dom13477-bib-0023 class="bibLink tab-link" id=dom13477-bib-0023_R_d9094365e447 data-tab=pane-pcw-references aria-label="Reference 23 - Pharmacoepidemiol Drug Saf">23</a></span> Variables included in the propensity score modeling were patient age and sex, measures of use of health care services (ie, total number of outpatient visits, total number of inpatient visits), presence of comorbidities (ie, asthma, chronic obstructive pulmonary disease, chronic kidney disease [CKD], ischaemic heart disease, depression, stroke, hypoglycaemia, cancer, hypertension, MI, heart failure), use of other diabetes medications (ie, insulin, metformin, TZDs, α-Glucosidase inhibitors, glucagon-like peptide-1 receptor agonists, meglitinides) and use of other medications (ie, angiotensin-converting enzyme inhibitors, aldosterone receptor antagonists, α-blockers, angiotensin receptor blockers, β-blockers, calcium channel blockers, loop diuretics, potassium-sparing diuretics, thiazide diuretics, direct vasodilators). Baseline CVD was defined as history of MI, angina pectoris, stroke, coronary revascularization, coronary artery disease, cerebrovascular diseases, cerebral infarction, transient ischaemic attack, cerebral haemorrhage and subarachnoid haemorrhage.</p>
 </section>
 
 <section class=article-section__sub-content id=dom13477-sec-0011>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0011-title>2.5 Statistical analysis</h3>
 
 <p>Descriptive statistics were summarized using means for continuous variables and proportion for categorical variables. Demographics and clinical characteristics were compared between exposure groups using a chi-square test for categorical variables and independent t-test for continuous variables. Standardized differences were used to examine the balance in baseline characteristics post matching, where imbalance was defined as an absolute value higher than 0.2.<span><a href=#dom13477-bib-0024 class="bibLink tab-link" id=dom13477-bib-0024_R_d9094365e459 data-tab=pane-pcw-references aria-label="Reference 24 - SAS Global Forum">24</a>, <a href=#dom13477-bib-0025 class="bibLink tab-link" id=dom13477-bib-0025_R_d9094365e459 data-tab=pane-pcw-references aria-label="Reference 25 - Stat Med">25</a></span> Following propensity score matching, proportional hazard models were used to obtain the HR and associated 95% CI. Several sensitivity analyses were conducted to examine the robustness of study results, including the exclusion of TZDs and insulin users, and changing the outcome definition to primary diagnosis only. We further evaluated heterogeneity in treatment effect in selected subgroups of diabetic patients, including patients with baseline CVD vs those with baseline CVD, and those aged less than 65 years vs those 65 years and older. Separate propensity score matching was performed within each of the subgroup analyses and for each pair of within-class effect comparisons (eg, dapagliflozin vs DPP-4 inhibitors). For secondary analyses of lower extremity amputation, patients with a history of lower extremity amputation were excluded. All analyses were performed using SAS 9.4 (SAS Institute Inc., Cary, North Carolina).</p>
 </section>
 </section>
 <section class=article-section__content id=dom13477-sec-0012>
 
 <h2 class="article-section__title section__title section1" id=dom13477-sec-0012-title>3 RESUlTS</h2>
 
 <p>We identified a total of 147 352 new users of SGLT2 inhibitors, 624 069 new users of sulfonylureas and 300 607 new users of DPP-4 inhibitors. After matching, a total of 125 534 patients were included in the SGLT2 inhibitors vs sulfonylureas cohort (n = 62 767 per exposure group) and a total of 133 266 patients in the SGLT2 inhibitors vs DPP-4 inhibitors cohort (n = 66 633 per exposure group) (Table <a class="tableLink scrollableLink" title="Link to table" href=#dom13477-tbl-0001>1</a>). In both propensity-matched cohorts, patient characteristics including age, sex and presence of comorbid conditions were comparable. Table <a class="suppLink scrollableLink" href=#support-information-section>S1</a> summarizes baseline characteristics among the three groups before propensity score matching.</p>
 
 <div class=article-table-content id=dom13477-tbl-0001>
 <header class=article-table-caption><span class=table-caption__label>Table 1.
 </span>Demographics and clinical characteristics in propensity score-matched cohorts of new users of SGLT2 inhibitors, sulfonylureas and DPP-4 inhibitors</header>
 
 
 
 <div class=article-table-content-wrapper>
 <table class="table article-section__table">
 
 
 
 
 
 
 
 
 <thead>
 
 <tr>
 
 <th class="bottom-bordered-cell right-bordered-cell left-aligned">Patient characteristics after PS matching</th>
 
 <th class="bottom-bordered-cell left-aligned">SGLT2 inhibitors (n = 62 767)</th>
 
 <th class="bottom-bordered-cell left-aligned">Sulfonylureas (n = 62 767)</th>
 
 <th class="bottom-bordered-cell left-aligned">Std-diff %<a class="noteLink scrollableLink" title="Link to note" id=dom13477-note-0003_23-controller href=#dom13477-note-0003_23 aria-controls=dom13477-note-0003_23 aria-haspopup=false aria-expanded=true aria-label=Note>a</a><span class="footNotePopup sf-hidden" id=dom13477-note-0003_23 aria-labelledby=dom13477-note-0003_23-controller></span>
 </th>
 
 <th class="bottom-bordered-cell left-aligned">SGLT2 inhibitors (n = 66 633)</th>
 
 <th class="bottom-bordered-cell left-aligned">DPP4 inhibitors (n = 66 633)</th>
 
 <th class="bottom-bordered-cell left-aligned">Std-diff %<a class="noteLink scrollableLink" title="Link to note" id=dom13477-note-0003_24-controller href=#dom13477-note-0003_24 aria-controls=dom13477-note-0003_24 aria-haspopup=false aria-expanded=true aria-label=Note>a</a><span class="footNotePopup sf-hidden" id=dom13477-note-0003_24 aria-labelledby=dom13477-note-0003_24-controller></span>
 </th>
 </tr>
 </thead>
 
 <tbody>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Mean age, y (± SD)</td>
 
 <td class=left-aligned>54 (±12.4)</td>
 
 <td class=left-aligned>54 (±9.6)</td>
 
 <td class=left-aligned>0.10</td>
 
 <td class=left-aligned>55 (±9.2)</td>
 
 <td class=left-aligned>54 (±11.0)</td>
 
 <td class=left-aligned>0.10</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Sex, n (%)</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Male</td>
 
 <td class=left-aligned>32 827 (52.3)</td>
 
 <td class=left-aligned>32 890 (52.4)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>35 915 (53.9)</td>
 
 <td class=left-aligned>35 849 (53.8)</td>
 
 <td class=left-aligned>0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Female</td>
 
 <td class=left-aligned>29 940 (47.7)</td>
 
 <td class=left-aligned>29 877 (47.6)</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned>30 718 (46.1)</td>
 
 <td class=left-aligned>30 784 (46.2)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Comorbidities, n (%)</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Asthma</td>
 
 <td class=left-aligned>3766 (6.0)</td>
 
 <td class=left-aligned>3766 (6.0)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>3865 (5.8)</td>
 
 <td class=left-aligned>3998 (6.0)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">COPD</td>
 
 <td class=left-aligned>2260 (3.6)</td>
 
 <td class=left-aligned>2134 (3.4)</td>
 
 <td class=left-aligned>0.02</td>
 
 <td class=left-aligned>2532 (3.8)</td>
 
 <td class=left-aligned>2332 (3.5)</td>
 
 <td class=left-aligned>0.02</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">CKD</td>
 
 <td class=left-aligned>2197 (3.5)</td>
 
 <td class=left-aligned>2071 (3.3)</td>
 
 <td class=left-aligned>0.04</td>
 
 <td class=left-aligned>2599 (3.9)</td>
 
 <td class=left-aligned>2132 (3.2)</td>
 
 <td class=left-aligned>0.02</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Ischaemic heart disease</td>
 
 <td class=left-aligned>7,469 (11.9)</td>
 
 <td class=left-aligned>7030 (11.2)</td>
 
 <td class=left-aligned>0.04</td>
 
 <td class=left-aligned>8396 (12.6)</td>
 
 <td class=left-aligned>7729 (11.6)</td>
 
 <td class=left-aligned>0.03</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Depression</td>
 
 <td class=left-aligned>2636 (4.2)</td>
 
 <td class=left-aligned>2636 (4.2)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>2665 (4.0)</td>
 
 <td class=left-aligned>2665 (4.0)</td>
 
 <td class=left-aligned>0.03</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Hypoglycaemia</td>
 
 <td class=left-aligned>2699 (4.3)</td>
 
 <td class=left-aligned>2636 (4.2)</td>
 
 <td class=left-aligned>0.01</td>
 
 <td class=left-aligned>2998 (4.5)</td>
 
 <td class=left-aligned>2865 (4.3)</td>
 
 <td class=left-aligned>0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Hyperlipidaemia</td>
 
 <td class=left-aligned>41 363 (65.9)</td>
 
 <td class=left-aligned>41 175 (65.6)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>44 311 (66.5)</td>
 
 <td class=left-aligned>44 244 (66.4)</td>
 
 <td class=left-aligned>0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Cancer</td>
 
 <td class=left-aligned>4268 (6.8)</td>
 
 <td class=left-aligned>4143 (6.6)</td>
 
 <td class=left-aligned>0.02</td>
 
 <td class=left-aligned>4598 (6.9)</td>
 
 <td class=left-aligned>4065 (6.1)</td>
 
 <td class=left-aligned>0.02</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Hypertension</td>
 
 <td class=left-aligned>42 242 (67.3)</td>
 
 <td class=left-aligned>42 054 (67)</td>
 
 <td class=left-aligned>0.02</td>
 
 <td class=left-aligned>45 644 (68.5)</td>
 
 <td class=left-aligned>45 244 (67.9)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Use of other diabetes medications, n (%)</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Insulin</td>
 
 <td class=left-aligned>14 750 (23.5)</td>
 
 <td class=left-aligned>13 872 (22.1)</td>
 
 <td class=left-aligned>0.06</td>
 
 <td class=left-aligned>14 793 (22.2)</td>
 
 <td class=left-aligned>13 860 (20.8)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Metformin</td>
 
 <td class=left-aligned>36 279 (57.8)</td>
 
 <td class=left-aligned>36 907 (58.8)</td>
 
 <td class=left-aligned>−0.02</td>
 
 <td class=left-aligned>39 847 (59.8)</td>
 
 <td class=left-aligned>41 312 (62)</td>
 
 <td class=left-aligned>−0.03</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">TZDs</td>
 
 <td class=left-aligned>4017 (6.4)</td>
 
 <td class=left-aligned>4017 (6.4)</td>
 
 <td class=left-aligned>−0.01</td>
 
 <td class=left-aligned>4931 (7.4)</td>
 
 <td class=left-aligned>4931 (7.4)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">α-Glucosidase inhibitor</td>
 
 <td class=left-aligned>251 (0.4)</td>
 
 <td class=left-aligned>251 (0.4)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>267 (0.4)</td>
 
 <td class=left-aligned>333 (0.5)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">GLP-1</td>
 
 <td class=left-aligned>8725 (13.9)</td>
 
 <td class=left-aligned>7846 (12.5)</td>
 
 <td class=left-aligned>0.05</td>
 
 <td class=left-aligned>6930 (10.4)</td>
 
 <td class=left-aligned>530 (8.6)</td>
 
 <td class=left-aligned>0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Meglitinides</td>
 
 <td class=left-aligned>1067 (1.7)</td>
 
 <td class=left-aligned>1004 (1.6)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>999 (1.5)</td>
 
 <td class=left-aligned>933 (1.4)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Use of other medications, n (%)</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">ACE</td>
 
 <td class=left-aligned>20 588 (32.8)</td>
 
 <td class=left-aligned>20 588 (32.8)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>23 122 (34.7)</td>
 
 <td class=left-aligned>23 388 (35.1)</td>
 
 <td class=left-aligned>−0.02</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Aldosterone receptor antagonists</td>
 
 <td class=left-aligned>1506 (2.4)</td>
 
 <td class=left-aligned>1506 (2.4)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>1599 (2.4)</td>
 
 <td class=left-aligned>1533 (2.3)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">α-Blocker</td>
 
 <td class=left-aligned>3138 (5.0)</td>
 
 <td class=left-aligned>3138 (5.0)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>3532 (5.3)</td>
 
 <td class=left-aligned>3465 (5.2)</td>
 
 <td class=left-aligned>0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Angiotensin-receptor blocker</td>
 
 <td class=left-aligned>10 357 (16.5)</td>
 
 <td class=left-aligned>10 357 (16.5)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>10 994 (16.5)</td>
 
 <td class=left-aligned>10 928 (16.4)</td>
 
 <td class=left-aligned>−0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">β-Blocker</td>
 
 <td class=left-aligned>14 185 (22.6)</td>
 
 <td class=left-aligned>14 185 (22.6)</td>
 
 <td class=left-aligned>0.01</td>
 
 <td class=left-aligned>15 925 (23.9)</td>
 
 <td class=left-aligned>15 659 (23.5)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Calcium-channel blocker</td>
 
 <td class=left-aligned>9917 (15.8)</td>
 
 <td class=left-aligned>10 043 (16)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>11 194 (16.8)</td>
 
 <td class=left-aligned>11 194 (16.8)</td>
 
 <td class=left-aligned>−0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Loop diuretic</td>
 
 <td class=left-aligned>4959 (7.9)</td>
 
 <td class=left-aligned>4770 (7.6)</td>
 
 <td class=left-aligned>0.02</td>
 
 <td class=left-aligned>5464 (8.2)</td>
 
 <td class=left-aligned>5264 (7.9)</td>
 
 <td class=left-aligned>0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Potassium-sparing diuretic</td>
 
 <td class=left-aligned>1569 (2.5)</td>
 
 <td class=left-aligned>1569 (2.5)</td>
 
 <td class=left-aligned>0.01</td>
 
 <td class=left-aligned>1732 (2.6)</td>
 
 <td class=left-aligned>1599 (2.4)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Thiazide</td>
 
 <td class=left-aligned>1067 (1.7)</td>
 
 <td class=left-aligned>1130 (1.8)</td>
 
 <td class=left-aligned>0.01</td>
 
 <td class=left-aligned>1066 (1.6)</td>
 
 <td class=left-aligned>1066 (1.6)</td>
 
 <td class=left-aligned>0.00</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Vasodilator</td>
 
 <td class=left-aligned>527 (0.84)</td>
 
 <td class=left-aligned>521 (0.83)</td>
 
 <td class=left-aligned>0.00</td>
 
 <td class=left-aligned>600 (0.9)</td>
 
 <td class=left-aligned>600 (0.9)</td>
 
 <td class=left-aligned>0.01</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Healthcare utilization, mean (± SD)</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Mean number of inpatient visits</td>
 
 <td class=left-aligned>1 (±0.7)</td>
 
 <td class=left-aligned>1 (±0.8)</td>
 
 <td class=left-aligned>−0.01</td>
 
 <td class=left-aligned>1 (±0.7)</td>
 
 <td class=left-aligned>1 (±0.8)</td>
 
 <td class=left-aligned>−0.01</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Mean number of outpatient visits</td>
 
 <td class=left-aligned>16 (±17)</td>
 
 <td class=left-aligned>17 (±18.7)</td>
 
 <td class=left-aligned>−0.07</td>
 
 <td class=left-aligned>14 (±13.9)</td>
 
 <td class=left-aligned>14 (±14.5)</td>
 
 <td class=left-aligned>−0.07</td>
 </tr>
 </tbody>
 </table>
 </div>
 
 
 
 <div class=article-section__table-footnotes>
 <ul>
 <li id=dom13477-note-0002>Abbreviations: ACE, angiotensin-converting enzyme inhibitor; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DPP-4, dipeptidyl peptidase-4 inhibitor; GLP-1, glucagon-like peptide-1 receptor agonists; PS, propensity score; SD, standard deviation; SGLT2, sodium-glucose co-transporter 2 inhibitors; Std-diff, standardized difference; TZDs, thiazolidinediones.</li>
 <li id=dom13477-note-0003 class=footNotePopup__item aria-labelledby="Footnote 1" title="Footnote 1"><span><sup><i>a</i></sup> </span>Imbalance in standardized difference is defined as a absolute value &gt;0.20.</li>
 </ul>
 </div>
 <div class=article-section__table-source></div>
 </div>
 
 <section class=article-section__sub-content id=dom13477-sec-0013>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0013-title>3.1 Incident cardiovascular disease</h3>
 
 <p>Table <a class="tableLink scrollableLink" title="Link to table" href=#dom13477-tbl-0002>2</a> shows the risk of the composite CVD with SGLT2 inhibitors vs sulfonylurea users and DPP-4 inhibitor users in the propensity score-matched cohorts. The composite CVD outcome occurred in 569 of 62 767 (0.91%) SGLT2 inhibitor users and in 1272 of 62 767 (2.02%) sulfonylurea users. The crude incidence of the composite CVD outcome was 9.5 per 1000 person-years in the SGLT2 inhibitor group and 15.7 per 1000 person-years in the sulfonylurea group. In the SGLT2 inhibitor/DPP-4 inhibitor matched cohort, 660 of 66 633 (0.99%) SGLT2 inhibitor users experienced the composite CVD outcome vs 1519 of 66 633 (2.28%) DPP-4 inhibitor users. The crude incidence of the composite CVD was 7.9 per 1000 person-years with SGLT2 inhibitors and 17.2 per 1000 person-years with DPP-4 inhibitors. In the proportional hazard models, use of SGLT2 inhibitors was associated with a decreased risk of developing CVD compared with use of sulfonylureas (HR, 0.50; 95% CI, 0.45, 0.55) and DPP-4 inhibitors (HR, 0.57; 95% CI, 0.52-0.62) after adjusting for baseline demographics, comorbidities and use of other medications (Table <a class="tableLink scrollableLink" title="Link to table" href=#dom13477-tbl-0002>2</a>). We also observed a reduced risk of hospitalization because of heart failure with the use of SGLT2 inhibitors as compared to use sulfonylureas (HR, 0.48; 95% CI, 0.40, 0.57) and DPP-4 inhibitors (HR, 0.54; 95% CI, 0.48, 0.60).</p>
 
 <div class=article-table-content id=dom13477-tbl-0002>
 <header class=article-table-caption><span class=table-caption__label>Table 2.
 </span>Risk of cardiovascular diseases with SGLT2 Inhibitors versus comparators in propensity score-matched analyses</header>
 
 
 
 <div class=article-table-content-wrapper>
 <table class="table article-section__table">
 
 
 
 
 
 
 
 
 <thead>
 
 <tr>
 
 <th class="bottom-bordered-cell right-bordered-cell left-aligned">Study population</th>
 
 <th class="bottom-bordered-cell left-aligned">Medications</th>
 
 <th class="bottom-bordered-cell left-aligned">No. of Patients</th>
 
 <th class="bottom-bordered-cell left-aligned">Pearson-years</th>
 
 <th class="bottom-bordered-cell left-aligned">No. of events</th>
 
 <th class="bottom-bordered-cell left-aligned">Crude incidence</th>
 
 <th class="bottom-bordered-cell left-aligned">Adjusted HR (95% CI)</th>
 </tr>
 </thead>
 
 <tbody>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">SGLT2 inhibitors vs sulfonylureas</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>59 678</td>
 
 <td class=left-aligned>569</td>
 
 <td class=left-aligned>9.5</td>
 
 <td class=left-aligned>0.50 (0.45, 0.55)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Composite of CVD (MI and stroke) by outcome</td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>81 001</td>
 
 <td class=left-aligned>1272</td>
 
 <td class=left-aligned>15.7</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">MI</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>70 821</td>
 
 <td class=left-aligned>341</td>
 
 <td class=left-aligned>4.8</td>
 
 <td class=left-aligned>0.70 (0.61, 0.81)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>68 457</td>
 
 <td class=left-aligned>499</td>
 
 <td class=left-aligned>7.3</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Stroke</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>68 434</td>
 
 <td class=left-aligned>381</td>
 
 <td class=left-aligned>5.6</td>
 
 <td class=left-aligned>0.69 (0.61, 0.78)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>70 739</td>
 
 <td class=left-aligned>571</td>
 
 <td class=left-aligned>8.1</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Secondary outcomes</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Heart failure</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>68 438</td>
 
 <td class=left-aligned>368</td>
 
 <td class=left-aligned>5.4</td>
 
 <td class=left-aligned>0.48 (0.40, 0.57)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>70 600</td>
 
 <td class=left-aligned>767</td>
 
 <td class=left-aligned>10.9</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Lower extremity amputation</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>59 385</td>
 
 <td class=left-aligned>59 499</td>
 
 <td class=left-aligned>92</td>
 
 <td class=left-aligned>1.5</td>
 
 <td class=left-aligned>0.74 (0.57, 0.96)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>59 385</td>
 
 <td class=left-aligned>82 092</td>
 
 <td class=left-aligned>158</td>
 
 <td class=left-aligned>1.9</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">SGLT2 inhibitors vs DPP-4 inhibitors</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>83 505</td>
 
 <td class=left-aligned>660</td>
 
 <td class=left-aligned>7.9</td>
 
 <td class=left-aligned>0.57 (0.52, 0.62)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Composite of CVD (MI and stroke) by outcome</td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>88 077</td>
 
 <td class=left-aligned>1519</td>
 
 <td class=left-aligned>17.2</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">MI</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>73 853</td>
 
 <td class=left-aligned>313</td>
 
 <td class=left-aligned>4.2</td>
 
 <td class=left-aligned>0.72 (0.63, 0.82)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>73 206</td>
 
 <td class=left-aligned>407</td>
 
 <td class=left-aligned>5.6</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Stroke</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>60 307</td>
 
 <td class=left-aligned>379</td>
 
 <td class=left-aligned>6.3</td>
 
 <td class=left-aligned>0.61 (0.50, 0.73)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>59 566</td>
 
 <td class=left-aligned>542</td>
 
 <td class=left-aligned>9.1</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Secondary outcomes</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Heart failure</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>73 824</td>
 
 <td class=left-aligned>360</td>
 
 <td class=left-aligned>4.9</td>
 
 <td class=left-aligned>0.54 (0.48, 0.60)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>73 031</td>
 
 <td class=left-aligned>649</td>
 
 <td class=left-aligned>8.9</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Lower extremity amputation</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>65 847</td>
 
 <td class=left-aligned>66 845</td>
 
 <td class=left-aligned>120</td>
 
 <td class=left-aligned>1.8</td>
 
 <td class=left-aligned>0.88 (0.65, 1.15)</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>65 847</td>
 
 <td class=left-aligned>89 161</td>
 
 <td class=left-aligned>171</td>
 
 <td class=left-aligned>1.9</td>
 
 <td class=left-aligned>Reference</td>
 </tr>
 </tbody>
 </table>
 </div>
 
 
 
 <div class=article-section__table-footnotes>
 <ul>
 <li id=dom13477-note-0004>Abbreviations: CI, confidence interval; CVD, cardiovascular diseases; DPP-4, dipeptidyl peptidase-4; HR, hazard ratio; MI, myocardial infarction; SGLT2, sodium-glucose co-transporter 2.</li>
 </ul>
 </div>
 <div class=article-section__table-source></div>
 </div>
 </section>
 
 <section class=article-section__sub-content id=dom13477-sec-0014>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0014-title>3.2 Risk of lower extremity amputation</h3>
 
 <p>The crude incidence rates of lower extremity amputation were 1.5 per 1000 person-years in the SGLT2 inhibitor group and 1.9 in the sulfonylurea group. In the SGLT2 inhibitor vs DPP-4 inhibitor analysis, the crude incidence rates were 1.8 per 1000 person-years in the SGLT-2 inhibitor group and 1.9 per 1000 person-years in the DPP-4 inhibitor groups (Table <a class="tableLink scrollableLink" title="Link to table" href=#dom13477-tbl-0002>2</a>). Use of SGLT2 inhibitors was associated with lower risk of amputation compared to use of sulfonylureas (adjusted HR, 0.74; 95% CI, 0.57, 0.96), but not compared to use of DPP-4 inhibitors (HR, 0.88; 95% CI, 0.65, 1.15).</p>
 </section>
 
 <section class=article-section__sub-content id=dom13477-sec-0015>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0015-title>3.3 Subgroup and sensitivity analyses</h3>
 
 <p>Results of subgroup and sensitivity analyses are shown in Tables <a class="tableLink scrollableLink" title="Link to table" href=#dom13477-tbl-0003>3</a> and <a class="tableLink scrollableLink" title="Link to table" href=#dom13477-tbl-0004>4</a>. In subgroup analyses, we found a lower risk of CVD among patients 65 years of age or younger who were exposed to SGLT2 inhibitors compared exposure to sulfonylureas (HR, 0.59; 95% CI, 0.52, 0.66) and DPP-4 inhibitors (HR, 0.65; 95% CI, 0.57, 0.74). Conversely, we observed no significant difference in outcomes among those above 65 years of age, comparing SGLT2 inhibitor users to sulfonylurea users (HR, 0.80; 95% CI, 0.65, 1.00) and DPP-4 inhibitor users (HR, 0.90; 95% CI, 0.71, 1.14), although the treatment-by-age group interaction tests in each cohort were not statistically significant (<i>P</i> = 0.420 and <i>P</i> = 0.936). We observed no significant difference in effect when stratifying by baseline CVD presence or absence (<i>P</i> value for interaction in each cohort, <i>P</i> = 0.083 and <i>P</i> = 0.092). Finally, we observed no evidence of differential effects comparing individual SGLT2 inhibitors. Compared to sulfonylureas, a similarly lower risk was observed with dapagliflozin (HR, 0.55; 95% CI, 0.43, 0.70) and canagliflozin (HR, 0.61; 95% CI, 0.54, 0.69). Likewise, compared to DPP-4 inhibitors, a similarly lower risk was observed with dapagliflozin (HR, 0.57; 95% CI, 0.46, 0.70) and canagliflozin (HR, 0.66; 95% CI, 0.54, 0.71). Study results remained consistent when using an outcome definition based on primary diagnosis only, and by excluding insulin users or TZD users.</p>
 
 <div class=article-table-content id=dom13477-tbl-0003>
 <header class=article-table-caption><span class=table-caption__label>Table 3.
 </span>Risk of cardiovascular disease with SGLT2 inhibitors versus sulfonylureas in propensity score matched sensitivity and subgroup analyses</header>
 
 
 
 <div class=article-table-content-wrapper>
 <table class="table article-section__table">
 
 
 
 
 
 
 
 
 
 <thead>
 
 <tr>
 
 <th class="bottom-bordered-cell right-bordered-cell left-aligned">Study population</th>
 
 <th class="bottom-bordered-cell left-aligned">Medications</th>
 
 <th class="bottom-bordered-cell left-aligned">No. of patients</th>
 
 <th class="bottom-bordered-cell left-aligned">Pearson-years</th>
 
 <th class="bottom-bordered-cell left-aligned">No. of CVD Events</th>
 
 <th class="bottom-bordered-cell left-aligned">Crude incidence</th>
 
 <th class="bottom-bordered-cell left-aligned">Adjusted HR of CVD (95% CI)</th>
 
 <th class="bottom-bordered-cell left-aligned"><i>P</i>-value for interaction</th>
 </tr>
 </thead>
 
 <tbody>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Subgroup analysis</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Age</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">≤65 y</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>55 805</td>
 
 <td class=left-aligned>53 055</td>
 
 <td class=left-aligned>420</td>
 
 <td class=left-aligned>7.9</td>
 
 <td class=left-aligned>0.59 (0.52, 0.66)</td>
 
 <td class=left-aligned>0.420</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>55 805</td>
 
 <td class=left-aligned>70 094</td>
 
 <td class=left-aligned>890</td>
 
 <td class=left-aligned>12.7</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">&gt;65 y</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>5517</td>
 
 <td class=left-aligned>5109</td>
 
 <td class=left-aligned>122</td>
 
 <td class=left-aligned>23.9</td>
 
 <td class=left-aligned>0.80 (0.65, 1.00)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>5517</td>
 
 <td class=left-aligned>8292</td>
 
 <td class=left-aligned>298</td>
 
 <td class=left-aligned>35.9</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Baseline CVD</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">With baseline CVD</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>8962</td>
 
 <td class=left-aligned>8900</td>
 
 <td class=left-aligned>220</td>
 
 <td class=left-aligned>24.7</td>
 
 <td class=left-aligned>0.51 (0.43, 0.60)</td>
 
 <td class=left-aligned>0.083</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>8962</td>
 
 <td class=left-aligned>12 007</td>
 
 <td class=left-aligned>494</td>
 
 <td class=left-aligned>41.1</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Without baseline CVD</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>53 242</td>
 
 <td class=left-aligned>50 259</td>
 
 <td class=left-aligned>337</td>
 
 <td class=left-aligned>6.7</td>
 
 <td class=left-aligned>0.56 (0.49, 0.64)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>53 242</td>
 
 <td class=left-aligned>68 902</td>
 
 <td class=left-aligned>715</td>
 
 <td class=left-aligned>10.4</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Drug</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Dapagliflozin vs. DPP-4 inhibitors</td>
 
 <td class=left-aligned>Dapagliflozin</td>
 
 <td class=left-aligned>13 816</td>
 
 <td class=left-aligned>13 896</td>
 
 <td class=left-aligned>126</td>
 
 <td class=left-aligned>9.1</td>
 
 <td class=left-aligned>0.55 (0.43, 0.70)</td>
 
 <td class=left-aligned>0.585</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>13 816</td>
 
 <td class=left-aligned>15 420</td>
 
 <td class=left-aligned>234</td>
 
 <td class=left-aligned>15.2</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Canagliflozin vs. DPP-4 inhibitors</td>
 
 <td class=left-aligned>Canagliflozin</td>
 
 <td class=left-aligned>32 603</td>
 
 <td class=left-aligned>33 682</td>
 
 <td class=left-aligned>428</td>
 
 <td class=left-aligned>12.7</td>
 
 <td class=left-aligned>0.61 (0.54, 0.69)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>32 603</td>
 
 <td class=left-aligned>41 483</td>
 
 <td class=left-aligned>695</td>
 
 <td class=left-aligned>16.8</td>
 
 <td colspan=2 class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Sensitivity analysis</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Excluding insulin users</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>45 844</td>
 
 <td class=left-aligned>43 239</td>
 
 <td class=left-aligned>323</td>
 
 <td class=left-aligned>7.5</td>
 
 <td class=left-aligned>0.45 (0.41, 0.49)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>45 844</td>
 
 <td class=left-aligned>59 404</td>
 
 <td class=left-aligned>696</td>
 
 <td class=left-aligned>11.7</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Excluding TZD users</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>58 149</td>
 
 <td class=left-aligned>74 922</td>
 
 <td class=left-aligned>526</td>
 
 <td class=left-aligned>7.0</td>
 
 <td class=left-aligned>0.49 (0.41, 0.50)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>58 149</td>
 
 <td class=left-aligned>55 061</td>
 
 <td class=left-aligned>1145</td>
 
 <td class=left-aligned>20.8</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Using primary diagnosis</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>46 664</td>
 
 <td class=left-aligned>371</td>
 
 <td class=left-aligned>8.0</td>
 
 <td class=left-aligned>0.51 (0.45, 0.59)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>Sulfonylureas</td>
 
 <td class=left-aligned>62 767</td>
 
 <td class=left-aligned>66 582</td>
 
 <td class=left-aligned>984</td>
 
 <td class=left-aligned>14.8</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 </tbody>
 </table>
 </div>
 
 
 
 <div class=article-section__table-footnotes>
 <ul>
 <li id=dom13477-note-0005>Abbreviations: CI, confidence interval; CVD, cardiovascular diseases; DPP-4, dipeptidyl peptidase-4; HR, hazard ratio; SGLT2, sodium-glucose co-transporter 2; TZDs, thiazolidinediones.</li>
 </ul>
 </div>
 <div class=article-section__table-source></div>
 </div>
 
 <div class=article-table-content id=dom13477-tbl-0004>
 <header class=article-table-caption><span class=table-caption__label>Table 4.
 </span>Risk of cardiovascular disease with SGLT2 inhibitors versus DPP-4 inhibitors in propensity score matched sensitivity and subgroup analyses</header>
 
 
 
 <div class=article-table-content-wrapper>
 <table class="table article-section__table">
 
 
 
 
 
 
 
 
 
 
 <thead>
 
 <tr>
 
 <th class="bottom-bordered-cell right-bordered-cell left-aligned">Study population</th>
 
 <th class="bottom-bordered-cell left-aligned">Medications</th>
 
 <th class="bottom-bordered-cell left-aligned">No. of patients</th>
 
 <th class="bottom-bordered-cell left-aligned">Pearson-years</th>
 
 <th class="bottom-bordered-cell left-aligned">No. of CVD events</th>
 
 <th class="bottom-bordered-cell left-aligned">Crude incidence</th>
 
 <th class="bottom-bordered-cell left-aligned">Adjusted HR of CVD (95% CI)</th>
 
 <th class="bottom-bordered-cell left-aligned"><i>P</i> value for interaction</th>
 </tr>
 </thead>
 
 <tbody>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Subgroup analysis</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Age</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">≤65 y</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>56 240</td>
 
 <td class=left-aligned>53 523</td>
 
 <td class=left-aligned>465</td>
 
 <td class=left-aligned>8.7</td>
 
 <td class=left-aligned>0.65 (0.57, 0.74)</td>
 
 <td class=left-aligned>0.936</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>56 240</td>
 
 <td class=left-aligned>67 155</td>
 
 <td class=left-aligned>840</td>
 
 <td class=left-aligned>12.5</td>
 
 <td colspan=2 class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">&gt;65 y</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>5472</td>
 
 <td class=left-aligned>5,133</td>
 
 <td class=left-aligned>145</td>
 
 <td class=left-aligned>28.2</td>
 
 <td class=left-aligned>0.90 (0.71, 1.14)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>5472</td>
 
 <td class=left-aligned>7671</td>
 
 <td class=left-aligned>275</td>
 
 <td class=left-aligned>35.8</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Baseline CVD</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">With baseline CVD</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>8477</td>
 
 <td class=left-aligned>8498</td>
 
 <td class=left-aligned>231</td>
 
 <td class=left-aligned>27.2</td>
 
 <td class=left-aligned>0.58 (0.50, 0.67)</td>
 
 <td class=left-aligned>0.092</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>8477</td>
 
 <td class=left-aligned>11 290</td>
 
 <td class=left-aligned>511</td>
 
 <td class=left-aligned>45.3</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Without baseline CVD</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>55 274</td>
 
 <td class=left-aligned>69 471</td>
 
 <td class=left-aligned>394</td>
 
 <td class=left-aligned>5.7</td>
 
 <td class=left-aligned>0.60 (0.53, 0.68)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>55 274</td>
 
 <td class=left-aligned>52 564</td>
 
 <td class=left-aligned>908</td>
 
 <td class=left-aligned>17.3</td>
 
 <td colspan=2 class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Drug</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Dapagliflozin vs DPP-4 inhibitors</td>
 
 <td class=left-aligned>Dapagliflozin</td>
 
 <td class=left-aligned>18 483</td>
 
 <td class=left-aligned>15 689</td>
 
 <td class=left-aligned>139</td>
 
 <td class=left-aligned>8.9</td>
 
 <td class=left-aligned>0.57 (0.46, 0.70)</td>
 
 <td class=left-aligned>0.626</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>18 483</td>
 
 <td class=left-aligned>22 594</td>
 
 <td class=left-aligned>286</td>
 
 <td class=left-aligned>12.7</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td style=padding-left:2em class="right-bordered-cell left-aligned">Canagliflozin vs DPP-4 inhibitors</td>
 
 <td class=left-aligned>Canagliflozin</td>
 
 <td class=left-aligned>49 191</td>
 
 <td class=left-aligned>48 683</td>
 
 <td class=left-aligned>548</td>
 
 <td class=left-aligned>11.3</td>
 
 <td class=left-aligned>0.66 (0.54, 0.71)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>49 191</td>
 
 <td class=left-aligned>60 525</td>
 
 <td class=left-aligned>934</td>
 
 <td class=left-aligned>15.4</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Sensitivity analysis</td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Excluding insulin users</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>50 489</td>
 
 <td class=left-aligned>48 040</td>
 
 <td class=left-aligned>413</td>
 
 <td class=left-aligned>8.6</td>
 
 <td class=left-aligned>0.56 (0.50, 0.63)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>50 489</td>
 
 <td class=left-aligned>64 642</td>
 
 <td class=left-aligned>1009</td>
 
 <td class=left-aligned>15.6</td>
 
 <td colspan=2 class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Excluding TZD users</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>60 391</td>
 
 <td class=left-aligned>57 662</td>
 
 <td class=left-aligned>622</td>
 
 <td class=left-aligned>10.8</td>
 
 <td class=left-aligned>0.59 (0.54, 0.65)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>60 391</td>
 
 <td class=left-aligned>76 535</td>
 
 <td class=left-aligned>1391</td>
 
 <td class=left-aligned>18.2</td>
 
 <td colspan=2 class=left-aligned>Reference</td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned">Using primary diagnosis</td>
 
 <td class=left-aligned>SGLT2 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>83 505</td>
 
 <td class=left-aligned>301</td>
 
 <td class=left-aligned>3.6</td>
 
 <td class=left-aligned>0.65 (0.58, 0.73)</td>
 
 <td class=left-aligned></td>
 </tr>
 
 <tr>
 
 <td class="right-bordered-cell left-aligned"></td>
 
 <td class=left-aligned>DPP-4 inhibitors</td>
 
 <td class=left-aligned>66 633</td>
 
 <td class=left-aligned>88 077</td>
 
 <td class=left-aligned>836</td>
 
 <td class=left-aligned>9.5</td>
 
 <td class=left-aligned>Reference</td>
 
 <td class=left-aligned></td>
 </tr>
 </tbody>
 </table>
 </div>
 
 
 
 <div class=article-section__table-footnotes>
 <ul>
 <li id=dom13477-note-0006>Abbreviations: CI, confidence interval; CVD, cardiovascular diseases; DPP-4, dipeptidyl peptidase-4; HR, hazard ratio; SGLT2, sodium-glucose co-transporter 2; TZDs, thiazolidinediones.</li>
 </ul>
 </div>
 <div class=article-section__table-source></div>
 </div>
 </section>
 </section>
 <section class=article-section__content id=dom13477-sec-0016>
 
 <h2 class="article-section__title section__title section1" id=dom13477-sec-0016-title>4 DISCUSSION</h2>
 
 <p>In this large, contemporary cohort of patients with type 2 diabetes, we found that the use of SGLT2 inhibitors was associated with a 43% to 50% reduced risk of developing nonfatal CVD when compared to use of sulfonylureas or to use of DPP-4 inhibitors. These results were consistent among patients with and without pre-existing CVD. We also found that use of SGLT2 inhibitors was associated with a 46% to 52% reduction in the risk of hospitalization because of heart failure, a finding that complements those reported in the EMPA-REG, CANVAS trials and in recent observational studies.<span><a href=#dom13477-bib-0004 class="bibLink tab-link" id=dom13477-bib-0004_R_d9094365e3358 data-tab=pane-pcw-references aria-label="Reference 4 - N Engl J Med">4</a>-<a href=#dom13477-bib-0006 class="bibLink tab-link" id=dom13477-bib-0006_R_d9094365e3358 data-tab=pane-pcw-references aria-label="Reference 6 - Diabetes Res Clin Pract">6</a>, <a href=#dom13477-bib-0010 class="bibLink tab-link" id=dom13477-bib-0010_R_d9094365e3358 data-tab=pane-pcw-references aria-label="Reference 10 - Circulation">10</a>, <a href=#dom13477-bib-0015 class="bibLink tab-link" id=dom13477-bib-0015_R_d9094365e3358 data-tab=pane-pcw-references aria-label="Reference 15 - Circulation">15</a>, <a href=#dom13477-bib-0017 class="bibLink tab-link" id=dom13477-bib-0017_R_d9094365e3358 data-tab=pane-pcw-references aria-label="Reference 17 - J Am Coll Cardiol">17</a>, <a href=#dom13477-bib-0026 class="bibLink tab-link" id=dom13477-bib-0026_R_d9094365e3358 data-tab=pane-pcw-references aria-label="Reference 26 - Eur Heart J">26</a></span> Finally, we observed a modestly lower risk of lower extremity amputation comparing use of SGLT2 inhibitors to use of sulfonylureas, but not to use of DPP-4 inhibitors.</p>
 
 <p>Unlike the EMPA-REG OUTCOME trial and the CANVAS study, which compared SGLT2 inhibitors to placebo, the current study used active comparators which is more relevant to guidance concerning prescribing decisions in routine clinical practice.<span><a href=#dom13477-bib-0004 class="bibLink tab-link" id=dom13477-bib-0004_R_d9094365e3363 data-tab=pane-pcw-references aria-label="Reference 4 - N Engl J Med">4</a>, <a href=#dom13477-bib-0005 class="bibLink tab-link" id=dom13477-bib-0005_R_d9094365e3363 data-tab=pane-pcw-references aria-label="Reference 5 - N Engl J Med">5</a></span> Observational studies, such as the CVD-REAL study, have compared SGLT2 inhibitors to other glucose-lowering agents, with conflicting findings.<span><a href=#dom13477-bib-0010 class="bibLink tab-link" id=dom13477-bib-0010_R_d9094365e3365 data-tab=pane-pcw-references aria-label="Reference 10 - Circulation">10</a>, <a href=#dom13477-bib-0013 class="bibLink tab-link" id=dom13477-bib-0013_R_d9094365e3365 data-tab=pane-pcw-references aria-label="Reference 13 - Diabetes Obes Metab">13</a>, <a href=#dom13477-bib-0016 class="bibLink tab-link" id=dom13477-bib-0016_R_d9094365e3365 data-tab=pane-pcw-references aria-label="Reference 16 - J Am Coll Cardiol">16</a>, <a href=#dom13477-bib-0017 class="bibLink tab-link" id=dom13477-bib-0017_R_d9094365e3365 data-tab=pane-pcw-references aria-label="Reference 17 - J Am Coll Cardiol">17</a></span> In the first follow-up analysis of the CVD-REAL study, the authors did not find a significant difference between use of dapagliflozin and use of DPP-4 inhibitors in risk of MI and stroke, but subsequent analyses reported a reduction in risk.<span><a href=#dom13477-bib-0013 class="bibLink tab-link" id=dom13477-bib-0013_R_d9094365e3367 data-tab=pane-pcw-references aria-label="Reference 13 - Diabetes Obes Metab">13</a></span> Compared to our study, the first follow-up analysis was limited by the small sample size (10 227 vs 66 633) and the outcome sources (outcome definition based on inpatient and outpatient claims vs inpatients claims only). Our case definition of MI was based only on inpatient discharge diagnoses as this approach has a high sensitivity (94%) and specificity (99%).<span><a href=#dom13477-bib-0027 class="bibLink tab-link" id=dom13477-bib-0027_R_d9094365e3369 data-tab=pane-pcw-references aria-label="Reference 27 - Health Serv Res">27</a></span> Additionally, the CVD-REAL study used a different exposure definition. Patients who received a comparator drug but switched to SGLT2 inhibitors were classified as SGLT2 inhibitor-exposed, whereas patients who received a comparator drug and died were classified as comparator-exposed. To address this in our study, we employed an incident new-user design and we censored follow-up when patients switched from one drug to another. Two other recent analyses of real-world data reported findings similar to those of our study.<span><a href=#dom13477-bib-0012 class="bibLink tab-link" id=dom13477-bib-0012_R_d9094365e3371 data-tab=pane-pcw-references aria-label="Reference 12 - BMJ">12</a>, <a href=#dom13477-bib-0015 class="bibLink tab-link" id=dom13477-bib-0015_R_d9094365e3371 data-tab=pane-pcw-references aria-label="Reference 15 - Circulation">15</a></span></p>
 
 <p>In this study, we found no evidence of within-class effect in risk of CVD between the SGLT2 inhibitors dapagliflozin and canagliflozin. Unfortunately, we were unable to examine empagliflozin because of the limited sample size in this group. Nevertheless, a class effect would appear to be supported by the fact that these drugs seem to exhibit similar effects on the metabolic and non-metabolic surrogate markers associated with cardiovascular risk. Qualitatively similar findings concerning cardiovascular risk have also been observed in the EMPA-REG OUTCOME and CANVAS studies.</p>
 
 <p>The mechanisms by which SGLT2 inhibitors may exert cardioprotective effects are not fully understood. Improvement in glycaemic indices may play a role, but do not fully explain the differences in cardiovascular risk between antidiabetic classes. Beyond these effects, SGLT2 inhibitors are also known to modify other possibly important parameters, including metabolic factors (weight loss, improved insulin sensitivity, reduced glucose toxicity) and non-metabolic factors (reduced blood pressure (BP), reduced uric acid, modulation of renal hemodynamics and attenuation of albuminuria).<span><a href=#dom13477-bib-0028 class="bibLink tab-link" id=dom13477-bib-0028_R_d9094365e3377 data-tab=pane-pcw-references aria-label="Reference 28 - Circulation">28</a></span> The latter group is of particular interest with regard to explaining the differential cardiovascular risk with the use of SGLT2 inhibitors and other classes. For example, lowering of BP seems to be fairly consistent across SGLT2 inhibitors and among individuals with and without hypertension, averaging a reduction of 4 mm Hg in systolic and 1.6 mm Hg in diastolic BP, which is sufficient to prompt clinically important reductions in cardiovascular outcomes and death.<span><a href=#dom13477-bib-0029 class="bibLink tab-link" id=dom13477-bib-0029_R_d9094365e3379 data-tab=pane-pcw-references aria-label="Reference 29 - J Am Soc Hypertens">29</a>, <a href=#dom13477-bib-0030 class="bibLink tab-link" id=dom13477-bib-0030_R_d9094365e3379 data-tab=pane-pcw-references aria-label="Reference 30 - JAMA">30</a></span> These beneficial effects on BP may be related to volume contraction, similar in magnitude to the early phase of thiazide diuretic treatment, to reduced arterial stiffness or to weight loss.<span><a href=#dom13477-bib-0028 class="bibLink tab-link" id=dom13477-bib-0028_R_d9094365e3381 data-tab=pane-pcw-references aria-label="Reference 28 - Circulation">28</a>, <a href=#dom13477-bib-0031 class="bibLink tab-link" id=dom13477-bib-0031_R_d9094365e3381 data-tab=pane-pcw-references aria-label="Reference 31 - Diabetes Obes Metab">31</a></span> Additionally, the EMPA-REG trial demonstrated a 39% reduction in the composite renal outcome of new albuminuria, doubling of serum creatinine, renal replacement therapy or death from renal disease. In comparison, use of sulfonylureas and DPP-4 inhibitors does not appreciably lower BP or weight, and only use of DPP-4 inhibitors comparably lowers uric acid and offer renoprotective effects, but these appear to be modest.<span><a href=#dom13477-bib-0032 class="bibLink tab-link" id=dom13477-bib-0032_R_d9094365e3383 data-tab=pane-pcw-references aria-label="Reference 32 - N Engl J Med">32</a></span></p>
 
 <p>Results from our subgroup analyses suggest that the beneficial effects of use of SGLT2 inhibitors on cardiovascular risk occur irrespective of the presence of baseline CVD. These findings are in disagreement with those reported by Birkeland et al. from a study which, although limited in sample size, reported a lower risk of major CVD in SGLT2 inhibitor-exposed patients with baseline CVD (HR, 0.70; 95% CI, 0.59, 0.83) but not in those without baseline CVD (HR, 0.90; 95% CI, 0.76, 1.07).<span><a href=#dom13477-bib-0011 class="bibLink tab-link" id=dom13477-bib-0011_R_d9094365e3388 data-tab=pane-pcw-references aria-label="Reference 11 - Lancet Diabetes Endocrinol">11</a></span> Our findings, however, are consistent with those of the CVD-REAL 2 study which found that the beneficial effect of use of SGLT2 inhibitors extends to both low- and high-risk patients.<span><a href=#dom13477-bib-0017 class="bibLink tab-link" id=dom13477-bib-0017_R_d9094365e3390 data-tab=pane-pcw-references aria-label="Reference 17 - J Am Coll Cardiol">17</a></span> Additionally, although there was a minimal overlap in confidence intervals of the different age groups (&gt;65 years, ≤65 years), the <i>P</i> value for interaction was not significant, suggesting an absence of difference in the cardiovascular benefits of use of SGLT2 inhibitors between the different age groups.</p>
 
 <p>Finally, we found that use of SGLT2 inhibitors was associated with a decreased risk of lower extremity amputation compared to use of sulfonylureas, but not compared to use of DPP-4 inhibitors. Given the relatively low number of lower amputation events, we cannot be certain whether our findings represent a true differential effect between these classes or an underpowered analysis. Our findings are consistent with those from the studies by Yuan et al. and Adimadhyam et al. which found no difference in the risk of amputation with use of SGLT2 inhibitors compared to use of other glucose-lowering medications (Yuan et al.<span><a href=#dom13477-bib-0018 class="bibLink tab-link" id=dom13477-bib-0018_R_d9094365e3397 data-tab=pane-pcw-references aria-label="Reference 18 - Diabetes Obes Metab">18</a></span>) and compared to use of DPP-4 inhibitors (Adimadhyam et al.<span><a href=#dom13477-bib-0019 class="bibLink tab-link" id=dom13477-bib-0019_R_d9094365e3399 data-tab=pane-pcw-references aria-label="Reference 19 - Diabetes Obes Metab">19</a></span>). The results, however, are discordant with those from the EASEL study which found a higher risk of lower extremity amputation comparing SGLT-2 inhibitors to other glucose-lowering medications (HR, 1.99; 95% CI, 1.12, 3.51).<span><a href=#dom13477-bib-0015 class="bibLink tab-link" id=dom13477-bib-0015_R_d9094365e3401 data-tab=pane-pcw-references aria-label="Reference 15 - Circulation">15</a></span> The discordant findings between the EASEL study and our own may be explained by a greater than 5-fold difference in sample size and study populations (military vs commercially and Medicare insured), and by some methodological differences (prevalent-user design vs new-user design). For instance, EASEL allowed users of SGLT2 inhibitors to use other glucose lower medications including insulin in the baseline period. As a result, patients in the SGLT2 inhibitor group were probably more ill, that is, in an advanced stage of diabetes, and presumably at greater risk of amputation.</p>
 
 <p>The clinical implications of the current analysis are several-fold. First, our results suggest that SGLT2 inhibitors may be the preferred second-line oral agent, after metformin, for reducing cardiovascular risk in patients with type 2 diabetes. Although we were unable to directly assess the effect of underlying cardiovascular risk on the differential effects of treatment, our finding of no interaction between baseline CVD and reduced outcomes with use of SGLT2 inhibitors suggests that the preference for SGLT2 inhibitors may be prudent across the cardiovascular risk spectrum. However, the CVD benefits observed here also must be considered alongside other concerns, including greater costs with use of SGLT2 inhibitors.</p>
 
 <p>The current study has several strengths. We used the Truven Marketscan database, which is nationally representative of patients enrolled in employer-based insurance programmes (approximately 55% of the US population) or with Medicare supplementary insurance. This large sample size allowed us to examine the within-class effect of use of SGLT2 inhibitors between dapagliflozin and canagliflozin, and we adjusted for measured confounders using propensity score matching to minimize the impact of confounding by indication. Finally, we conducted numerous sensitivity analyses to ensure the robustness of our results.</p>
 
 <p>Several limitations of this analysis should be noted. First, we cannot exclude the possibility of residual confounding as the result of missing lab values such as HbA1c and missing data concerning lifestyle variables such as smoking status, which were not captured in the administrative data used in this study. Residual confounding as the result of unmeasured variables would occur if the distribution of risk factors (eg, obesity, smoking status) were not balanced between the two groups. However, we tried to minimize this risk by balancing differences among measured variables between the exposure groups, using propensity score matching. Second, the average follow-up period was approximately 12 months in our study, which may be insufficient to fully evaluate the long-term risk of CVD with use of SGLT2 inhibitors. This limitation reflects the relatively recent introduction of the SGLT2 inhibitors. Third, we did not have access to mortality in the outpatient setting.</p>
 
 <p>In conclusion, this retrospective, cohort, propensity score-matched study supports that the use of SGLT2 inhibitors is associated with a reduced risk of developing CVD compared to use of sulfonylureas and DPP-4 inhibitors. These findings were consistent between dapagliflozin and canagliflozin users, although a low sample size of empagliflozin users precluded analysis of this group separately. These findings suggest that CVD risk reduction is a class effect of SGLT2 inhibitors. In addition, use of SGLT2 inhibitors portended lower risk of hospitalization because of heart failure, as compared to use of sulfonylureas and DPP-4 inhibitors, and lower risk of lower extremity amputation as compared to use of sulfonylureas. Future studies, with longer follow-up periods, are needed to confirm these findings.</p>
 </section>
 <div class=article-section__content>
 
 <h2 class="article-section__title section__title section1" id=dom13477-sec-0017-title> ACKNOWLEDGMENT</h2>
 
 <p>G. D. is a recipient of the American Association of Graduate Women (AAUW) fellowship for the 2017 to 2018 year.</p>
 
 <section class=article-section__sub-content id=dom13477-sec-0018>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0018-title> Conflict of interest</h3>
 
 <p>The authors declare that they have no competing interests.</p>
 </section>
 
 <section class=article-section__sub-content id=dom13477-sec-0019>
 
 <h3 class="article-section__sub-title section2" id=dom13477-sec-0019-title> Author contributions</h3>
 
 <p>G. D. and H. P. created the study concept and design. G. D. analyzed data. Data interpretation was performed by G. D. and H. P., with assistance from S. S. The manuscript was written primarily by G. D. and was revised by H. P and S. S.</p>
 
 <p>Each author has substantially contributed to this project. In addition, each author has read and approved the manuscript and assumes responsibility of the content of the manuscript.</p>
 </section>
 
 <ol></ol>
 </div>
 <section class="article-section article-section__supporting" data-suppl="/doi/suppl/10.1111/dom.13477?onlyLog=true">
 <div class="accordion article-accordion">
 <h2><a class=accordion__control role=button aria-controls=dom13477-supInfo-0001 aria-expanded=false>
 <div tabindex=0 class=section__title id=support-information-section><span>Supporting Information</span><i aria-hidden=true class=icon-section_arrow_d></i></div></a></h2>
 <div class=accordion__content role=region aria-labelledby=support-information-section style=display:none id=dom13477-supInfo-0001 aria-hidden=false>
 
 </div>
 </div>
 </section>
 <section class="article-section article-section__references" id=references-section>
 <div class="accordion article-accordion">
 <h2>
 <div tabindex=0 role=button class=accordion__control aria-controls=iddom13477-bibl-0001 aria-expanded=false data-references="/action/ajaxShowEnhancedAbstract?widgetId=5cf4c79f-0ae9-4dc5-96ce-77f62de7ada9&amp;ajax=true&amp;doi=10.1111%2Fdom.13477&amp;pbContext=%3BrequestedJournal%3Ajournal%3A14631326%3Bissue%3Aissue%3Adoi%5C%3A10.1111%2Fdom.2019.21.issue-1%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1111%2Fdom.13477%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3A14631326%3Bwebsite%3Awebsite%3Adom-pubs%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;accordionHeadingWrapper=h2&amp;onlyLog=true"><span class=section__title id=references-section-1>REFERENCES</span><i aria-hidden=true class=icon-section_arrow_d></i></div>
 </h2>
 <div class=accordion__content style=display:none role=region aria-labelledby=references-section-1 id=dom13477-bibl-0001>
 
 </div>
 </div>
 </section>
 </section>
 <div style=display:none>
 
 </div>
 <div class=pb-dropzone data-pb-dropzone=citedBy-dropzone><section id=cited-by class="article-section article-section__citedBy cited-by"><div class="accordion article-accordion"><h2><div tabindex=0 role=button aria-controls=cited-by__content aria-expanded=false class=accordion__control><span id=citedby-section class=section__title>Citing Literature</span><i aria-hidden=true class=icon-section_arrow_d></i></div></h2><div id=cited-by__content data-source="/pb/widgets/citedBy?page=0&amp;widgetId=f6d59956-1f70-4e88-8811-a42ff3d9d1fa&amp;pbContext=%3BrequestedJournal%3Ajournal%3A14631326%3Bissue%3Aissue%3Adoi%5C%3A10.1111%2Fdom.2019.21.issue-1%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1111%2Fdom.13477%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3A14631326%3Bwebsite%3Awebsite%3Adom-pubs%3Bwgroup%3Astring%3APublication+Websites%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="accordion__content cited-by__content" style=display:none></div></div></section></div>
 </article></div></div><div class="col-lg-4 col-md-4 col-sm-4 hidden-xs hidden-sm hidden-md article-row-right"><div class="publication-cover-info clearfix">
 
 <div class="cover-image-wrapper cover-image__image hasDetails"><a href=https://dom-pubs.onlinelibrary.wiley.com/toc/14631326/2019/21/1 title="View Volume 21, Issue 1"><img src="data:image/jpeg;base64,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" alt></a></div><div class="extra-info-wrapper cover-image__details"><p class=volume-issue><a href=https://dom-pubs.onlinelibrary.wiley.com/toc/14631326/2019/21/1 title="View Volume 21, Issue 1"><span>Volume</span><span class=val>21</span>, <span>Issue</span><span class=val>1</span></a><p>January 2019<p class=page-range><span>Pages</span><span> 28-36</span></p>
 
 
</div>
</div>
 
 
 <div class=pb-ad>
 <div id=advert-rail-1 class="advert advert-rail advert--no-spinner" data-google-query-id=CNWBkc7MzfsCFQno4wcdmjsELg>
 
 
 
 <div id=google_ads_iframe_/2215/wly.endocrin_000051/diabetes-obesity-metabolism_dom_1__container__ style="border:0pt none"></div></div>
 </div>
 
<div class=tabs__wrapper><div data-default-tab=related class="tab tab--slide tab--flex sticko__md tabs--xs dynamic-sticko article__tab"><ul data-mobile-toggle=slide role=tablist class="rlist tab__nav w-slide--list cloned"><li role=presentation class=tab__nav__item><a id=pane-pcw-referencescon href=#pane-pcw-references data-slide-clone=self aria-controls=#pane-pcw-references role=tab data-toggle=tab data-slide-target=#pane-pcw-references class="tab__nav__item__link article-row-right__tabLinks w-slide__btn references-tab empty" tabindex=-1 aria-selected=false><i aria-hidden=true class=icon-chain></i><h2>References</h2></a><li role=presentation class="tab__nav__item active"><a id=pane-pcw-relatedcon href=#pane-pcw-related data-slide-clone=self aria-controls=#pane-pcw-related role=tab data-toggle=tab data-slide-target=#pane-pcw-related class="tab__nav__item__link article-row-right__tabLinks w-slide__btn related-tab" tabindex=0 aria-selected=false><i aria-hidden=true class=icon-related-circles-extend-button></i><h2>Related</h2></a><li role=presentation class=tab__nav__item><a id=pane-pcw-detailscon href=#pane-pcw-details data-slide-clone=self aria-controls=#pane-pcw-details role=tab data-toggle=tab data-slide-target=#pane-pcw-details class="tab__nav__item__link article-row-right__tabLinks w-slide__btn details-tab empty" tabindex=-1 aria-selected=false><i aria-hidden=true class=icon-Icon_Information></i><h2>Information</h2></a></ul><div role=presentation class=tab__content><div id=pane-pcw-references aria-labelledby=pane-pcw-referencescon role=tabpanel class="tab__pane article-row-right__panes empty sf-hidden" aria-hidden=true></div><div id=pane-pcw-related aria-labelledby=pane-pcw-relatedcon role=tabpanel class="tab__pane article-row-right__panes active" aria-hidden=true><div data-pb-dropzone=relatedTabDropZone class="pb-dropzone ui-sortable">
<div>
<h3 class=show-recommended__title>Recommended</h3><div data-exp-type data-query-id=10.1111/dom.13477 class=show-recommended__content><ul class="rlist lot"><li class=grid-item><div class=creative-work><p class=creative-work__title><a href=https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.13696 class=visitable>Effects of sodium-glucose cotransporter inhibitors on cardiorenal and metabolic systems: Latest perspectives from the outcome trials</a><div class="loa comma"><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Lim%2C+Soo"><span>Soo Lim MD<i aria-hidden=true class="icon-mail_outline sf-hidden"></i></span></a><span class="comma-separator sf-hidden">, </span></span></span></div><div class=parent-item><span><a href=https://dom-pubs.onlinelibrary.wiley.com/journal/14631326 class=visitable>Diabetes, Obesity and Metabolism</a></span></div></div><li class=grid-item><div class=creative-work><p class=creative-work__title><a href=https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.14474 class=visitable>Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: An observational study using data from routine care</a><div class="loa comma"><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Fralick%2C+Michael"><span>Michael Fralick MD<i aria-hidden=true class="icon-mail_outline sf-hidden"></i></span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Schneeweiss%2C+Sebastian"><span>Sebastian Schneeweiss MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Redelmeier%2C+Donald+A"><span>Donald A. Redelmeier MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Razak%2C+Fahad"><span>Fahad Razak MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Gomes%2C+Tara"><span>Tara Gomes PhD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Patorno%2C+Elisabetta"><span>Elisabetta Patorno MD</span></a><span class="comma-separator sf-hidden">, </span></span></span></div><div class=parent-item><span><a href=https://dom-pubs.onlinelibrary.wiley.com/journal/14631326 class=visitable>Diabetes, Obesity and Metabolism</a></span></div></div><li class=grid-item><div class=creative-work><p class=creative-work__title><a href=https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.14657 class=visitable>Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease</a><div class="loa comma"><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Rhee%2C+Jinnie+J"><span>Jinnie J. Rhee ScD<i aria-hidden=true class="icon-mail_outline sf-hidden"></i></span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Han%2C+Jialin"><span>Jialin Han MS</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Montez-Rath%2C+Maria+E"><span>Maria E. Montez-Rath PhD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Kim%2C+Sun+H"><span>Sun H. Kim MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Cullen%2C+Mark+R"><span>Mark R. Cullen MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Stafford%2C+Randall+S"><span>Randall S. Stafford MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Winkelmayer%2C+Wolfgang+C"><span>Wolfgang C. Winkelmayer MD, ScD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Chertow%2C+Glenn+M"><span>Glenn M. Chertow MD</span></a><span class="comma-separator sf-hidden">, </span></span></span></div><div class=parent-item><span><a href=https://dom-pubs.onlinelibrary.wiley.com/journal/14631326 class=visitable>Diabetes, Obesity and Metabolism</a></span></div></div><li class=grid-item><div class=creative-work><p class=creative-work__title><a href=https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.13424 class=visitable>Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (OBSERVE-4D)</a><div class="loa comma"><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Ryan%2C+Patrick+B"><span>Patrick B. Ryan PhD<i aria-hidden=true class="icon-mail_outline sf-hidden"></i></span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Buse%2C+John+B"><span>John B. Buse MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Schuemie%2C+Martijn+J"><span>Martijn J. Schuemie PhD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=DeFalco%2C+Frank"><span>Frank DeFalco BA</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Yuan%2C+Zhong"><span>Zhong Yuan MD, PhD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Stang%2C+Paul+E"><span>Paul E. Stang PhD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Berlin%2C+Jesse+A"><span>Jesse A. Berlin ScD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Rosenthal%2C+Norman"><span>Norman Rosenthal MD</span></a><span class="comma-separator sf-hidden">, </span></span></span></div><div class=parent-item><span><a href=https://dom-pubs.onlinelibrary.wiley.com/journal/14631326 class=visitable>Diabetes, Obesity and Metabolism</a></span></div></div><li class=grid-item><div class=creative-work><p class=creative-work__title><a href=https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.14261 class=visitable>Effectiveness and safety of sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A nationwide population-based study</a><div class="loa comma"><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Han%2C+Seung+Jin"><span>Seung Jin Han MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Ha%2C+Kyoung+Hwa"><span>Kyoung Hwa Ha PhD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Lee%2C+Nami"><span>Nami Lee MD</span></a><span class=comma-separator>, </span></span></span><span class=comma__item><span><a class=publication_contrib_author href="https://dom-pubs.onlinelibrary.wiley.com/action/doSearch?ContribAuthorRaw=Kim%2C+Dae+Jung"><span>Dae Jung Kim MD<i aria-hidden=true class="icon-mail_outline sf-hidden"></i></span></a><span class="comma-separator sf-hidden">, </span></span></span></div><div class=parent-item><span><a href=https://dom-pubs.onlinelibrary.wiley.com/journal/14631326 class=visitable>Diabetes, Obesity and Metabolism</a></span></div></div></ul></div>
</div>
</div></div><div id=pane-pcw-details aria-labelledby=pane-pcw-detailscon role=tabpanel class="tab__pane article-row-right__panes empty sf-hidden" aria-hidden=true></div><div class=tab__spinner style=display:none></div></div></div></div><div class="articleAdvert fixed-element" style=top:0px>
 
 
 <div class=pb-ad>
 <aside>
 <div id=advert-rail-2 class="advert advert-rail advert--no-spinner" data-google-query-id=CNaBkc7MzfsCFQno4wcdmjsELg>
 
 
 
 <div id=google_ads_iframe_/2215/wly.endocrin_000051/diabetes-obesity-metabolism_dom_2__container__ style="border:0pt none"></div></div><div class="sr-only js--adFocusableEl" aria-hidden=true tabindex=-1></div>
</aside>
 </div>
 
</div></div></div></article><div id=figure-viewer data-ux3-wrapper=figure-viewer data-ux3-transformed-by=figureInit data-ux3-role=parent role=dialog class="figure-viewer js--focusCycle sf-hidden"></div>
 
 <div style=text-align:right!important><a style=font-weight:300!important;font-size:90% href=https://dom-pubs.onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13477>Download PDF</a></div>
</div>
</div></div></div>
 </section>
 
 </div>
 </div>
<div class="w-slide padding-top">
 <div class=w-slide_head>
 <a class=w-slide__back>
 <i class=icon-arrow_l aria-hidden=true></i>
 <span>back</span>
 </a>
 <span class=w-slide__title></span>
 </div>
 <div class=w-slide__content></div>
 </div></main>
 </div>
 
 <div data-widget-def=pageFooter data-widget-id=053994f3-7d80-4bb1-97a4-c67fbc4768cd class=pageFooter>
 
 
 <footer class=page-footer>
 <div data-pb-dropzone=main>
 
 <section data-widget-def=ux3-layout-widget data-widget-id=efb69c87-9ba0-4904-93cf-43e770aee16e class="footer-sections padded-content hub-footer hub-first-footer">
 
 
 <div class=container><div class=row><div>
 <div data-widget-def=ux3-layout-widget data-widget-id=cae47753-902f-4371-98d0-422ea9741270>
 
 
 <div class=container><div class=row><div class=col-md-4>
 <div data-widget-def=ux3-general-image data-widget-id=cdd2cb52-dd6b-403e-bac5-424c44c43d67 class=hub-footer-logo>
 
 
 <img alt="Diabetes, Obesity and Metabolism Logo" src=data:image/png;base64,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>
 </div>
 
 
 <div class="hub-copyright hidden-xs hidden-sm hidden-md">
© John Wiley &amp; Sons Ltd
</div>
</div><div class=col-md-4>
 <div data-widget-def=UX3HTMLWidget data-widget-id=2c559261-a434-444d-8836-b1967ce4a89e class=hub-links>
 
 
 <ul class=rlist>
 <li><a href=https://dom-pubs.onlinelibrary.wiley.com/hub/journal/14631326/homepage/productinformation.html>About DOM</a></li>
</ul> 
 </div>
 
</div><div class=col-md-4>
 <div data-widget-def=UX3HTMLWidget data-widget-id=4f2c6ddf-29e8-448d-9659-ff1d3c01effd class=hub-links>
 
 
 <ul class=rlist>
 
</ul> 
 </div>
 
</div></div></div>
 </div>
 
 
 <div class=col-md-12>
 <div class="hub-copyright visible-xs visible-sm visible-md sf-hidden">
 © John Wiley &amp; Sons Ltd
 </div>
</div>
</div></div></div>
 </section>
 
 
 <div class=main-footer>
 
 <style class=sf-hidden>.footer-links{text-align:center}.footer-links h3{font-weight:300}.footer-links a{font-weight:600}@media (min-width:992px){.footer-links{text-align:left}}</style>
 <div data-widget-def=ux3-layout-widget data-widget-id=2753bec1-a79d-4403-827b-6c788ddd6db3 class=footer-sections>
 
 
 <h2 class=sr-only>
 Additional links
 </h2>
 
 <div class=container><div class=row><div class=col-md-3>
 
 <div class="footer-links mb-3">
 <h3>About Wiley Online Library</h3>
 <ul class=rlist>
 <li><a href=https://www.wiley.com/privacy>Privacy Policy</a></li>
 <li><a href=https://onlinelibrary.wiley.com/terms-and-conditions>Terms of Use</a></li>
 <li><a href=https://onlinelibrary.wiley.com/cookies>About Cookies</a></li>
 <li><button class=mange-cookies-btn>Manage Cookies</button></li>
 <li><a href=https://onlinelibrary.wiley.com/accessibility>Accessibility</a></li>
 <li><a href=https://onlinelibrary.wiley.com/publishing-policies>Wiley Research DE&amp;I Statement and Publishing Policies</a></li>
 </ul>
</div>
<style class=sf-hidden>.mange-cookies-btn{background:none;color:inherit;border:none;padding:0;cursor:pointer;font-weight:600}.mange-cookies-btn:hover,.mange-cookies-btn:focus,.mange-cookies-btn:active{text-decoration:none;outline:0;background-color:transparent}.mange-cookies-btn:focus{outline:5px auto -webkit-focus-ring-color}</style>
</div><div class=col-md-3>
 
 <div class="footer-links mb-3">
 <h3>Help &amp; Support</h3>
 <ul class=rlist>
 <li><a href=https://hub.wiley.com/community/support/onlinelibrary>Contact Us</a></li>
 <li><a href=https://www.wiley.com/customer-success/wiley-online-library-training-hub>Training and Support</a></li>
 <li><a href=https://onlinelibrary.wiley.com/dmca-notification-policy>DMCA &amp; Reporting Piracy</a></li>
 
 </ul>
 </div>
</div><div class=col-md-3>
 
 <div class="footer-links mb-3">
 <h3>Opportunities</h3>
 <ul class=rlist>
 <li><a href=https://onlinelibrary.wiley.com/agents>Subscription Agents</a></li>
 <li><a href=https://onlinelibrary.wiley.com/advertisers>Advertisers &amp; Corporate Partners</a></li>
 </ul>
 </div>
</div><div class=col-md-3>
 
 <div class="footer-links mb-3">
 <h3>Connect with Wiley</h3>
 <ul class=rlist>
 <li><a href=https://www.wiley.com/network>The Wiley Network</a></li>
 <li><a href=https://newsroom.wiley.com/>Wiley Press Room</a></li>
 </ul>
 </div>
</div></div></div>
 </div>
 
 <div data-widget-def=ux3-layout-widget data-widget-id=86584e25-e4db-4118-9550-9b4f5341a4ac class=copyright-container>
 
 
 <div class=container><div class=row><div class=col-md-12>
 <div data-widget-def=UX3HTMLWidget data-widget-id=bfbf6c5d-a650-4662-828f-5275fada9120 class=copyright>
 
 
 <div class="copyright pull-left">Copyright © 1999-2022 <a href=https://www.wiley.com/>John Wiley &amp; Sons, Inc</a>. All rights reserved</div>
 </div>
 
 
 <div class="footer-logo pull-right">
 
<a href=https://www.wiley.com/ title="Wiley Home Page" aria-label=Wiley><img alt="Wiley Home Page" src="data:image/png;base64,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"></a>
</div>
</div></div></div>
 </div>
 
</div>
 </div>
</footer>
 </div>
 
 
 
<div class="popup login-popup hidden sf-hidden" role=dialog tabindex=-1 aria-labelledby=loginPopupHead>
 
</div>
 
 
<div class="popup change-password-drawer hidden sf-hidden" role=dialog tabindex=-1 aria-labelledby=changePasswordPopupHead>
 
</div>
 
 
<div class="popup registration-popup hidden sf-hidden" role=dialog tabindex=-1 aria-labelledby=createAccountPopupHead>
 
</div>
 
 
<div class="popup top-drawer request-reset-password-drawer hidden sf-hidden" role=dialog tabindex=-1 aria-labelledby=resetPasswordPopupHead>
 
</div>
 
 
<div class="popup top-drawer request-username-drawer username-popup hidden sf-hidden" role=dialog tabindex=-1 aria-labelledby=requestUsernamePopupHead>
 
 
</div>
 
 
 </div>
 </div><img src="data:image/gif;base64,R0lGODlhAQABAIABAAAAAP///yH5BAEAAAEALAAAAAABAAEAAAICTAEAOw==">
 
 
 
 
 
 
 
 
 
 
<div style=visibility:hidden;height:1px;width:1px;position:absolute;top:-9999px;z-index:100000 id=_atssh></div><div id=crossmark-widget style=display:none></div><ul class="ui-autocomplete ui-front ui-menu ui-widget ui-widget-content ui-corner-all quickSearchAutocomplete" id=ui-id-1 tabindex=0 style=display:none;padding-top:0px></ul><ul class="ui-autocomplete ui-front ui-menu ui-widget ui-widget-content ui-corner-all quickSearchAutocomplete" id=ui-id-2 tabindex=0 style=display:none;padding-top:0px></ul><ul class="ui-autocomplete ui-front ui-menu ui-widget ui-widget-content ui-corner-all quickSearchAutocomplete" id=ui-id-3 tabindex=0 style=display:none;padding-top:0px></ul><img src=data:, style=display:none width=1 height=1><img src=data:, style=display:none width=1 height=1>